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Summary 
Gastrointestinal diseases, and in particular those caused by bacterial infections, are a major 
cause of morbidity and mortality worldwide. Treatment is becoming increasingly difficult 
due to the increase in number of species developing resistance to antibiotics. Different 
treatment strategies need to be developed. 
Probiotic lactic acid bacteria (LAB) have considerable potential as alternatives to antibiotics, 
both in prophylactic and therapeutic applications. Lactic acid bacteria have a long history of 
safe use in food and therapeutic products and is increasingly recognised for their beneficial 
effects. However, the underlying mechanisms by which probiotic LAB enhance the health of 
the consumer have not been fully elucidated. Demonstrating key antimicrobial and protective 
probiotic mechanisms in vivo will allow for industry and consumers to choose scientifically 
validated probiotics for the prevention or treatment of targeted gastrointestinal diseases. The 
present study aimed to contribute to this area of probiotic research. 
The first part of this study focus on monitoring the survival, metabolic activities and 
persistence of Lactobacillus plantarum 423 and Enterococcus mundtii ST4SA in the 
gastrointestinal tract (GIT) of mice using a bioluminescence imaging (BLI) system. The route 
and destination of both probiotic strains in the GIT were determined after single and multiple 
doses. Both strains prominently colonized the cecum and colon. Enterococcus mundtii 
ST4SA persisted in the GIT and faeces the longest and in higher numbers while also actively 
colonizing the small intestine. This is the first report of in vivo and ex vivo BLI of E. mundtii 
ST4SA in a murine model. 
The second part of the study encompassed the development of a novel system that facilitates 
the rapid and efficient isolation of double-crossover integration or deletion mutants of L. 
plantarum 423 and E. mundtii ST4SA. The system was useful in the construction of L. 
plantarum 423 and E. mundtii ST4SA bacteriocin and adhesion gene mutants. The newly 
described method expands the LAB molecular research genetic toolkit and has significant 
potential to allow genetic modification of most, if not all LAB species. This provides the 
unique opportunity to study the role of specific probiotic LAB genes in complex 
environments using reverse genetics analysis.  
In the final part of the study, the ability of L. plantarum 423 and E. mundtii ST4SA to 
competitively exclude L. monocytogenes EGDe, an intestinal pathogen, from the GIT of mice 
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was proven. Valuable insight was gained on the molecular modes of action of the two 
probiotic strains. Plantaricin 423 and mundticin ST are bacteriocins produced by L. 
plantarum 423 and E. mundtii ST4SA, respectively. Bacteriocin-negative mutants of L. 
plantarum 423 and E. mundtii ST4SA failed to exclude L. monocytogenes EGDe from the 
GIT, confirming in situ bacteriocin production as an anti-infective mediator. Additional 
confirmation of in situ bacteriocin production as a mechanism of action was provided by 
using variant strains of L. monocytogenes EGDe expressing the immunity genes of 
plantaricin 423 and mundticin ST, respectively, which provided resistance to the respective 
bacteriocins. Furthermore, the exclusion of L. monocytogenes EGDe from the GIT was 
reduced when mice were administered with L. plantarum 423 and E. mundtii ST4SA 
adhesion gene knockout strains. These results substantiate our understanding of the functional 
attributes of probiotics currently available to consumers and the improvement of future 
probiotic products. 
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Opsomming 
Spysverteringskanaal (SVK) siektes, en veral dié wat veroorsaak word deur bakteriële 
infeksies, is wêreldwyd 'n belangrike oorsaak van morbiditeit en mortaliteit. Behandeling van 
SVK siektes word toenemend moeiliker weens 'n toename in die getal spesies wat weerstand 
ontwikkel teen antibiotika. Verskillende behandel strategieë moet ontwikkel word. 
Probiotiese melksuur bakterieë (MSB) het potensiaal as ‘n alternatief vir antibiotika, in 
profilaktiese- sowel as terapeutiese-toepassings. Melksuur bakterieë het 'n lang geskiedenis 
van veilige gebruik in voedsel- en terapeutiese produkte en geniet toenemend erkenning vir 
hul voordelige uitwerking op die mens se gesondheid. Die onderliggende meganismes 
waarvolgens probiotiese MSB die gesondheid van die verbruiker verbeter, is egter nie ten 
volle toegelig nie. Demonstrasie van belangrike antimikrobiese en beskermende probiotiese 
meganismes in vivo sal die industrie en verbruikers toelaat om wetenskaplik gevalideerde 
probiotika te kies vir die voorkoming of behandeling van geteikende SVK siektes. Die 
huidige studie beoog om by te dra tot hierdie gebied van probiotiese navorsing. 
Die eerste gedeelte van die studie fokus op die monitering van die oorlewing, metaboliese 
aktiwiteite en volharding van Lactobacillus plantarum 423 en Enterococcus mundtii ST4SA 
in die SVK van muise deur gebruik te maak van 'n bioluminisensie beeldvorming (BLB) 
stelsel. Die roete en ligging van beide probiotiese stamme in die SVK is suksesvol bepaal ná 
enkel- en veelvuldige dosisse. Beide stamme is prominent teenwoordig in die cecum en 
kolon. Enterococcus mundtii ST4SA het die langste, en teen hoër selgetalle, in die SVK 
oorleef, terwyl die dunderm ook aktief gekoloniseer is. Hierdie is die eerste bekendmaking 
van in vivo en ex vivo BLB van E. mundtii ST4SA in 'n muis model. 
Die tweede deel van die studie het betrekking op die ontwikkeling van 'n nuwe sisteem wat 
die vinnige en doeltreffende isolasie van dubbel oorkruis-integrasie of delesie mutante van L. 
plantarum 423 en E. mundtii ST4SA insluit. Die sisteem is nuttig vir die konstruksie van L. 
plantarum 423 en E. mundtii ST4SA bakteriosien- en adhesie mutante. Die nuut beskryfde 
metode maak ‘n belangrike bydrae tot die molekulêre tegnieke vir MSB en het die potensiaal 
om genetiese modifikasie van die meeste, indien nie alle, MSB-spesies, toe te laat. Dit bied 
die unieke geleentheid om die rol van spesifieke probiotiese MSB-gene in komplekse 
omgewings te bestudeer deur middel van omgekeerde genetiese analise. 
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In die finale deel van die studie is bewys dat L. plantarum 423 en E. mundtii ST4SA die 
vermoë het om L. monocytogenes EGDe, ‘n patogeen, uit die SVK te verwyder. Waardevolle 
insig is verkry rakende die molekulêre werkswyse van die twee probiotiese stamme. 
Plantaricin 423 and mundticin ST is bakteriosiene wat onderskeidelik deur L. plantarum 423 
en E. mundtii ST4SA geproduseer word. Bakteriosien-negatiewe mutante van L. plantarum 
423 en E. mundtii ST4SA het nie daarin geslaag om L. monocytogenes EGDe in die SVK te 
onderdruk nie. Dit bevestig dat die in situ produksie van bakteriosiene ‘n belangrike rol speel 
in die bekamping van infeksies in die SVK. Ter bevestiging hiervan het stamme van L. 
monocytogenes EGDe, waarin die immuniteitsgene van plantaricin 423 en mundticin ST 
gekloneer is, weerstand gebied teen die twee bakteriosiene. Verdermeer het pogings om L. 
monocytogenes EGDe van die SVK te verwyder afgeneem met die dosering van L. plantarum 
423 en E. mundtii ST4SA waarvan adhesie gene verwyder is. Hierdie resultate ondersteun 
ons begrip van die funksionele eienskappe van probiotika wat tans beskikbaar is vir 
verbruikers en die verbetering van toekomstige probiotiese produkte. 
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Preface 
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Introduction 
Motivation for the study 
The term probiotics stems from the Greek word “pro-bios”, meaning- for life and is defined 
as viable microorganisms which, when administered in sufficient amounts, confer health-
promoting effects on the host (1). Probiotics play a major role in maintaining a healthy and 
stable intestinal microbiota, primarily by preventing infection (2). Several studies have shown 
that probiotics, when administered orally, can be used for the prevention or treatment of 
infectious diseases, acute or antibiotic-associated diarrhoea, the alleviation of constipation, 
bloating and atopic dermatitis, colon cancer and irritable bowel syndrome, also known as IBS 
(3-8). As a result of these findings, there is a growing appreciation for the potential of 
probiotic microorganisms (9). In recent years, a remarkable number of probiotic-containing 
commercial products that confer beneficial health-effects on the host have been developed. 
However, the mechanisms employed by probiotic microorganisms responsible for these 
effects have not been fully elucidated. 
Lactic acid bacteria (LAB) are the most important species used as probiotics for the 
maintenance of a healthy and stable human gastrointestinal microflora and the treatment of 
gastrointestinal tract (GIT) disorders (10, 11). The most predominant genera used in 
probiotics are Lactococcus, Lactobacillus and Bifidobacterium (9). Lactic acid bacteria 
strains are characterized by their production of lactic acid and comprise a large variety of 
microorganisms that have been used for thousands of years for the production and 
preservation of fermented foods (12). Moreover, LAB are indigenous colonists of the GIT of 
humans and animals, and are believed to be among the most prevailing inhabitants of the 
small and large intestine. The GIT is considered to be the most important field of activity 
where probiotic LAB exert their host-health promoting effects when orally administered (2, 
9). Thus, it is important to understand the mechanisms whereby the administered bacteria 
exert their beneficial effects and the interaction between the bacteria and the host GIT. In the 
past, several in vitro studies simulating gastrointestinal models have been used to evaluate 
probiotics (13-17). Although in vitro models have produced valuable data on the survival of 
probiotic LAB in gastrointestinal conditions, these methods are not a true reflection of in situ 
conditions. A more complete understanding of the in vivo metabolic activities, adherence to 
epithelial cells, antimicrobial activity and interaction of probiotic LAB with their host GIT 
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system can be facilitated by direct in vivo tracking of these processes using cells labelled with 
reporter genes. 
Bioluminescence imaging (BLI) represents one of the most remarkable uses of imaging 
technologies by allowing for in vivo non-invasive monitoring of cells expressing luciferase 
genes in real-time (18-20). Researchers have used bacterial and eukaryotic luciferase genes to 
track viral and bacterial infections, and as reporters of gene expression and tumour growth in 
small animals (18-23). The BLI technique is based on the detection and quantification of 
visible light produced by luciferase enzymes in the presence of ATP (23).  
Numerous studies using rodent models of infection have demonstrated the role of probiotic 
LAB in the treatment or prevention of infectious diseases caused by Salmonella typhimurium, 
Helicobacter pylori, enteropathogenic Escherichia coli, Citrobacter rodentium and Listeria 
monocytogenes (24-28). Although many of these papers have provided incremental support to 
the health-benefits of probiotic LAB, few address the causal relationship between their 
effects and their mechanistic basis of action. Thus, in vivo identification of the precise 
mechanistic basis of the beneficial effects conferred by probiotic LAB to the host remains a 
significant goal. 
In this study, BLI was implemented to allow a better understanding of the survival and 
metabolic activities of two relatively new LAB strains included in the probiotic product 
entiro
TM
. Bioluminescence imaging allowed the direct in vivo monitoring of the spatial and 
temporal persistence of the strains Lactobacillus plantarum 423 and Enterococcus mundtii 
ST4SA. In the second part of the study, the mechanisms by which the two probiotic strains 
suppresses the growth of Listeria monocytogenes EGDe in the GIT was studied. Specifically, 
the role of bacteriocins and adhesion proteins as in vivo probiotic mechanisms of action were 
investigated. Mice were used as experimental animals. A novel system was developed for the 
efficient detection of single or multiple gene knockouts in L. plantarum 423 and E. mundtii 
ST4SA. In addition, bacteriocin immune variant strains of L. monocytogenes EGDe were 
constructed. Using BLI, the interaction of the probiotic strains with L. monocytogenes EGDe 
in the GIT could be monitored in real-time, at molecular level. 
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Probiotic-Pathogen Interactions 
1. Introduction 
Lactic acid bacteria (LAB) play an important role in various applications, as starter cultures 
in fermented food products, food bio-preservation agents and as probiotic health supplements 
(1-4). The beneficial effects of probiotic LAB on human and animal health have been 
extensively researched. Some of the most important probiotic effects are stimulation of the 
host’s immune system, the prevention of antibiotic-associated diarrhoea, treatment of 
inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), the alleviation of 
lactose intolerance, lowering of cholesterol levels and prevention of life-threatening 
gastrointestinal infectious diseases such as Clostridium difficile-associated diarrhoea (5-10). 
It is thus not surprising that in recent years a profitable probiotic market has emerged together 
with an increasing number of probiotic-containing supplements conferring specific health 
benefits to the consumer (5, 11). Examples of successful probiotics and their effects are listed 
in Table 1. 
The primary habitat for LAB species used as probiotic health-supplements is either the small 
intestine or colon (large intestine) where they are among the most dominant colonizing 
organisms (11, 15). It is therefore important to have an in-depth understanding of the specific 
metabolic and genetic interactions between the administered probiotic bacteria, the host 
intestinal mucosa and enteric pathogens in the gastrointestinal tract (GIT). Ultimately, the 
detailed characterization of these interactions will significantly improve the application of 
probiotics to support and enhance human health.  
Probiotic LAB have shown remarkable potential for preventative and therapeutic applications 
in various gastrointestinal disorders, especially those caused by enteric pathogens (Table 2). 
Probiotic bacteria mediate their beneficial effects by interacting with the enteric pathogens to 
prevent the intestinal colonization of the pathogenic bacteria and the occurrence of disease. 
The mechanisms underlying these probiotics-pathogen interactions generally include the 
following categories: competitive exclusion, secretion of antimicrobial substances, 
strengthening of the gut mucosal barrier and modulation of immune responses (30-33). 
Figure 1 depicts a summarized overview of the different modes of action by which probiotics 
exclude pathogens from the GIT. Several probiotic strains, particularly strains from 
Bifidobacterium and Lactobacillus genera, improve resistance to intestinal infections by 
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inhibiting the growth of potentially harmful bacteria in the gut (11, 30). Nevertheless, for 
probiotics to confer their beneficial effects on the host, they must be able to resist stomach 
acid and bile and persist at high levels in the intestinal tract (11, 34).  
In the first part of this chapter, the survival of probiotics in the GIT and their in vivo 
persistence are reviewed. Finally, probiotic mechanisms of action and their health-promoting 
effects through interaction with enteric pathogens are discussed. 
TABLE 1. Examples of successful probiotics and reported effects 
Strain Reported effects 
Lactobacillus acidophilus LA1 Immune enhancement, modulation of intestinal microflora, adherence to 
human intestinal cells, adjuvant in Helicobacter pylori treatment 
 
L. acidophilus NFCO 1748 Treatment of constipation, used in prevention or alleviation of 
radiotherapy diarrhoea, lowering of faecal enzymes 
 
L. rhamnosus GG (ATCC 53103) Reduction of antibiotic-associated diarrhoea, treatment and prevention of 
rotavirus and Clostridium difficile associated diarrhoea, immune 
enhancement, treatment of Crohn’s disease, used for alleviation of atopic 
dermatitis in children, stabilisation of intestinal permeability 
 
L. plantarum 299v Modulation of intestinal microflora, prevention of antibiotic-associated 
diarrhoea 
L. reuteri SD2112 
 
Significantly decreases diarrhoea symptoms in infants and children 
Bifidobacterium bifidum Prevention and treatment of rotavirus diarrhoea, modulates intestinal 
microflora 
 
Pediococcus pentasaceus NB-17 Stimulation of immune cells and cytokines, stimulation of allergic 
inhibitory effects 
 
Oenococcus oeni 9115 Immune enhancer, significantly decreases acid-induced colitis in mice 
 
Lactobacillus casei Shirota Immune enhancer, modulates intestinal microflora, treatment of rotavirus 
diarrhoea, lowering of faecal enzymes, positive effects in the treatment of 
superficial bladder and cervical cancer 
 
Lactobacillus reuteri (BioGaia 
Biologicals) 
Reduces rotavirus diarrhoea symptoms in children, treatment of acute 
diarrhoea, safe in HIV-positive adult patients 
  
Lactobacillus bulgaricus Treatment of diarrhoea, modulates intestinal flora 
  
Bifidobacterium infantis UCC 3624 Modulates intestinal flora, reduces clostridia levels, immune enhancer, 
increased blood phagocytic levels 
  
Saccharomyces boulardii Prevention and treatment of antibiotics associated and acute diarrhoea in 
children, treatment of C. difficile colitis, prevention of diarrhoea in 
critically ill tube-fed patients 
Adapted from (5, 12-14) 
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TABLE 2. Effects of different probiotics on selected gastrointestinal pathogens 
Probiotic strains Pathogen Reported outcomes (in vivo) 
Lactobacillus rhamnosus 
GG (16) 
Helicobacter pylori Reduced diarrhoea and nausea in a human 
trial 
 
L. johnsonii La1 (17) H. pylori Regular ingestion modulated H. pylori 
colonization in children 
 
L. casei DG (18) H. pylori Increased eradication rate of H. pylori 
infection when supplemented with first-line 
therapies 
L. casei CRL431 (19) Salmonella enterica serovar 
Typhimurium 
 
Preventative administration protected mice 
against infection 
L. rhamnosus HN001 
(20) 
Salmonella enterica serovar 
Typhimurium 
 
Conferred immune enhancement and 
protection against Salmonella infection in 
mice 
Bifidobacterium longum 
Bb46 (21) 
Salmonella enterica serovar 
Typhimurium 
 
Protective effect against Salmonella 
challenge in gnotobiotic mice 
 
L. plantarum 423 and 
Enterococcus mundtii 
ST4SA (22) 
Salmonella enterica serovar 
Typhimurium 
 
Alleviated symptoms of Salmonella 
infections in challenge study using rats 
 
L. casei BL23 and L. 
paracasei CNCM I-3689 
(23) 
Listeria monocytogenes Decreased pathogen systemic dissemination 
in orally infected mice 
L. salivarus UC118 (24) L. monocytogenes Protected mice from pathogenic infection in 
liver and spleen 
L. plantarum 423 and E. 
mundtii ST4SA (25) 
 
L. monocytogenes Excluded the pathogen from the intestinal 
tract of mice after daily administrations of 
probiotic strains 
Lactococcus lactis 
MM19 and Pediocin 
acidilactici MM33 (26) 
 
Vancomycin resistant enterococci 
(VRE) 
Modulated intestinal microbiota and 
reduced pathogen intestinal colonization in 
mice. 
L. rhamnosus R0011 and 
L. acidophilus R0052 
(27) 
Citrobacter rodentium Pre-treatment of the probiotic strains 
attenuated pathogen infection in mice 
L. reuteri (28) C. rodentium Attenuated C. rodentium-induced colitis in 
mice 
B. breve (29) Escherichia coli O157:H7 Protected mice from Shiga toxic-producing 
E. coli 
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FIG. 1. Major modes of probiotic mechanisms of action against enteric pathogens in the GIT (32). 
2. Survival and persistence of probiotic bacteria in the GIT 
The human intestinal tract is colonized by a large number of microorganisms, representing a 
highly complex microbial ecosystem. This ecosystem is primarily inhabited by bacteria and is 
mainly confined to the ileum and colon. The large intestine is the most heavily populated area 
of the GIT, containing estimated bacterial concentrations ranging from 10
11
 - 10
12
 CFU/ml of 
contents (35). Moreover, according to a recent study, the ratio between bacterial cells and 
human cells in the human body is one to one (36). These bacteria form part of a microbiota 
that plays an essential role in the breakdown of food particles and the metabolism of faecal 
residue (5). In addition, the microbiota also acts as a protective barrier against pathogens by 
providing mucosal protection and stimulation of the immune system (5). Species of the 
genera Lactobacillus and Bifidobacterium are responsible for many of the beneficial effects 
of the microbiota (37) and are incorporated in most of the commercially available probiotics 
(11, 38) (Table 1).  
Stellenbosch University  https://scholar.sun.ac.za
12 
 
Probiotic species are mainly isolated from the commensal gut microbiota (39). Thus, the 
potential modes of action employed by probiotic bacteria to defend against infectious enteric 
diseases may not differ much from those employed by the natural microbiota. A prerequisite 
of a good probiotic strain is its survival during transit of the acidic conditions of the stomach 
and bile salts in the small intestine in order to colonize the GIT in sufficient numbers (40, 
41). Moreover, the most obvious mechanism of probiotic action against enteric pathogens in 
the GIT involves the production of antimicrobial agents, a task that can only be performed by 
viable and metabolically active cells. The number of viable cells that reach the intestine to 
gain therapeutic benefits may be strain specific and vary by the amount ingested and the 
duration of administration.  
2.1 Factors affecting the survival of probiotic bacteria in the GIT 
In vitro methods that mimic the conditions during gastrointestinal transit are routinely used to 
assess the effect of exposure to different pH values and the presence of bile on potential 
probiotics (42-44). The survival of probiotic cells in stomach acid and bile varies among 
strains and depends on degree of gastric juice acidity, bile concentration and length of 
exposure.  
Once in the stomach, probiotic bacteria are confronted by gastric acid where the pH level can 
be as low as 1.5 (45). Low pH may decrease the survival of probiotic LAB. The best 
probiotics should survive at least a pH of 3.0 (46). Hydrochloric acid (HCl) present in the 
human stomach is a strong oxidizing agent that can destroy important biological compounds 
such as fatty acids, proteins, cholesterol and DNA (47, 48). In an in vitro study, two 
Bifidobacterium strains demonstrated different levels of growth inhibition after exposure to 
simulated gastric juice for 90 min (49). The growth of one strain was inhibited by only 0.5 
log units, whereas the growth of the other strain declined by 4 log units. In another study, in 
vitro growth of six Lactobacillus acidophilus and nine Bifidobacterium strains was 
maintained between pH levels of 1.5-3.0 for a 3 h incubation period (45). The authors 
reported that the growth of Bifidobacterium adolescentis and Bifidobacterium breve was 
retarded at all pH levels (1.5, 2.0, 2.5 and 3.0), while the most robust strains were L. 
acidophilus (strains 2401, 2409 and 2415), Bifidobacterium longum 1941 and B. 
pseudolongum 1969 (45). A report by Hood and Zottola showed that L. acidophilus BG2FO4 
cell numbers declined rapidly at pH 2.0 but that cell numbers did not decrease significantly at 
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pH 4 (50). Moreover, Conway and co-workers (51) reported that bacterial strains that 
originate from the gut have increased levels of gastric acid resistance. In addition to a rapid 
transit time of probiotics in the stomach, the consumption of food also protects probiotic 
LAB during transit through the GIT (52). The buffering capacity of yogurt and milk provides 
a protective effect for bacteria in the GIT (53). Furthermore, Gram-positive bacteria can 
employ several mechanisms that aid resistance to acid. These include, cell envelope structural 
changes, proton pumps, electrogenic transport systems, the decarboxylation of amino acids, 
and the repair or degradation of damaged proteins by chaperones (54). 
Once probiotic cultures reach the upper section of the small intestine (duodenum), the 
secretion of bile greatly affects probiotic survival. Bile salts act as a biological detergent that 
alters the lipids and fatty acid composition in cell membranes and increases the permeability 
of cells (42, 55). In humans, bile and the associated bile acids are continuously produced by 
the liver and stored in the gallbladder (56). After food intake, this stored bile is secreted into 
the duodenum and aids the digestion of lipids and oils (57). The two primary bile acids 
synthesized by the liver are cholic acid and chenodeoxycholic acid which have strong 
inhibitory effects on intestinal bacteria (58). Secondary bile acids such as deoxycholic acids 
(DCA) are toxic to LAB (59). Exposure of Lactobacillus reuteri CRL 1098 to DCA revealed 
changes in the integrity of the cell wall, rendering cells completely permeable and preventing 
glucose uptake, resulting in cell death (59). The rate at which bile is secreted depends on the 
food composition. Food with a high fat content could affect the levels of faecal bile acids, and 
fatty acids may decrease the survival of Lactobacillus and Bifidobacterium spp. (60).  
Probiotics contained in five different brands of commercial milk drinks showed increasing 
levels of inhibition as bile concentrations and pH acidity levels increased (61). The authors 
demonstrated that bile tolerance of the probiotic strains showed a similar trend after pre-
exposure of cells at pH levels 1.5, 3.0 and 7.2 (Table 3 and Fig. 2). Bile concentrations in the 
small intestine range from 0.5 to 2.0 % during the first hour of food digestion (57). Clark and 
Martin reported that the survival rate of B. longum is best in 2% - 4% bile (62). In another 
study, Lankaputhra and Shah reported that the survival rates in bile varied (1-1.5%) 
significantly among strains of Lactobacillus and Bifidobacterium (45). The authors showed 
that while some strains were bile tolerant (L. acidophilus 2404 and B. longum 1941), other 
strains (L. acidophilus 2409 and B. longum 1963) survived poorly in the presence of bile. 
Moreover, yogurt starter cultures Lactobacillus delbrueckii subsp. bulgaricus and 
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Streptococcus thermophilus are not bile resistant and thus unable to survive gastrointestinal 
transit (63). 
TABLE 3. List of probiotic species in commercial milk brands (61)  
Brand Species 
A L. acidophilus 
B L. acidophilus 
C L. casei Shirota  
D L. acidophilus, Streptococcus 
thermophilus, Bifidobacterium strains 
E L. acidophilus, L. casei, 
Bifidobacterium 
 
                  
                                                               
                                                      
 
FIG. 2. Survival of probiotic bacteria in different probiotic brands (A-E, Table 3) at bile 
concentrations of 0% (control), 0.3% and 2% after 24 h incubation period at 37
o
C. Before bile 
resistance test, cells were pre-exposed to pH (A) 1.5, (B) 3 and (C) 7.2 for 3 h (61).  
 
A. B. 
C. 
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Changes in cell wall integrity can protect cells from harsh intestinal conditions (64). Using 
DNA micro-arrays it was demonstrated that genes of Lactobacillus plantarum WCFSI 
involved in membrane and cell wall-associated functions, stress response and redox reactions 
were all up-regulated in the presence of 0.1% porcine bile (64, 65). Survival in bile-rich 
environments also depends on the regulation of gene transcription, amino acid transport and 
fatty acid biosynthesis (66, 67). Bile salt hydrolase (BSH) activity is also important for the 
survival of probiotic LAB in bile. Bile salt hydrolase-encoding genes are present in several 
Lactobacillus spp., thus emphasizing the potential importance of these genes to the survival 
and persistence of strains in the GIT (68). Conjugated bile acids produced in the liver are 
hydrolysed by BSH, thus reducing their bactericidal effects (61, 69). 
The survival of probiotic bacteria during gastrointestinal transit has also been studied in vivo 
by using several animal models (70, 71). In these assessments, the re-isolation of orally 
administered probiotic cells in faecal samples was used to assess the survival of the probiotic 
in the intestinal tract. In a murine model, L. plantarum 423 and Enterococcus mundtii ST4SA 
survived passage through the intestinal tract and persisted in faeces for at least 72 h after a 
single oral administration (72). Lactobacillus casei L26 survived within the GIT of mice for 
at least 48 h after a single oral administration (73). The number of probiotic cells that survive 
gastrointestinal transit is also important. In a human intubation study, the sampling of 
Bifidobacterium spp. from the cecum after administration in fermented milk showed that the 
average number recovered were 23.5 ± 10.4% of the ingested dose (74). In another study, the 
estimated survival of L. bulgaricus NCIMB 8826 in faeces was 25 ± 29% at day 7 (10
8
 
CFU/g) after 7 consecutive daily administrations of 10
8
 CFU and could be detected in faeces 
for two weeks after the last administered dose (75). 
2.2 Colonization and persistence of probiotic bacteria in the GIT 
For a probiotic bacterium to successfully fulfil a prophylactic role it must be able to colonize 
and persist in the digestive tract to confer functional beneficial effects on the host (76, 77). 
While colonization is not an absolute requirement for probiotic activity, LAB strains that 
transit only passively through the GIT are usually not selected as probiotics for industrial 
purposes (78). The in vivo persistence of probiotic organisms is related not only to the 
physiological or genotypical properties of strains, but also the dosage, administration method 
and metabolic activity (79). The intestinal persistence of probiotic LAB is also limited by 
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interactions with the enteric microbiota. Commensal enteric microorganisms compete with 
exogenously administered probiotic bacteria for essential nutritional substrates and mucosal 
adhesion sites (80).  
For probiotic LAB to persist and become permanently established in the host’s intestine, they 
must be able to attach to intestinal mucosal cells (80). The persistence or at least temporary 
colonization of probiotics in the host’s intestine is a phenotypical trait that can be related to 
the beneficial action of probiotics against enteric pathogens. Many enteric pathogens require 
attachment to intestinal mucosal cells to exert their deleterious effects and probiotics have 
been demonstrated to interfere with this adherence (81). This implies that probiotics compete 
with enteric pathogens for intestinal adhesion sites to decrease the activity of the detrimental 
bacteria and in turn proceed to colonize the gut themselves. Several in vitro studies have 
reported that probiotics interfere with the ability of gastrointestinal pathogens such as 
Salmonella typhimurium, Clostridium sporogenes and Enterococcus faecalis, to adhere to 
Caco-2 cells (82-84).  
A review of the literature suggests that many of the earlier studies on the colonization of 
probiotics were based on the ability of the strains to adhere to in vitro cell lines such as Caco-
2, HT-29 and HT29-MTX (85, 86).  Although these studies using simulated GIT-models have 
provided valuable insights into the adherence of probiotic cells, they remain an in vitro 
approach (37). Moreover, colonization studies using cell lines is laborious and requires 
special facilities to maintain the cells. Hence, studies on the survival and colonization of 
administered probiotic bacteria are most frequently done by analysing faecal samples (70). 
Faecal recuperation enables microbiologists to compare the intestinal persistence of different 
probiotic strains provided that the same ingested doses and methods for enumeration are 
used. The in vivo pharmacokinetics of probiotics can be studied by comparing specific strains 
before and after ingestion and whether the ingested bacteria increase in number (in faecal 
material) following consumption (75, 87). The pharmacokinetics of different probiotic LAB 
are listed in Table 4. Species of the Lactobacillus and Bifidobacterium genera have been 
extensively explored as probiotics, since they form an integral part of the natural gut 
microbiome of both humans and animals (88). Strains that persist in high numbers for the 
longest time in faeces are usually considered to be the best probiotics. Bifidobacterium lactis 
LAFTI B94 and B. longum SB T2928 and Lactobacillus rhamnosus DR20 persisted in 
highest proportions or for the longest duration in faeces (Table 4). In comparison, faecal 
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recuperation of Lactococcus lactis MG 1363, L. rhamnosus GG and Lactobacillus fermentum 
KLD was much lower. 
TABLE 4. Pharmacokinetics of probiotic strains 
Adapted from (78). 
Some reports have suggested that non-viable and thus non-colonizing probiotics may also 
confer certain health benefits to the host (11, 89, 90). According to these studies the death of 
probiotic cells in the GIT is not related to the absence of a positive effect given that certain 
beneficial effects produced by live microorganisms may also be due to their metabolites, 
DNA or cell wall components (78). During gastrointestinal passage, non-colonizing or 
transiently colonizing probiotic bacteria continue to be metabolically active, thus conferring 
beneficial health effects to their host (40). In a study by Kullen and co-workers (91), human 
volunteers were administered a Bifidobacterium probiotic strain and the recovery of the strain 
in the faeces was monitored. It was observed that faecal recuperation of the strain increased 
during the days of administration, but that it was no longer recovered in faeces after 
administration was discontinued. The authors concluded that although the administered strain 
did not colonize the human GIT, colonization and prolonged persistence may not be required 
to achieve a significant probiotic effect. Similar results were reported by Fujiwara and co-
workers (92). The authors found that bifidobacteria produce a 100 000-kDa protein, which 
Strain Dosage Faecal recuperation Persistence (day) 
B. lactis LAFTI B94 1 x 10
11
 CFU for 7 days 1.8 x 10
9
 CFU/g 28 
B. lactis Bb12 1 x 10
11
 CFU 8 x 10
7
 CFU/g 14 
B. longum SB T2928 7 x 10
11
 CFU for 7 days 1 x 10
9
 CFU/g >30 
L. rhamnosus GG 6 x 10
10
 CFU for 12 days 4 x 10
4
 CFU/g 14 
L. rhamnosus DR20 1.6 x 10
9
 CFU for ±182 days 6.3 x 10
5
 CFU/g 60 
L. salivarus UCC118 1 x 10
10
 CFU for 21 days 1 x 10
3
-1 x 10
7
 CFU/g >21 
L. plantarum 299v 2 x 10
10
 CFU for 21 days  1 x 10
7
 CFU/g >8 
L. plantarum NCIMB 8826 5 x 10
10
 CFU for 7 days 1 x 10
8
 CFU/g 14 
L. fermentum KLD 1.5 x 10
9
 CFU 3.2 x 10
4
 CFU/g 1 
L. gasseri SBT2055 1 x 10
11
 CFU for 7 days 1 x 10
7
 CFU/g >31 
S. thermophilus 1.2 x 10
12
 CFU 5 x 10
6
 CFU/g 6 
Lc. lactis MG 1363 1 x 10
11
 CFU for 4 days 1 x 10
4
 CFU/g 3 
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actively prevents the adherence of pathogenic Escherichia coli to intestinal mucosal cells. 
Therefore, the competitive exclusion of the pathogenic strain may not have been related to 
direct live cell-to-cell competition for intestinal adhesion sites. 
A major drawback of using only faecal recuperation to analyse in vivo probiotic persistence is 
that it does not accurately reflect the amount of cells that remain colonized in the intestinal 
tract. Furthermore, the microbial inhabitants of faecal samples represent a part of the luminal 
environment that is more indicative of the lower intestine, such as the colon (5). Colonization 
studies in humans using intubation at specific intestinal sites is a better indicator of probiotic 
persistence in the upper sections of the GIT. Biopsies can be taken of the portions of the 
intestinal tract where probiotics are likely to colonize, proliferate and produce their 
metabolites (75, 78. 93, 94).  
Lactobacillus rhamnosus GG is one of the most studied probiotic strains and reportedly plays 
a role in the prevention or treatment of antibiotic-associated diarrhoea, flatulence, rotavirus 
gastro-enteritis, stomach and abdominal pain (12-14, 95-97). However, when L. rhamnosus 
GG in fermented milk was administered to human volunteers, the strain showed only limited 
persistence in faeces after feeding was stopped (96). The strain was no longer recovered in 
67% of the subjects within 7 days of the last dosage. The same results were obtained when 
the strain was fed in milk formulas to premature infants (98). However, Alander and co-
workers (94) reported that L. rhamnosus GG was recoverable from colonic biopsies for 
lengthy periods after its administration was ceased. Human volunteers were administered 
with 6 x 10
10
 CFU of L. rhamnosus GG twice a day for 12 consecutive days. The authors 
observed that the amount of L. rhamnosus GG recuperated in the faeces decreased with time 
after the last bacterial dosage was administered and that the strain disappeared completely 
from faeces 14 days after the last dosage.  However, L. rhamnosus GG persisted in biopsies 
taken from the colonic mucosa for up to 21 days at 7 x 10
4
 CFU/biopsy sample after 
consumption ceased (94). Concluded from these results and others, faecal emuneration for 
analysis of probiotic persistence is not truly reflective of real in situ conditions in the human 
digestive tract. 
2.3 Optical imaging techniques to study probiotic bacteria in vivo 
The survival and persistence of probiotic or pathogenic bacteria in the GIT are mostly based 
on in vitro models and the analysis of faecal samples (37, 70). However, in vitro models are 
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not a true reflection of real-life conditions and faecal recuperation does not accurately reflect 
the amount of cells that remain colonized in the intestinal tract or the bacterial sites of 
colonization in the intestinal tract. Using bioluminescence imaging (BLI), the spatial and 
temporal course of colonization or infection can be detected without killing large numbers of 
animals (99). For a review on the application of optical imaging systems in the in vivo 
tracking of LAB in small animals, refer to the article by Van Zyl et al. (100). 
Optical imaging techniques are used in in vivo studies to track probiotic or pathogenic 
bacteria in the GIT of small animals (101). Bioluminescence imaging is used for real-time, 
non-invasive, monitoring of bacterial cells that are genetically tagged with light-producing 
luciferase genes (101). The light produced by cells tagged with luciferase is detectable 
through the tissues of live small animals using an in vivo imaging system (IVIS). Luciferases 
produce bioluminescent light in the presence of ATP and oxygen (100). The BLI technique is 
a means to rapidly and accurately determine sites of bacterial replication because only 
growing or metabolically active cells emit detectable levels of light (100). Numerous studies 
have demonstrated the use of bioluminescent bacteria tagged with bacterial or eukaryotic 
luciferase genes to monitor real-time progression of infection or bacterial colonization in vivo 
(25, 100-103).  
3. Interactions between probiotic and pathogenic bacteria 
Although the viability and persistence of probiotic bacteria in the GIT contribute immensely 
to the ability of strains to exert their beneficial effects on the host, the ultimate goal of 
probiotic research is the characterization of specific probiotic-pathogenic bacteria interactions 
that result in health-promoting effects. However, the exact modes of probiotic action during 
these interactions remain largely uncharacterized (11). Only a few scientific papers provide 
evidence to support the inhibitory activities of probiotic LAB on gastrointestinal pathogens 
(104).  
Elucidating the mechanisms of action of probiotic strains is a difficult task given the complex 
nature of the human GIT. A specific health benefit may also be attributed to a combination of 
mechanisms. The mechanism(s) of action of one specific probiotic strain against a particular 
disease or pathogen cannot be generalized since different strains evoke different responses in 
the host (31). This suggests that probiotic effects may vary from one probiotic strain to 
another. Thus, the health benefits conferred by one strain are not applicable to another strain, 
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even within the same species (32, 105). Furthermore, different probiotic strains are associated 
with different effects relating to their specific capacities to secrete antimicrobial substances or 
to express particular surface proteins interacting directly with host or pathogenic cells (32). 
The specific aspects of potential probiotic mechanisms of action are discussed below (Fig. 1). 
3.1 Competitive exclusion of enteric pathogens 
The term competitive exclusion was first used in a report published in 1969 by Greenberg, 
who used the term to describe the total exclusion of S. typhimurium from maggots of 
blowflies (106). This anti-pathogenic mechanism describes the scenario in which one species 
of bacteria more rigorously competes for intestinal adhesion sites in the GIT than another 
species. The mechanisms of action used by one species of bacteria to exclude another species 
from the GIT are varied and may include microbe-microbe interactions mediated by binding 
to the host mucosal interface at specific attachment sites, the secretion of antimicrobial 
substances and competition for available nutrients (32, 33).  
For enteropathogens to initiate infection, they have to cross the intestinal mucosal barrier 
before colonization of the intestine can occur (107). Once pathogens have penetrated the 
mucus layer overlying the intestinal epithelium they can attach to binding sites on the 
epithelial cells (108). Subsequently, attachment is followed by intestinal colonization and 
infection. One of the mechanisms by which probiotics can protect the gut against enteric 
infections is by preventing this attachment (109). Results from in vitro studies using human 
or animal mucosal material have demonstrated the effect of probiotic LAB on the competitive 
exclusion of pathogens (84, 110-112). A L. rhamnosus strain with excellent adhesion 
properties was able to prevent the internalization of enterohemorrhagic E. coli (EHEC) in 
human intestinal cell lines (110). Enteric pathogens such as EHEC, utilize their mannose-
sensitive type 1 fimbriae to attach to oligosaccharide receptor sites on intestinal epithelial 
cells (IECs) (113). Evidence suggests that probiotics, including lactobacilli and 
bifidobacteria, are capable of attaching to the same specific carbohydrate receptor sites on 
host gut cells so that enteric pathogens are in constant competition for binding and are 
thereby prevented from subsequent pathogenic elaboration of toxins or invasion (32, 114, 
115).  
The host-beneficial effects of different probiotic strains vary and therefore it is reasonable to 
suggest that different probiotics may vary in their effectiveness to block pathogen adhesion 
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sites in the gut. Specific adhesion proteins may contribute to the probiotic competitive 
exclusion mechanism(s) of action, although probiotic inhibition of pathogen attachment to 
enterocyte receptors in the gut based on steric hindrance is also possible (31-33, 116). 
Carbohydrate-binding adhesion proteins on the bacterial cell surface stereo-specifically bind 
to carbohydrate moieties on the intestinal surface (117). For an overview of studies that 
analysed the effect of lactobacilli surface proteins on adhesion using mutant analysis, see 
Table 5. One example of a specific adhesion protein involved in competitive exclusion 
adhesion-receptor interactions in the gut is the L. plantarum mannose-specific adhesion 
(Msa) protein (117). A spontaneously mutated strain of the probiotic L. plantarum 299v, 
thought to be affected in the msa gene, was unable to inhibit the attachment of EHEC to HT-
29 epithelial cells compared to the wild-type (123). This suggests that Msa-containing 
probiotic strains could effectively exclude several other, if not all, type 1 fimbriated 
enteropathogens. 
TABLE 5. Lactobacillus cell surface proteins putatively involved in adhesion 
 
 
Strain Gene Predicted function Mutant phenotype 
L. plantarum WCFS1 (118) srtA Sortase Reduced mannose-specific binding; competitive 
ability in murine GIT not affected 
L. plantarum WCFS1 (118) msa Mannose-specific adhesin Reduced mannose-specific binding 
L. plantarum WCFS1 (119) lp_2940 Sortase-dependent cell 
wall protein 
Reduced  persistence in murine GIT 
L. acidophilus NCFM (120) mub Mucus-binding protein 
(MUB) 
Reduced binding to human Caco-2 cells 
L. acidophilus NCFM (120) slpA S-layer protein Reduced binding to human Caco-2 cells 
L. salivarus UCC18 (121) srtA Sortase Reduced binding to human Caco-2 and HT-29 
cells 
L. salivarus UCC18 (121) lspA Large surface protein 
(LSP), putative MUB 
Reduced binding to human Caco-2 and HT-29 
cells 
L. salivarus UCC18 (121) lspB LSP, putative MUB Binding to human Caco-2 and HT-29 cells not 
affected 
L. reuteri 100-23 (122) lsp LSP Reduced  persistence in murine GIT 
L. johnsonii NCC533 (79) LJ1476 Transpeptidase Sortase Colonization dynamics similar to that of wild-
type 
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Another example of a putative competitive exclusion factor is the collagen-binding protein of 
L. fermentum. Heinemann and co-workers (124) characterized and purified the collagen 
surface-binding protein of the L. fermentum RC-14 strain, which was shown to inhibit the 
adherence of E. faecalis 1131. Other studies have demonstrated the role of surface layer (S-
layer) extracts in the prevention of pathogens from attaching to and thus colonizing IECs 
(125, 126). Chen and co-workers (125) showed that S-layer proteins of Lactobacillus 
crispatus ZJ001 were responsible for competitive exclusion against S. typhimurium and 
EHEC. Similar results were obtained by Johnson-Henry and co-workers (126), who showed 
that S-layer protein extracts from Lactobacillus helveticus R0052 inhibited the adhesion of E. 
coli O157:H7 to the Caco-2 intestinal cell line. However, due to the high hydrophobicity of 
S-layer proteins, the process of pathogen adherence inhibition by S-layers was suggested to 
be mediated by hydrophobic group interactions as opposed to adhesion-receptor interactions.  
Previous studies suggest that sortase-dependent cell surface proteins (SDPs) play a crucial 
role in probiotic-host interactions, adherence and colonization (127). Several SDPs have been 
identified with a role in in vitro and in vivo adhesion to intestinal cells, including mucus-
binding cell surface proteins (Table 5). In Gram-positive bacteria, sortase enzymes decorate 
the cell surface with a diverse array of proteins by covalently joining them to the cell wall 
(Sortase A) or by polymerizing proteins to construct complex multi-subunit pilin structures 
(Sortase C) on the cell surface (128). Sortase enzymes are characterized as cysteine 
transpeptidases that join SDPs containing a specific cell wall sorting signal (CWSS) to an 
amino group located on the cell surface (129). Sortase A enzymes anchor proteins that 
contain a CWSS with a LPXTG (where X donates any amino acid) C-terminal motif to the 
cell surface (128) (Fig. 3). The LPXTG motif is recognized by the SrtA enzyme, which 
breaks the threonine and glycine peptide bond and then covalently links the threonine residue 
to the amino group of the pentaglycine cell wall cross bridge of the bacterium (121, 130). 
Sortase C proteins catalyse a similar transpeptidation reaction, but recognize a QVPTGV 
sorting motif to construct pili that promote microbial adhesion (131).  
Several strains of lactobacilli and bifidobacteria inhibit, displace and adhere to the same 
enterocyte layer previously colonized by enteropathogenic Salmonella choleraesuis serovar 
Typhimurium (132). This indicates that the probiotic strains have the ability to effectively 
displace the pathogen after pathogenic colonization of the gut has occurred instead of being 
administered only in a preventative setup. To gain a competitive advantage, the probiotics 
can thus modify the gut environment by producing inhibitory compounds, lowering pH levels 
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and competing for nutrients (32). Lactobacillus species such as L. acidophilus and L. 
plantarum have the ability to utilize complex carbohydrates such as fructans (133). Similarly, 
bifidobacteria are capable of metabolising various plant dietary fibres using several 
depolymerizing enzymes (134). Utilizing carbohydrate sources other than those used by 
enteropathogenic bacteria enable probiotic bacteria to widen their areas of colonization in the 
GIT and inhibit pathogens. 
                                                                           
 
FIG. 3. Sortase-dependent cell surface proteins containing the LPXTG C-terminal motif are anchored 
to the bacterial cell wall by Sortase A enzymes. Image modified from (31). 
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3.2 Production of antimicrobial compounds 
Besides competing for nutrients, competitive inhibition of the epithelial and mucosal 
adherence of pathogens and thus prevention of pathogenic colonization, probiotic bacteria 
also produce a variety of compounds that exert direct antimicrobial action toward competing 
enteropathogens (Fig. 4). 
 
 
FIG. 4. Inhibition of pathogens by probiotic bacteria   adhered to gut intestinal epithelial cells (5). 
Inhibitory activity of probiotic bacteria is achieved by (A) secretion of organic acids ; surfactants
 and antimicrobial compounds including bacteriocins  and hydrogen peroxide . (B) Probiotic 
bacteria compete with pathogens by adherence and signal exchange through epithelial cell receptors
. (C) Probiotics can stimulate a host immune response (via trophic stimuli and cytokine synthesis) 
against pathogens , including viruses . 
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3.2.1 Bacteriocins 
The production of bacteriocins by probiotic bacteria (usually LAB) is a key mechanism by 
which the inhibition of pathogenic adhesion to IECs and invasion can occur (Fig. 5). 
Bacteriocins are ribosomally produced antimicrobial peptides that differ in terms of their size 
(2-6 kDa), mechanisms of action and immunity (for a review, see reference 135). 
Bacteriocins usually only inhibit specific species, often those closely related to the strain 
producing them (135, 136). Bacteriocins are produced by many LAB strains (for example, 
nisin from Lc. lactis, plantaricin from L. plantarum and lacticin B from L. acidophilus) that 
are active against food-borne enteropathogens such as Listeria, Clostridium, Bacillus and 
antibiotic-resistant pathogens such as methicillin-resistant Staphylococcus aureus and 
vancomycin-resistant enterococci (VRE) (32, 137-141). Bacteriocins may have a 
bacteriostatic or direct bactericidal effect on pathogens, thus limiting their ability to colonize 
the gut. The associated antimicrobial activities of bacteriocins allow bacteriocin-producing 
probiotic strains to gain a competitive advantage within the complex gastrointestinal 
environment (142). 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG. 5. Beneficial effects of probiotic bacteria and their bacteriocins against enteric pathogens. 
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The general mechanisms of bacteriocin-mediated pathogen killing include the induction of 
cytoplasmic membrane permeabilization of sensitive bacteria that leads to cell leakages 
and/or the inhibition of cell wall synthesis (143). For instance, nisin acts by forming a 
complex with the cell membrane lipid II precursor, which is followed by the aggregation and 
incorporation of peptides to form discrete pores in the bacterial cell membrane (144). A 
unique bacteriocin, bifidocin B, produced by Bifidobacterium bifidum NCFB, is active 
against several Gram-positive bacteria, including Listeria, Enterococcus, Bacillus and 
Lactobacillus, but shows no activity towards several other Gram-positive and Gram-negative 
bacteria (145). The difference in activity between strains is related to the ability of Gram-
negative bacteria to resist adsorption of bifidocin B, due to their cell wall composition (146). 
However, several bacteriocins, such as mutacins (A-D), nisins (A and Z), lacticins (A164 and 
BH5), bacteriocins E 50-52 and OR7 have been reported with activity against medically 
important Gram-negative organisms such as Campylobacter, Helicobacter, Haemophilus, 
Neiserria and Salmonella spp., by disruption of their outer cell membrane (147-150). 
In addition to in vitro studies, several in vivo studies have demonstrated the inhibitory effect 
of purified bacteriocins and probiotic bacteriocin-producing strains in infectious animal 
models. Simonova and co-workers (151) observed that feeding rabbits with bacteriocin-
producing Enterococcus faecium CCM7420 and its partially purified bacteriocin significantly 
reduced Staphylococci spp. cell numbers in the cecum thus protecting the animals against 
infection. Other studies found that the E. faecium EK13, enterocin A producing strain 
reduced Salmonella cell numbers in gnotobiotic Japanese quails and also reduced the 
colonization of pathogenic Staphylococcus in the digestive tract of rabbits (152, 153). The 
capacity of human-isolated nisin- and pediocin-producing LAB to reduce the intestinal 
colonization of VRE in mice was demonstrated for the first time by Millette and co-workers 
(26). Svetoch and co-workers (154) reported a significant reduction of Salmonella enteritidis 
in broilers after oral administration of the E. faecium E 50-52 bacteriocin. Corr and co-
workers (24) demonstrated that feeding mice with the Lactobacillus salivarus UCC11 
bacteriocin Abp118- producing strain reduced Listeria monocytogenes cell numbers in the 
liver and spleen. A similar reduction in cell numbers of the same pathogen in the GIT of mice 
was observed when the animals were pre-treated with probiotic strains L. plantarum 423 and 
E. mundtii ST4SA, producing bacteriocins plantaricin 423 and mundticin ST, respectively 
(25).   
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It is also important to consider that not all potential or developed probiotic strains that show 
in vitro antimicrobial activity against enteropathogens will be active in vivo (30). For 
example, despite the fact that a Lactobacillus sp. strain adhered to the jejunum and ileum of 
gnotobiotic pigs after oral administration and that the strain showed in vitro activity against 
enteropathogenic E. coli (EPEC), the LAB strain failed to prevent EPEC colonization in the 
GIT of infected animals (155). Similar results were observed when L. casei subsp. casei 
failed to prevent the intestinal colonization of EPEC in the GIT of gnotobiotic or 
conventional piglets when the LAB strain was administered in a preventative setup (156). 
Nevertheless, the probiotics discussed in the above experiments use their bacteriocins to 
effectively interact with enteropathogens through either bacteriostatic or bactericidal 
activities. In doing so, they prevent pathogenic colonization of the host GIT and subsequent 
occurrence of disease. 
3.2.2 Bacteriocin-like compounds 
Other antimicrobial bacteriocin-like compounds that are incompletely defined or that do not 
share the typical characteristics of bacteriocins, are produced by probiotic bacteria (30). As 
opposed to bacteriocins, bacteriocin-like compounds are characterized by having a broader 
spectrum of antimicrobial activity. In addition, their antimicrobial activities are not related to 
the production of lactic or organic acids or hydrogen peroxide (30, 157). Lactobacillus sp. 
strain GG secretes an antimicrobial substance with inhibitory activity against Clostridium 
spp., Staphylococcus spp., Enterobacteriaceae, Streptococcus spp., Bacteriodes spp., and 
Pseudomonas spp. (158). This low molecular weight (LMW) substance was characterized as 
heat-stable, distinct from lactic and acetic acids and closely resembled a microcin that is 
normally produced by Enterobacteriaeae spp. These characteristics suggest that it could be a 
non-bacteriocin bacteriocin-like substance (30). Similar substances with molecular weights 
and broad activity spectrums uncharacteristic of bacteriocins have been shown to be produced 
by other lactobacilli strains, including L. acidophilus, L. delbrueckii and L. rhamnosus 
strains, whose bactericidal affects are related to neither lactic acid nor hydrogen peroxide (30, 
159, 160). Other studies have identified bacteriocin-like antimicrobial substances produced 
by several Bifidobacterium strains with broad spectrums of activity against both Gram-
positive and Gram-negative pathogens such as L. monocytogenes, Salmonella spp. and E. coli 
spp. (161-163). 
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3.2.3 Lactic and other organic acids 
An additional mechanism of pathogen displacement in the gut employed by probiotic bacteria 
is their ability to make the intestinal environment less suitable for pathogen growth. Probiotic 
LAB and commensal microbiota ferment carbohydrates in the GIT that lead to the production 
of metabolites such as acetic, formic, succinic and lactic acids, rendering the intestinal 
environment acidic and inhibiting the growth of bacterial pathogens (164). Organic acids, in 
particular lactic and acetic acid repress the growth of many pathogenic bacteria in the GIT 
(30, 32, 37, 165). The undissociated form of lactic acid functions as a permeabilizer of the 
Gram-negative bacterial outer cell membrane, after which it dissociates inside the bacterial 
cytoplasm following entry. The bacterial killing activity is then exerted by lowering the 
intracellular pH level, through the accumulation of ionized forms of the organic acid and 
other antimicrobial compounds inside the cytoplasm (32, 166).  
De Keersmaecker and co-workers (167) demonstrated that the strong inhibitory effects of L. 
rhamnosus GG against S. typhimurium was due to lactic acid production. The potential role 
of lactic acid in the ability of Lactobacillus strain GG to prevent the invasion of Caco-2 cells 
by S. enterica serovar Typhimurium was demonstrated by Lehto and Salminen (168). The 
authors suggested a pH-dependent mechanism after they observed that inhibition of the 
pathogen was eliminated when the LAB culture was set to pH 7. In another study, the growth 
and expression of virulence factors by Salmonella were shown to be affected by lactic acid 
(169).  
The inhibition of E. coli O157:H7 by different Lactococcus and Lactobacillus strains was 
attributed to the production of lactic acid and low pH (170, 171). The growth of Helicobacter 
pylori was inhibited by different Lactobacillus and Bifidobacterium strains including L. 
acidophilus, L. bulgaricus and Bifidobacterium bifidus (172, 173). These effects were 
attributed to the production of lactic, acetic and hydrochloric acid. In another study, the 
growth of four species of known enteropathogens, H. pylori, Campylobacter jejuni, 
Campylobacter coli and C. difficile were inhibited by Lactobacillus strains isolated from the 
human GIT, probably due to the production of organic acids (174). Based on these studies, it 
is reasonable to suggest that the production of organic acids by probiotics in the GIT makes 
the intestinal environment less favourable for their competitors and decreases the risk of 
enteric infections by pathogens.  
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3.2.4 Hydrogen peroxide 
In addition to lactic acid and bacteriocin production, hydrogen peroxide (H2O2) production by 
commensal or probiotic LAB may be an important antimicrobial mechanism against 
pathogens (175). Hydrogen peroxide may cause reduced pathogen virulence, reduced 
pathogen invasion of epithelial cells or death of intestinal pathogens after intracellular 
diffusion which alters gene transcription and signal transduction (176-179). Several H2O2-
producing bacterial species with probiotic properties have been isolated, such as B. bifidum, 
the Lactobacillus johnsonii NCC 533 gut isolate, a L. delbrueckii subsp. bulgaricus yogurt 
isolate and normal microflora vaginal isolates such as L. crispatus and Lactobacillus gasseri 
(178-184).  
The ability of L. johnsonii NCC533 to generate up to millimolar quantities of H2O2 under 
aerobic conditions has been demonstrated (179). The authors demonstrated the antimicrobial 
role of L. johnsonii NCC533 produced-H2O2 against S. enterica serova Typhimurium in vitro, 
and proposed that L. johnsonii NCC533 H2O2-production could contribute to protection 
against the pathogen in vivo. Other studies have shown that H2O2-producing L. crispatus 
F117 and Lactobacillus paracasei strains (F2 and F28) inhibited the growth of S. aureus in 
vitro (184, 185). The beneficial role of H2O2-producing probiotic LAB that form part of the 
vaginal microflora of healthy women has been studied extensively (183-186). Previous 
studies have reported that women carrying H2O2-producing lactobacilli are less likely to 
develop bacterial vaginosis (183, 186). 
3.2.5 Siderophores 
Iron is an essential micronutrient that plays a central role in the metabolism and proliferation 
of most gut microbes, including commensal bacteria and gut pathogens (187). Siderophores 
are LMW organic, high-affinity iron-chelating compounds produced by microorganisms such 
as bacteria and fungi (188). These compounds inhibit the growth, proliferation and 
persistence of competing microbes by depriving them of iron. In doing so, siderophore-
producing bacteria sequester free iron available in their environment that is essential to other 
microorganisms. For example, the growth of Lc. lactis, C. difficile and Clostridium 
perfringens was inhibited in the GIT by iron-binding Bifidobacterium strains that produce 
siderophores (189). In a recent study, the growth and adhesion to IECs of enteropathogenic S. 
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typhimurium N15 and EHEC were inhibited by B. pseudolongum PV8-2 and Bifidobacterium 
kashiwanohense PV20-2 with high iron sequestration properties (190). 
3.2.6 Biosurfactants 
The production of biosurfactants by some LAB is another mechanism that can interfere with 
pathogen growth in the GIT. Biosurfactants are a group of compounds with surface and 
emulsifying activities that can be used in many different biomedical applications (191, 192). 
Several LAB strains have been isolated that produce either cell-bound or excreted 
biosurfactants with antibacterial, antiviral and antifungal properties (191-196). Biosurfactants 
cause permeabilization of cells by effecting changes that disrupt or lyse the physical cell 
membrane structure (197). The use of biosurfactant-producing lactobacilli in the prevention 
of urogenital tract infections is of considerable interest (191). These organisms are believed 
to compete with urogenital bacterial pathogens and yeast for adhesion sites on epithelial cells 
and control their growth by the production of biosurfactants (198-200). In another study, L. 
casei MRTL3 that produces a bacteriocin and a biosurfactant was shown to inhibit several 
food-borne pathogens (201). 
3.2.7 Compounds inhibiting pathogen adhesion to intestinal cells 
Adhesion to intestinal cells and subsequent colonization by enteropathogens is regarded as a 
prerequisite for their virulence (202). Probiotic bacteria have been shown to produce 
compounds that do not have a direct bactericidal effect, but which inhibit the binding of 
pathogenic bacteria to intestinal cells. Fujiwara and co-workers purified and characterized a 
novel proteinaceous compound in culture supernatants of B. longum SBT2928, termed BIF, 
that inhibits the adhesion of enterotoxigenic E. coli Pb176 (ETEC) to human HCT-8 IECs 
(92, 203, 204). The authors demonstrated that BIF blocks the binding of the ETEC Pb176 
colonization factor antigen (CFA) II adhesive factor to gangliotetraosylceramide (bacterial 
binding structure) receptors on the intestinal cell surface (92), thereby preventing ETEC 
Pb176 colonization. Two Bifidobacterium strains, CA1 and F9, isolated from the GIT of 
infants produce a LMW lipophilic antibacterial compound that inhibits the adhesion of 
several pathogenic bacteria, including S. typhimurium SL1344 and E. coli C1845 (205). 
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3.3 Stabilization of intestinal epithelial barrier 
The intestinal epithelium consists of a uni-layer of cells covered by a mucus layer that is 
constantly exposed to the luminal contents and various enteric bacteria (107, 206). The 
intestinal epithelial barrier consists of the mucus layer, the intestinal cells and the gut innate 
immune system (206). This intestinal barrier functions as a key defence mechanism required 
to maintain epithelial integrity and to prevent infection by pathogens and excessive 
inflammation (206). Stabilization and maintenance of this barrier is thus of utmost 
importance to the host. Important defence mechanisms of the intestinal barrier against 
unwelcome intrusion of harmful antigens include the mucosal layer (mucin production), 
intercellular junctional complexes (tight and adherence junctions) and the secretion of 
antimicrobial peptides (such as defensins) and immunoglobulin A (IgA) (206-209). 
Disruptions of this barrier function can lead to inappropriate inflammatory responses due to 
invasion of the submucosa by bacteria or food antigens, which may result in intestinal 
disorders such as inflammatory bowel disease (IBD) and ulcerative colitis (207, 210, 211). 
Consumption of colonizing or non-colonizing probiotics can enhance barrier integrity which 
helps to protect the intestinal epithelium against enteric pathogens and chronic inflammation 
by direct effects on the epithelium (e.g. increasing mucin expression), modulation of the 
immune system and by direct effects on commensal and pathogenic bacteria (e.g. 
antimicrobial peptides and competition for adherence) (Fig. 6). 
Intestinal epithelium cells are overlaid with a protective inner and outer mucus layer that 
limits bacterial movement and acts as a dynamic defence barrier against enteropathogens and 
other potentially harmful antigens (208). For enteropathogens to colonize the intestine, they 
have to penetrate the mucus layer before they reach the intestinal epithelium (212). Mucins 
are the major macromolecular constituents of the epithelial mucus layer and are produced by 
specialized goblet cells in the intestinal tract (213) (Fig. 6). Probiotics are able to inhibit 
pathogen adherence to IECs by promoting the secretion of intestinal mucins. Several 
Lactobacillus species have been shown to increase the expression of specific mucin genes in 
human intestinal Caco-2 and HT29 cells, thus preventing the adherence and internalization of 
pathogenic E. coli (123, 214, 215). The adherence of EPEC was inhibited by L. plantarum 
299v-mediated increase in expression of the MUC2 and MUC3 mucins (123, 215). Rats 
administered with VSL3 (pre- and probiotic mixture) for 7 consecutive days showed a 60-
fold increase in MUC2 expression and an associated increase in mucin production (216). 
Therefore, increased mucus production mediated by probiotic bacteria in vivo may be a key 
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mechanism in their interactions with enteropathogens to prevent infections and to improve 
intestinal barrier function. 
 
FIG. 6. Beneficial effects of probiotics on intestinal epithelial barrier function (206). Probiotics can 
affect epithelial barrier integrity by numerous mechanisms. These include: A. direct effects on the 
intestinal epithelial cells (IECs). Probiotics can increase the secretion of mucin glycoproteins by 
goblet cells that assemble into a thick mucus layer. Probiotics can augment the secretion of 
antimicrobial proteins (defensins) by IECs that help to eliminate commensals or pathogens that 
penetrate the mucus layer. Probiotics can enhance the stability of intercellular junctional complexes 
(tight junctions (TJ)), which decreases the intercellular permeability of IECs to pathogens and other 
antigens. B. Mucosal immunomodulation. Probiotics can augment the levels of IgA-secreting plasma 
cells in the lamina propria and promote the transcytosis of secretory IgA (sIgA) across the epithelial 
cell layer and secretion into the luminal mucus layer, preventing and limiting bacterial penetration of 
host tissues. C. Effects on commensal and infectious bacteria. Probiotics can alter the natural gut 
microbiota composition and/or gene expression, enhancing barrier integrity through the commensal 
microbiota. Most probiotics can inhibit enteric pathogens via the production of antimicrobial 
substances such as bacteriocins. Finally, probiotics can compete with commensals and enteric 
pathogens for adhesion sites in the mucus layer or IECs, thereby preventing harmful colonization and 
enhancing barrier function. 
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3.4 Co-aggregation 
Probiotic bacteria can prevent enteropathogenic adherence and intestinal colonization by co-
aggregating with pathogens (217-219). This process allows probiotic bacteria to interact 
closely with pathogens, allowing them the opportunity to release their anti-pathogenic 
substances in very close proximity. Lactobacillus plantarum strains (S1, A and B) co-
aggregate with selected food-borne pathogens including S. typhimurium and L. 
monocytogenes (220). The adherence of ETEC to porcine enterocytes was affected by co-
aggregation of the pathogen with selected Lactobacillus spp. (221). Schachtsiek and co-
workers (222) described the role of a Lactobacillus coryniformis DSM 20001 surface protein 
encoded by a cpf gene (co/aggregation-promoting factor) in the ability of the LAB strain to 
co-aggregate with E. coli K-88, C. coli and C. jejuni. 
3.5 Inhibition of flagella motility 
Foodborne pathogens such as S. enterica serovar Typhimurium require actively rotating 
flagella to rapidly contact and to efficiently penetrate gastrointestinal epithelial cells (223, 
224). A recent study by Líeven-Le Moal and co-workers (225) demonstrated that 
antidiarrhoeic L. acidophilus LB inhibited the entry of S. enterica serovar Typhimurium into 
human intestinal Caco-2 cells by disrupting the swimming motility of the diarrhoea-
associated enteropathogen. Therefore, impairment of the flagella motility of enteropathogens 
by probiotic bacteria in the intestinal tract could prevent pathogenic colonization of the gut. 
3.6 Immune system modulation 
It is well known that probiotic bacteria can exert regulatory effects on host innate and 
adaptive immune responses (226). These bacteria have the ability to modulate the functions 
of dendritic cells (DC), monocytes/macrophages, and T and B lymphocytes, which enhances 
phagocytosis of invading gut pathogens (227, 228). By stimulation of the host immune 
responses (specific and non-specific), probiotic bacteria can displace pathogens in the GIT 
and prevent intestinal diseases (228-231).  
Probiotic bacteria can interact with pathogens in the gut by antagonizing inflammatory 
responses induced by the gut pathogens, which can lead to intestinal diseases such as 
gastroenteritis and irritable bowel syndrome (226). Inflammation allows pathogens to flourish 
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at the expense of the natural microbiota and host intestinal health. Probiotic bacteria are able 
to trigger an anti-inflammatory response from the innate immune system by signaling DCs to 
secrete anti-inflammatory cytokines such as interleukin 10 (IL-10) (232, 233) (Fig. 1). They 
can also elicit a decrease in pro-inflammatory cytokines during inflammation (227). Down-
regulation of pro-inflammatory cytokine secretion from immune cells occurs as a result of 
probiotic bacterial interference with inflammatory signaling pathways such as nuclear factor-
kappa B (NF-ƘB) and mitogen activated protein kinases (MAPK) (234, 235) (Fig. 7). The 
activation of these pathways leads to the secretion of pro-inflammatory cytokines that can 
severely damage the intestinal epithelial barrier. NF-ƘB and MAPK signaling pathways are 
activated by enteric pathogens to stimulate the secretion of pro-inflammatory cytokines (e.g. 
IL-8), that lead to the recruitment of inflammatory immune cells (e.g. neutrophils) to the 
infected area resulting in severe inflammation, tissue damage and disease (234, 235). Several 
studies have identified probiotic strains with the ability to suppress pro-inflammatory 
cytokine production to avoid pathogen-induced inflammation at infection sites (226, 235, 
237, 238). A recent study by Finamore and co-workers (237) reported that Lactobacillus 
amylovorus DSM 16698 protected IECs against the pro-inflammatory response induced by 
ETEC K88 through the suppression of pro-inflammatory cytokines IL-8 and IL-1ß. Another 
study demonstrated the ability of L. casei OLL2768 to suppress the ETEC-induced pro-
inflammatory response by inhibition of NF-ƘB and MAPK pathways which reduced pro-
inflammatory cytokine levels (238). 
             
FIG. 7. Down-regulation of pro-inflammatory cytokine (IL-8) secretion by probiotic bacteria in the 
GIT (236). Probiotic bacteria (or their products) may dampen an innate immune response by 
inhibiting the NF-ƘB inflammatory signaling pathway and influencing the production of IL-8 and 
subsequent recruitment of inflammatory immune cells to sites of intestinal injury. Abbreviations: IL-
8, interleukin 8; MФ, macrophage; NФ, neutrophil; NF-ƘB, nuclear factor-kappa B. 
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Probiotics also play a role in the stimulation and production of antibodies in the gut, 
particularly immunoglobulin A (IgA) (226, 227) (Fig. 6).  Antibodies released in the 
intestinal lumen can inhibit pathogen adherence to IECs by interfering with adhesive cell 
receptors on the pathogen’s cell membrane (33). Previous studies have indicated that 
Saccharomyces boulardii and L. rhamnosus GG increased secretory IgA levels or 
immunoglobulin-secreting cell levels in the GIT (239, 240). Other studies have reported that 
oral administration of probiotic lactobacilli increased IgA levels in children suffering from 
diarrhoea, thereby shortening the duration of symptoms (33, 227, 241-243). Several probiotic 
strains can also modulate the host immune mechanisms by influencing phagocytosis of 
enteric pathogens by host immune phagocytic cells such as macrophages (37, 239, 242, 244, 
245). The inhibition of enteropathogenic Pseudomonas aeruginosa and L. monocytogenes in 
mice by a strain of L. casei was correlated to an increase in abundance of macrophages (246). 
Furthermore, probiotic bacteria can affect phagocytotic cell activities not only in clinical 
situations but also in healthy subjects (247-249). 
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Spatial and Temporal Colonization of Lactobacillus 
plantarum 423 and Enterococcus mundtii ST4SA in the 
Intestinal Tract, as Revealed by In vivo Bioluminescence 
Imaging in a Murine Model 
Abstract 
Lactic acid bacteria (LAB) are major inhabitants and part of the normal microflora of the 
gastrointestinal tract (GIT) of humans and animals. Despite substantial evidence supporting 
the beneficial properties of LAB, only a few studies addressed the migration and colonization 
of probiotic bacteria in the GIT. The reason for this is mostly due to the limitations, or lack 
of, efficient reporter systems. This study reports on the application of the firefly luciferase 
gene (ffluc) from Photinus pyralis to develop luciferase-expressing Lactobacillus plantarum 
423 and Enterococcus mundtii ST4SA using a Lactococcus lactis NICE system high copy 
number plasmid (pNZ8048) and strong constitutive lactate dehydrogenase gene promoters 
(Pldh and STldh). The reporter system was used for the in vivo and ex vivo monitoring of 
both probiotic LAB strains in the GIT of mice after single and multiple oral administrations. 
Enterococcus mundtii ST4SA reached the large intestine 45 min after gavage, while L. 
plantarum 423 reached the cecum/colon after 90 min. Both strains predominantly colonized 
the cecum and colon after five consecutive daily administrations. Enterococcus mundtii 
ST4SA persisted in faeces at higher numbers and for more days compared to L. plantarum 
423. This is the first report of bioluminescence imaging of a luciferase-expressing E. mundtii 
strain to study colonization dynamics in the murine model. The bioluminescence system 
developed in this study has the potential to show the in vivo colonization dynamics of other 
important probiotic LAB species. 
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Introduction 
Lactic acid bacteria (LAB) are common inhabitants of a healthy human and animal 
gastrointestinal tract (GIT) and they play a major role in keeping the gut microbiota in a 
balanced state (1-4). Beneficial properties include the inhibition of enteric pathogens (5), 
alleviation of constipation (6) and diarrhoea (7), stimulation of the immune system (8), 
repression of cancer cell and tumor growth (9, 10), and synthesis of essential metabolites 
such as vitamins (11). Key to the function of probiotic bacteria is their ability to survive 
stomach acids and bile salts (12). Some strains have adapted to these harsh conditions by 
over-expressing specific genes when exposed to acids and bile salts (13-14). Changes on a 
genetic level will undoubtedly alter the way probiotic bacteria compete against pathogens and 
colonize the GIT. 
The survival and colonization of LAB in the GIT is usually studied in vitro and ex vivo by 
using models simulating the GIT (16-19). Although these studies are valuable in 
understanding the survival of LAB in the GIT, the findings seldom reflect real-life 
conditions. More in vivo studies are needed to understand the interactions between probiotic 
bacteria, pathogens, commensal bacteria and gut epithelial cells. The best approach to study 
real-time interactions between probiotic bacteria and their mammalian host in the GIT is by 
labelling the cells with fluorescent or bioluminescent markers (20, 21). A selection of genes, 
encoding proteins that emit light at specific wavelengths, are available for cloning into 
plasmids or insertion into the genomes of recipient cells (21, 22). The most commonly used 
luciferase labelling systems used in in vivo and ex vivo tracking of bacteria are bacterial 
luxABCDE from Photorabdus luminescence (23), click beetle luciferase (CBluc) from 
Pyrophorus plagiophthalamus (24) and firefly luciferase (Ffluc) from Photinus pyralis (25). 
The CBluc and Ffluc luciferases require the exogenous addition of D-Luciferin, whereas the 
bacterial lux substrate is naturally present within the bacterial cells (20). The half-life of 
luciferase is only several seconds and does not represent bioluminescence accumulated over a 
period (26). Another advantage is that only low levels of background luminescence are 
emitted by mammalian tissue.  
To date, very few studies have used whole-body imaging to monitor the persistence of LAB 
in the GIT, and with variable degrees of success. This is mostly due to the weak penetration 
of photons through muscles and tissue. Furthermore, labelled cells orally administered are 
often dispersed throughout the GIT or become metabolically inactive and emit 
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bioluminescent signals too weak to detect. Cronin and co-workers (27) used a bacterial lux 
system to study the persistence of Bifidobacterium breve in mice. The bioluminescent signal 
was, however, not emitted from the GIT of live mice and all imaging had to be done ex vivo 
after dissecting the GIT. In our own studies (28), fluorescence encoded by the mCherry gene, 
transformed into Lactobacillus plantarum 423 and Enterococcus mundtii ST4SA, was also 
only detected after surgical removal of the GIT. This is not unusual, as also reported by 
Oozeer et al. (23) and Corthier et al. (29) with studies done on mice. Lee and Moon (30) were 
one of the first to detect Lactococcus lactis in the GIT of live mice by using a pMG36e Ffluc 
plasmid vector, although the strain could only be detected for up to 2 h. In another study, 
Daniel and co-workers (31) successfully monitored the colonization and persistence of Lc. 
lactis and L. plantarum in live mice using the CBluc luciferase system. 
Lactobacillus plantarum 423, isolated from sorghum beer and E. mundtii ST4SA, isolated 
from soybeans both have probiotic properties (32-34). The strains survive conditions in the 
human GIT, as shown with studies performed on a computerized model simulating the 
intestinal conditions of infants (16). Both strains adhere to human intestinal epithelial cells 
(35) and produce antimicrobial peptides (36, 37), active against Listeria monocytogenes, 
Enterococcus faecalis, Clostridium sporogenes and Salmonella typhimurium (32, 33, 38-40). 
In a previous report, using the mCherry fluorescence gene, we have shown that L. plantarum 
423 and E. mundtii ST4SA were localized in the cecum and colon of mice after a single oral 
dosage (28). 
This study reports on the application of a red-shifted thermostable firefly luciferase-system 
(Ffluc) to study the spatial and temporal persistence of L. plantarum 423 and E. mundtii 
ST4SA in the GIT of mice after single and multiple dosages. The use of a red-emitting 
luciferase with a longer wavelength (620 nm) enabled optimal light penetration through 
intestinal and skin tissue. The in vitro and in vivo expression of the Ffluc system was 
optimized using a combination of a high-copy number plasmid vector and strong constitutive 
promoters. Differences between the two strains in viability and persistence in the GIT of mice 
were demonstrated by monitoring in vivo and ex vivo bioluminescence, using the Caliper in 
vivo imaging system (IVIS; Caliper Life Sciences, Hopkinton, MA). The bioluminescence 
system also allowed tracking each of the strains in different sections of the GIT.  
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Materials and methods 
Animals used 
Ethical approval for in vivo experiments was granted by the Ethics Committee of 
Stellenbosch University (reference number SU-ACU-2017-0206-454). Eight-week-old 
female BALB/c mice were used in all experiments. Animals were housed separately under 
controlled environmental conditions and fed a standard rodent diet. Animal procedures were 
performed according to the Stellenbosch University ethical guidelines. 
Bacterial strains, plasmid construction and culture conditions 
Lactobacillus plantarum 423 and E. mundtii ST4SA were labelled by transformation with 
plasmids encoding the red-shifted thermostable firefly luciferase gene from P. pyralis (ffluc) 
(41). The bioluminescence expression vectors are based on the pNZ8048 Lc. lactis NICE 
system high copy number plasmid (Mobitech, Goettingen, Germany). The vector contains the 
cat gene for chloramphenicol (Cm) resistance, the nisA gene promoter region (PnisA), a 
multiple cloning site (MCS), replication genes (repC and repA) for replication in LAB/E. coli 
and the termination (T) sequence of the Lc. lactis pepN gene (42). Primers used for PCR 
amplification are listed in Table S1 and were from Inqaba Biotechnical Industries (Pretoria, 
South Africa). DNA restriction enzymes and PCR polymerase were from New England 
Biolabs (NEB, Ipswich, MA, USA). The construction of pNZPldhFfluc and pNZSTldhFfluc 
luciferase expression vectors is shown in Fig. S1. Plasmid pNZPldhFfluc carried the ffluc 
gene under control of the strong constitutive L. plantarum 423 lactate dehydrogenase gene 
promoter (Pldh). In the pNZSTldhFfluc construct, the ffluc gene was cloned under control of 
the strong constitutive E. mundtii ST4SA lactate dehydrogenase gene promoter (STldh). The 
Pldh and STldh promoters were amplified from L. plantarum 423 and E. mundtii ST4SA 
genomic DNA, using primer pairs Pldh1/Pldh2 and ldhS1/ldhS2, respectively. The ffluc 
bioluminescence gene was amplified from plasmid pMV306G13+FflucRT using primers 
FlucFor and FlucRev. Briefly, the Pldh (520 bp), STldh (166 bp) and ffluc (1.6 kb) PCR 
fragments were cloned into pNZ8048 after digestion of Pldh and STldh with BglII/NcoI, 
digestion of ffluc with NcoI/XbaI and digestion of pNZ8048 with BglII/XbaI, yielding 
plasmids pNZPldhFfluc and pNZSTldhFfluc, respectively. 
The two bioluminescence expression vectors were introduced into L. plantarum 423 and E. 
mundtii ST4SA by electro-transformation as described by Van Zyl and co-workers (28) and 
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were named L. plantarum 423 Fluc and E. mundtii ST4SA Fluc. Lactobacillus plantarum 423 
and E. mundtii ST4SA containing the empty pNZ8048 vector were used as controls and were 
labelled L. plantarum 423 (pNZ8048) and E. mundtii ST4SA (pNZ8048). Plasmid stability in 
L. plantarum 423 Fluc and E. mundtii ST4SA Fluc, and growth comparison between wild-
type (WT) and recombinant strains was tested by standard methodology as described 
previously (28).  
Escherichia coli MC1061 (Mobitech) was used as a cloning host for construction of 
pNZ8048-derived bioluminescence expression vectors and was cultured aerobically at 37
o
C 
in Luria-Bertani (LB) broth, or brain heart infusion (BHI) and streaked onto the same media, 
supplemented with 1.5% (w/v) agar (all from Biolab Diagnostics, Midrand, South Africa). 
Lactobacillus plantarum 423 and E. mundtii ST4SA were grown without shaking at 30
o
C in 
MRS broth and streaked onto MRS agar (both from Biolab Diagnostics). Where appropriate, 
Cm was added at 10 µg/ml to growth media of E. coli MC1061 and L. plantarum 423 and 5 
µg/ml to media of E. mundtii ST4SA. 
Correlation between in vitro bioluminescence measurements and viable cell numbers 
Lactobacillus plantarum 423 Fluc and E. mundtii ST4SA Fluc were grown for 12 h at 30
o
C 
in MRS broth, supplemented with Cm as mentioned elsewhere. From these cultures, 1 ml was 
inoculated into freshly prepared MRS broth and incubated at 30
o
C to an optical density 
(OD550nm) of 2.5 (for L. plantarum 423) and 2.3 (for E. mundtii ST4SA). Viable cell numbers 
were determined by plating onto MRS agar containing Cm. The bacterial suspensions were 
harvested (3 min at 8000 x g), washed twice with sterile phosphate buffered saline (PBS), 
resuspended in gavage buffer (0.2 M NaHCO3 with 1%, w/v, glucose, pH 8.0) and serially 
diluted to 1/128 in the same buffer. Two-hundred microliters of each dilution was added in 
triplicate to black 96-well microtitre plates and bioluminescence measured after the addition 
of 5 µl of D-Luciferin potassium salt (Anatech Instruments, Bellville, South Africa) at 470 
µM. Bioluminescent readings were recorded using the Caliper in vivo imaging system (IVIS; 
Caliper Life Sciences, Hopkinton, MA, USA) and the photons emitted from regions of 
interest (ROI) calculated using the Living Image
®
 software, version 3.0 (Caliper Life 
Sciences). The ROI of each well were manually selected. Exposure times ranged from 30 s to 
2 min, depending on the intensity of the signal. Bacterial cell numbers were plotted against 
bioluminescence emitted, recorded as photons per second (p/s). Non-bioluminescent L. 
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plantarum 423 (pNZ8048) and E. mundtii ST4SA (pNZ8048) were used to set the 
background bioluminescence. 
Preparation of bacterial strains and dosing of mice 
Lactobacillus plantarum 423 Fluc and E. mundtii ST4SA Fluc were grown at 30°C for 12 h, 
whereafter 1 ml of each culture was inoculated into freshly prepared 10 ml MRS broth. 
Lactobacillus plantarum 423 Fluc was grown to an OD550 of 2.5 and E. mundtii ST4SA Fluc 
to an OD550 of 2.3. The cells were harvested (3 min at 8000 x g), washed twice with sterile 
PBS and resuspended in gavage buffer at a final concentration of 4 x 10
9
 CFU. Mice in each 
group were then gavaged with 200 µl (4 x 10
9
 CFU) of each strain. 
In vivo gastrointestinal persistence of LAB in the murine model 
Groups of mice each received a daily dose of 200 µl (4 x 10
9
 CFU) of live L. plantarum 423 
Fluc or E. mundtii ST4SA Fluc for one or five consecutive days by intragastric gavage. 
Control mice received 200 µl (4 x 10
9
 CFU) of non-bioluminescent L. plantarum 423 
(pNZ8048) or E. mundtii ST4SA (pNZ8048) in all experiments. Faeces (100 mg) were 
collected at different time points and vortexed in 1 ml sterile PBS for 5 min, followed by 
serial dilution in sterile PBS, and plating onto MRS agar supplemented with Cm and 
incubated, as described elsewhere. Viable cell numbers were expressed as CFU per 100 mg 
faeces. Two mice per strain were sacrificed by cervical dislocation at predetermined time 
points, the intestines surgically removed and immediately separated in a sterile Petri dish 
(refer to Fig. S2 for different sections of mouse GIT). The lumen of all intestinal sections was 
injected with air using a 27-gauge needle and syringe, as described by Rhee and co-workers 
(43), and bioluminescence recorded using the IVIS. The complete duodenum, jejunum, ileum 
and large intestine (cecum plus colon) were homogenized, separately, in 3 ml sterile PBS, 
serially diluted and plated (in duplicate) onto MRS agar. The plates were incubated and cell 
numbers determined as described elsewhere. 
In vivo bioluminescence measurements 
In vivo bioluminescence imaging (BLI) was recorded using the IVIS, equipped with a cooled-
charged-device camera mounted on a light-tight specimen chamber (dark box) and a 
Windows computer system. Mice were gavaged with 200 µl of a D-Luciferin potassium salt 
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suspension (30 mg/ml) 30 min before gavage with L. plantarum 423 Fluc and E. mundtii 
ST4SA Fluc. Mice were anesthetized with 2% (vol/vol) isoflurane in an oxygen-rich 
induction chamber before administering the D-Luciferin and bacteria. Mice were kept 
subdued during bioluminescent readings with a mixture of isoflurane (1.5%, vol/vol) and 
oxygen. Mice in ventral position were imaged for quantification of bioluminescent photon 
emission with exposure times ranging from 1 to 5 min, depending on the signal intensity. 
Pseudo-color images superimposed over grayscale reference images representing light 
intensity (red, most intense and purple being the least intense) were generated using the 
Living Image
®
 software program. ROIs were manually selected and bioluminescence 
expressed as photons emitted per second (p/s). 
Results 
In vitro functionality and stability of bioluminescent L. plantarum 423 and E. mundtii 
ST4SA 
Bacterial cultures resuspended in PBS were used to image the intensity of bioluminescent 
signals produced by L. plantarum 423 Fluc and E. mundtii ST4SA Fluc (Fig. 1A). No 
significant difference was observed in the maximum intensities of bioluminescent signals 
produced by L. plantarum 423 Fluc or E. mundtii ST4SA Fluc. Maximum bioluminescence 
was recorded for E. mundtii ST4SA Fluc with mean values of 2.49 x 10
8
 p/s, while slightly 
lower mean values of 1.94 x 10
8
 p/s was recorded for L. plantarum 423 Fluc. None of the 
control strains (L. plantarum 423 (pNZ8048) or E. mundtii ST4SA (pNZ8048)), emitted 
bioluminescent signals. No bioluminescence was detected in culture supernatants of L. 
plantarum 423 Fluc or E. mundtii ST4SA Fluc, indicating that bioluminescent light 
production was strictly intracellular. 
Bioluminescence emitted by cells that expressed firefly luciferase correlated with serial 
dilutions of total CFUs of cultures of L. plantarum 423 Fluc (R2=0.9830) and E. mundtii 
ST4SA Fluc (R2=0.9870), indicating that photon emission accurately reflects bacterial cell 
numbers (Figs 1B and 1C). The bioluminescence signal corresponded to the detection of 
bacterial CFU over a broad range, from approximately 6 x 10
6
 CFU to 8.5 x 10
8
 CFU for L. 
plantarum 423 Fluc (Fig. 1B) and from approximately 1 x 10
7
 CFU to 2 x 10
9 
CFU
 
for E. 
mundtii ST4SA Fluc (Fig. 1C).  
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FIG. 1. Quantification of bioluminescent L. plantarum 423 Fluc and E. mundtii ST4SA Fluc. (A) 
Bioluminescence measured in cultures of L. plantarum 423 Fluc and E. mundtii ST4SA Fluc 
distributed in black 96-well microtitre plates. Means from six independent cultures are shown with 
standard deviations, and the background from each strain has been subtracted from each respective 
measurement. Correlation between bioluminescent signals and bacterial cell numbers of (B) L. 
plantarum 423 Fluc and (C) E. mundtii ST4SA Fluc. Cultures of each strain were serially diluted in 
black microplates and the bioluminescent signals quantified using the IVIS and then correlated with 
CFUs. Log10 averages of three cultures are plotted, with error bars indicating standard deviations. The 
logarithmic trendline and the correlation of determination (R
2
) between bioluminescence 
measurements and bacterial numbers of each strain are shown. 
No significant difference in growth was observed between wild-types L. plantarum 423 and 
E. mundtii ST4SA and recombinants L. plantarum 423 Fluc and E. mundtii ST4SA Fluc, 
respectively, after 9 h of growth (not shown). Bioluminescent light production and the 
presence of the luciferase expressing plasmids in recombinant L. plantarum 423 Fluc and E. 
mundtii ST4SA Fluc strains had no detectable effect on bacterial growth. The stability of the 
luciferase-expressing plasmids pNZPldhFfluc in L. plantarum 423 Fluc and pNZSTldhFfluc 
in E. mundtii ST4SA Fluc was tested in vitro by subculturing for up to 7 days with replica-
plating on non-selective and selective media (Fig 2A). The stability of the autonomous 
plasmids in L. plantarum 423 Fluc and E. mundtii ST4SA Fluc transformants was indicated 
by 100% plasmid retention and retained resistance to Cm following culturing for 7 days in 
Fig 1C. 
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the absence of the antibiotic. The bioluminescent signals of the recombinant strains were also 
imaged with the IVIS in parallel to replica plating (Figs 2B and 2C). 
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FIG. 2. In vitro stability of bioluminescence. (A) Stability of plasmid pNZPldhFfluc in L. plantarum 
423 Fluc and plasmid pNZSTldhFfluc in E. mundtii ST4SA Fluc after subculturing for 7 days with 
replica plating on non-selective (antibiotic-free) and selective (Cm) media. The percentages of Cm-
resistant colonies of three independent cultures of each respective strain are shown. Bioluminescent 
colonies of (B) L. plantarum 423 Fluc and (C) E. mundtii ST4SA Fluc after 7 days of subculture in 
antibiotic-free MRS media. 
Colonization dynamics of bioluminescent L. plantarum 423 and E. mundtii ST4SA in the 
GIT of mice after a single dosage 
To determine the spatial and temporal colonization of L. plantarum 423 Fluc and E. mundtii 
ST4SA Fluc after a single oral administration, groups of mice (n=13, per strain) were 
monitored over a 24 h period by transcutaneous in vivo BLI and ex vivo BLI of GITs and 
faeces. The viable bacteria numbers in the GIT and faecal samples were also recorded. Three 
anesthetised mice (n=3, per strain) were imaged at 15 and 30 min and, 1, 1.5, 2, 3, 4, 6 and 24 
B. C. 
A. 
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h after the administration of L. plantarum 423 Fluc and E. mundtii ST4SA Fluc, respectively 
(Fig. 3). The same three mice were used throughout the 24 h trial period. At time zero (before 
administration) no bioluminescence was recorded (background signal corresponded to 
approximately 3 x 10
4
 p/s). A maximum bioluminescent signal of approximately 2 x 10
8
 p/s 
was detected for L. plantarum 423 Fluc and E. mundtii ST4SA Fluc at 1 h and 30 min, 
respectively. The bioluminescent signal of L. plantarum 423 Fluc remained at high levels 
until 2 h, but declined to lower levels 1 h later (mean value of approximately 9 x 10
6
 p/s). The 
bioluminescent signal of L. plantarum 423 Fluc remained at a plateau (mean value of 
approximately 4 x 10
5
 p/s) until 6 h. The bioluminescent signal of E. mundtii ST4SA Fluc 
steadily declined between 1 and 6 h and was significantly higher than that observed for L. 
plantarum 423 Fluc between 3 and 4 h. After 24 h, no bioluminescent signal could be 
detected for L. plantarum 423 Fluc (background level), whereas the signal of E. mundtii 
ST4SA Fluc declined to approximately 2 x 10
5
 p/s.  
Next, the localization of bioluminescent L. plantarum 423 Fluc and E. mundtii ST4SA Fluc 
in the GITs of mice after oral administration was determined by ex vivo imaging and 
recording viable cell numbers in the small and large intestinal tracts (Fig. 4). Results showed 
that 15 min after administration of bacterial strains, both L. plantarum 423 Fluc and E. 
mundtii ST4SA Fluc survived passage through the stomach by the observation of high cell 
numbers and bioluminescent cells throughout the small intestine (Fig. 4A and 4B). After 
approximately 45 min, bioluminescent cells of E. mundtii ST4SA Fluc reached the cecum 
and colon. From 90 to 240 min after oral administration of bacteria to mice, the majority of 
bioluminescent L. plantarum 423 Fluc and E. mundtii ST4SA Fluc had travelled through the 
small intestine and were located exclusively in the cecum and colon. Some of the viable cells 
of both strains remained in the small intestine after 90 min, but emitted weak or no 
bioluminescence signals (Fig. 4B). No bioluminescence of either strain was detected in the 
large intestine 15 min (Fig. 4A) after intragastric administration, suggesting that the viable 
cells’ bioluminescence emission was below the detection limit of the IVIS through the 
intestinal tissue or the cells were metabolically inactive (Fig. 4C). After 24 h, a significantly 
higher number of viable E. mundtii ST4SA Fluc was detected in the cecum/colon compared 
to L. plantarum 423 Fluc.  
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FIG. 3. Monitoring of L. plantarum 423 and E. mundtii ST4SA colonization in the digestive tract of 
mice by bioluminescence imaging in whole animals after one oral administration. Lactobacillus 
plantarum 423 Fluc and E. mundtii ST4SA Fluc were fed intragastrically (4 x 10
9
 CFU) to two sets of 
three mice. The bioluminescent signals in log10 photons/s measured from whole animals at different 
time-points over a 24 h period (A) are plotted, with standard deviations. Significant statistical 
differences between the bioluminescence signals of the two groups of mice are indicated with three 
asterisks (P<0.001); Mann-Whitney nonparametric test). The background bioluminescence signal 
emitted is represented by a dashed line. (B) Visual images of bioluminescence emission in whole 
animals by mice fed once with L. plantarum 423 Fluc or E. mundtii ST4SA Fluc. In each case, one 
representative image of one mouse is shown. The intensity of the photon emission is represented as a 
pseudo-color image. One representative scale bar is shown (p/s).  
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Fig. 3A. 
Fig. 3B. 
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Fig. 4. Transit of L. plantarum 423 and E. mundtii ST4SA through the digestive tract of mice after 
one oral administration. Groups of mice were gavaged once with 4 x 10
9
 CFU of L. plantarum 423 
Fluc or E. mundtii ST4SA Fluc and the intestines resected at 15, 45, 90, 180, 240 min and 24 h. At 
each time point two mice were sacrificed, and (A) one representative image of one mouse and its GIT 
are shown. Persistence of viable L. plantarum 423 Fluc or E. mundtii ST4SA Fluc cells in (B) the 
small and (C) large intestinal tract of mice sacrificed at time points indicated in A. Significant 
differences between the two groups were assessed using the Mann-Whitney nonparametric test are 
indicated with asterisks (P<0.001). 
Fig. 4B. 
Fig. 4C. 
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Colonization of L. plantarum 423 Fluc and E. mundtii ST4SA Fluc in the GIT of mice was 
also determined by monitoring the number of viable bacterial cells in faeces at different time 
points after intragastric administration (Fig. 5A). The respective bioluminescent signals of L. 
plantarum 423 Fluc and E. mundtii ST4SA Fluc in faeces were also monitored with the IVIS 
(Fig. 5 B). High cell numbers of both strains were excreted in the faeces and were 
proportionate to the respective bioluminescence signals emitted. The bacterial populations of 
both strains in faeces increased with time. Both strains reached a maximum number of 
approximately 2 x 10
8
 CFU/100 mg faeces after 4 h and remained at this level for the 
following 2 h. These peaks correlated excellently with maximum bioluminescent signals of 
approximately 4 x 10
6
 p/s/100 mg of faeces for L. plantarum 423 Fluc and 2 x 10
7
 p/s/100 mg 
of faeces for E. mundtii ST4SA Fluc, from 4 to 6 h. The maximum level of viable E. mundtii 
ST4SA Fluc cells shed in the faeces was significantly higher in the first 2 h, reaching 
approximately 8 x 10
7
 p/s/100 mg of faeces. Bioluminescence signals emitted by E. mundtii 
ST4SA Fluc cells in the faeces were higher compared to those of L. plantarum 423 Fluc 
throughout the 24 h study period. After 24 h, the number of L. plantarum 423 Fluc declined 
to approximately 4 x 10
4
 CFU/100 mg faeces with no bioluminescent signal (background), 
while E. mundtii ST4SA Fluc cells declined to approximately 1 x 10
5
 CFU/100 mg faeces 
with a weak bioluminescent signal of 1.5 x 10
4
 p/s/100 mg of faeces. 
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Fig. 5A. 
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FIG. 5. Transit of L. plantarum 423 and E. mundtii ST4SA in the faeces of mice after a single oral 
administration. Groups of three mice each were administered once with 4 x 10
9
 CFU L. plantarum 
423 Fluc or E. mundtii ST4SA Fluc. At each time point, log10 averages of the (A) cell counts per 100 
mg faeces and the corresponding (B) bioluminescence in log10 p/s per 100 mg faeces for each group 
of three mice are plotted with standard deviations. Significant differences between the two groups 
were assessed using the Mann-Whitney nonparametric test and are indicated with one (P<0.05) or 
three (P<0.001) asterisks.  The background bioluminescence signal emitted is represented by a dashed 
line. 
Persistence of bioluminescent L. plantarum 423 and E. mundtii ST4SA in the GIT of 
mice after five oral dosages 
In vivo bioluminescent signals were measured everyday (1 h after administration of bacteria 
to mice on days 1 to 5) for nine days after two groups of mice (n=22, per strain) each 
received daily doses of L. plantarum 423 Fluc and E. mundtii ST4SA Fluc for five 
consecutive days (Fig. 6). The experimental design is described in Fig. S3. High intensity 
bioluminescence was emitted by mice in both groups from days 1 to 5. Highest 
bioluminescent signals were recorded for E. mundtii ST4SA Fluc (mean = 4.27 x 10
8
 p/s) 
compared to L. plantarum 423 Fluc (mean = 7.78 x 10
7
 p/s) during the first 5 days. After 6 
days the signal for L. plantarum 423 Fluc rapidly declined to approximately 1 x 10
5
 p/s, while 
the signal for E. mundtii ST4SA Fluc declined to approximately 5 x 10
5
 p/s. From day 6, the 
L. plantarum 423 Fluc bioluminescent signal remained at a plateau until day 9 
(approximately 1 x 10
5
 p/s). The E. mundtii ST4SA Fluc bioluminescent signal declined to 
approximately 2 x 10
5
 p/s on day 7 and to approximately 8 x 10
4
 p/s after 9 days.  
Fig. 5B. 
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FIG. 6.  Monitoring of colonization and persistence of L. plantarum 423 and E. mundtii ST4SA in the 
GIT of mice by bioluminescence imaging in whole animals after five daily administrations. 
Lactobacillus plantarum 423 Fluc and E. mundtii ST4SA Fluc were fed once daily by intragastric 
gavage (4 x 10
9
 CFU) to two groups of mice for five consecutive days (days 1 to 5). The 
bioluminescent signals in log10 photons/s measured in whole animals from day 1 to 9 for each set of 
three mice (A) are plotted, with standard deviations. No statistical differences between the 
bioluminescence signals of the two groups of mice were observed. The background bioluminescence 
signal emitted is represented by a dashed line. (B) Visual images of bioluminescence emission in 
whole animals by mice fed once daily for five consecutive days with L. plantarum 423 Fluc or E. 
mundtii ST4SA Fluc. One representative image of one mouse is shown. The intensity of the photon 
emission is represented as a pseudo-color image. One representative scale bar is shown (p/s). 
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The intestines of mice were imaged ex vivo to determine which sections of the GIT the 
bacterial strains colonized after 5 oral administrations (Fig. 7). On day 1, both strains were 
detected throughout the small intestine as of 30 min after oral administration of bacteria. 
From day 2 to day 5, both strains were detected in the jejunum and ileum sections of the 
small intestine (jejunum and ileum) and in both the cecum and colon sections of the large 
intestinal tract. At days 6 and 7 (1 and 2 days after last bacterial dose), L. plantarum 423 Fluc 
colonized the small intestine and cecum readily, but the bioluminescent signal detected from 
the small intestine progressively declined and by day 9 a very weak or no bioluminescent 
signal remained (Fig. 7A). On day 9, L. plantarum 423 Fluc was predominantly localized in 
the cecum and colon. From day 6 to day 9, E. mundtii ST4SA Fluc colonized the upper 
section of the small intestine and the cecum/colon most prominently (Fig. 7B). 
Viable counts of the small and large intestine taken on days 1 to 5 revealed high numbers 
(approximately 10
8
 CFU) of both L. plantarum 423 Fluc and E. mundtii ST4SA Fluc (Fig. 7C 
and D). At day 7 (2 days after last bacterial dose), the colonization of the large intestine 
(mean value of 3 x 10
5
 CFU) by L. plantarum 423 Fluc was 10-fold superior to that of the 
small intestine (mean value of 3 x 10
6
 CFU). Two days later, the difference between the 
amount of viable L. plantarum 423 Fluc cells in the small (mean value of 9 x 10
2
 CFU) and 
large intestine (mean value of 8 x 10
4
 CFU) increased to 100-fold. In the case of E. mundtii 
ST4SA Fluc, the number of viable cells in the small intestine increased from approximately 
of 1 x 10
3
 CFU on day 6 to 2 x 10
4
 CFU on day 9. On day 9, mice administered with L. 
plantarum 423 Fluc harboured approximately 9 x 10
4
 CFU in the cecum/colon, while mice 
administered E. mundtii ST4SA Fluc, approximately to 7 x 10
4
 CFU in the cecum/colon. 
After 20 days, no L. plantarum 423 Fluc were detected in the intestines of mice. However, 
the number of E. mundtii ST4SA Fluc cells in the small intestine was still approximately 1.4 
x 10
3
 CFU and 5 x 10
3
 CFU in the large intestine. 
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Fig. 7. Comparison of colonization abilities of L. plantarum 423 and E. mundtii ST4SA in the GIT of 
mice after five daily oral administrations. Lactobacillus plantarum 423 Fluc and E. mundtii ST4SA 
Fluc were fed once daily by oral gavage (4 x 10
9
 CFU) to two groups of mice for five consecutive 
days (days 1 to 5). Four mice (two per group) were sacrificed from day 1 to 9, and a representative 
image of the GIT of one mouse is shown (days 1 to 9) in mice fed with (A) L. plantarum 423 Fluc or 
(B) E. mundtii ST4SA Fluc. Persistence of viable L. plantarum 423 Fluc or E. mundtii ST4SA Fluc 
cells in (C) the small and (D) large intestinal tract of mice sacrificed at time points indicated in A and 
B and day 20.  
 
 
Fig. 7C. 
Fig. 7D. 
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Persistence of L. plantarum 423 and E. mundtii ST4SA in faeces after five oral dosages 
The persistence of bioluminescent L. plantarum 423 Fluc and E. mundtii ST4SA Fluc in 
faeces and their respective bioluminescent signals were monitored every day for 20 
consecutive days (Fig. 8A and B). Enterococcus mundtii ST4SA Fluc persisted in the faeces 
throughout the trial, with significantly higher cell numbers recorded at days 4, 19 and 20 
compared to L. plantarum 423 Fluc. The maximum amount of viable E. mundtii ST4SA Fluc 
cells in faeces was excreted at day 4 (approximately 2 x 10
8
 CFU/100 mg faeces). From day 4 
to 9 the level of E. mundtii ST4SA Fluc cells in faeces declined to approximately 1 x 10
4
 
CFU/100 mg faeces. After day 9 there is a slight increase in the number of E. mundtii ST4SA 
Fluc cells in faeces until day 11 after which levels of approximately 10
4
 to 10
5
 CFU/100 mg 
faeces were maintained from days 12 to 20. Lactobacillus plantarum 423 Fluc, on the other 
hand, reached a maximum level of approximately 2 x 10
8
 CFU/100 mg faeces at day 1 and 
then steadily declined until day 19 (mean value of 1 x 10
4
 CFU/100 mg faeces). Lactobacillus 
plantarum 423 Fluc persisted for only 13 days in faeces after the last day of intragastric 
administration of bacteria (day 5). 
The bioluminescent signal of E. mundtii ST4SA Fluc cells in faeces was detected throughout 
the trial period, while the L. plantarum 423 Fluc bioluminescent signal declined to the 
background level at day 19. The peaks of the amount of viable cells per 100 mg faeces of 
both strains correlated perfectly with the amount of bioluminescent signals emitted at 
different time points. The bioluminescent signal of L. plantarum 423 Fluc was detected at 
lower levels between days 2 and 6, but displayed levels similar to those observed for E. 
mundtii ST4SA Fluc from day 7 until 18. The bioluminescent system allowed the detection of 
both L. plantarum 423 Fluc and E. mundtii ST4SA Fluc viable cells in faeces as low as 10
4
 
CFU/100 mg faeces. 
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FIG. 8. Persistence of L. plantarum 423 and E. mundtii ST4SA in mouse faeces after five daily oral 
administrations. Groups of three mice each were administered once daily (days 1 to 5) with 4 x 10
9
 
CFU L. plantarum 423 Fluc or E. mundtii ST4SA Fluc for five consecutive days. Mouse faeces were 
collected daily from days 1 to 20. At each time point, log10 averages of the (A) cell counts per 100 mg 
faeces and the corresponding (B) bioluminescence in log10 p/s per 100 mg faeces for each group of 
three mice are plotted with standard deviations. Significant differences between the two groups were 
assessed using the Mann-Whitney nonparametric test and are indicated with one (P<0.05), two 
(P<0.01) or three (P<0.001) asterisks.  The background bioluminescence signal emitted is represented 
by a dashed line. 
Fig. 8A. 
Fig. 8B. 
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Discussion 
A major advantage of using the BLI technique compared to conventional approaches is that it 
allows for drastic reductions in the number of animals to be sacrificed to establish the precise 
location of bacteria in mouse or rat models (20). Moreover, more information is gathered 
over a shorter period per experiment compared to traditional pre-clinical animal trials (21). In 
the current study, an IVIS system and the BLI technique were used to study the colonization 
dynamics of the probiotic LAB strains L. plantarum 423 and E. mundtii ST4SA in the GIT of 
mice. 
The stable expression of reporter genes during in vivo imaging is an absolute prerequisite for 
the detection of luminescent light through animal tissues. Stable expression of reporter genes 
depends on the nature of the expression vector used, including the promoters used to drive 
expression and plasmid copy numbers. With this in mind, expression of the firefly luciferase 
gene from P. pyralis (ffluc) was optimized for use in L. plantarum 423 and E. mundtii 
ST4SA. Results in this study demonstrate that highest bioluminescence signals were achieved 
using the pNZ8048 high-copy number plasmid (42) for luciferase gene expression (Fig 1). 
Attempts to use a low-copy number plasmid and chromosomally integrated ffluc genes in L. 
plantarum 423 and E. mundtii ST4SA resulted only in the emission of weak and inconsistent 
bioluminescent signals (not shown). The former results are most likely linked to the presence 
of multiple copies of the pNZ8048 plasmid that in turn leads to higher expression levels of 
the ffluc gene within the respective LAB hosts. The expression of reporter genes in bacteria 
using plasmids is widely used. Bacterial plasmids play an important role in the ability of 
bacteria to adapt in diverse environments (44). However, when introducing a new 
recombinant plasmid harbouring a reporter gene, it is critical to evaluate its stability and 
persistence within the bacterial host with and without antibiotic pressure. This study 
demonstrates that the ffluc expression plasmids were remarkably stable in L. plantarum 423 
Fluc and E. mundtii ST4SA Fluc and that bioluminescence did not affect the growth of the 
respective host strains compared to the wild-type derivatives (Fig. 2). In terms of promoter 
selection, the lactate dehydrogenase gene (ldh) promoters of L. plantarum 423 and E. mundtii 
ST4SA, respectively, drove highest bioluminescence for the ffluc gene. The L. plantarum ldh 
gene promoter has been used for the constitutive expression of genes in LAB in several 
studies (28, 31, 44, 46). These results demonstrated that both L. plantarum 423 Fluc and E. 
mundtii ST4SA Fluc could produce bioluminescence with no loss of the firefly luciferase-
expressing plasmids. 
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The current study was designed to study the colonization (spatial and temporal) dynamics of 
L. plantarum 423 and E. mundtii ST4SA orally inoculated once or for five consecutive days 
over a period of 24 h and 20 days, respectively. Strong bioluminescence signals emitted by L. 
plantarum 423 Fluc and E. mundtii ST4SA Fluc could be detected as soon as 15 min after 
oral administration with a single bacterial dosage of the respective strains (Fig. 3). The 
bioluminescence signals of both strains as recorded with whole body imaging showed an 
overall decline after a single oral administration to mice. This is an indication that the 
probiotic strains only transiently colonized the GIT of mice after a single oral administration. 
In a previous report, using the mCherry fluorescence gene and a conventional culture-based 
method, we showed similar transit dynamics of viable L. plantarum 423 and E. mundtii 
ST4SA after a single dose of each bacterial strain (28). However, we could not obtain 
fluorescence signals from in vivo whole body imaging for real-time analysis and could only 
locate the bacterial strains in the GIT after killing the animals. Interestingly, in the current 
study bioluminescence signals were detected up to 6 h in whole animals fed with either L. 
plantarum 423 or E. mundtii ST4SA and up to 24 h in mice fed with E. mundtii ST4SA. Eom 
and co-workers (25) could not detect a bioluminescence signal after 3 h from mice 
administered bioluminescent L. casei CJNU 0588. Based on whole body bioluminescence 
imaging in real-time, these results clearly reflect the superior active replication and 
colonization abilities of L. plantarum 423 and E. mundtii ST4SA in the mouse GIT compared 
to L. casei CJNU 0588. 
The bacterial transit time in the GIT for viable L. plantarum 423 and E. mundtii ST4SA 
varied. Lactobacillus plantarum 423 showed a slower transit time and was detected in the 
lower part of the jejunum and in the ileum 45 min post gavage, while E. mundtii ST4SA was 
detected in the ileum, cecum and colon (Fig. 4A). Similarly, Karimi and co-workers (47) 
demonstrated that the gastrointestinal transit time differs between strains of L. reuteri, using 
fluorescence and bioluminescence imaging techniques. However, the authors did not 
selectively monitor the bacterial cell numbers of the LAB strains present in gastrointestinal 
tissue or stool samples. Although it was shown in the current study that there is excellent 
correlation between bioluminescence and bacterial load, it is important to verify that a certain 
level of bioluminescence correlates to a certain number of cells. Enumeration of viable counts 
in dissected intestines revealed that both bioluminescent LAB strains were located 
predominantly in the large intestine (cecum/colon) 3 h post gavage (Fig. 4B). No 
bioluminescent cells of L. plantarum 423 or E. mundtii ST4SA were detected in the stomach 
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or duodenum compartments 45 min after intragastric administration of the respective bacteria 
(Fig. 4A). In a previous study, similar transit dynamics were observed with a L. plantarum 
and a Lc. lactis strain expressing click beetle luciferase (31). These results are indicative of 
the harsh conditions the LAB strains are exposed to in those compartments of the GIT and 
may be the reason for the rapid transit time in those sections of the gut. The CFU counts 
revealed the presence of viable cells of L. plantarum 423 and E. mundtii ST4SA in the small 
intestine at 4 and 24 h post gavage, but no bioluminescent signals could be detected. This 
might be caused by reduced cell activity or the inhibition of protein synthesis during passage 
in the stomach and duodenum compartments of the gut, which leads to inefficient 
bioluminescence emission. Bioluminescent light can only be produced in metabolically active 
cells (20). Both strains could be detected in the cecum and colon after 4 h, indicating the 
metabolically active state of the bacteria in the large intestine (Fig. 4A). 
After 24 h, no bioluminescent signal could be detected from mice administered with L. 
plantarum 423, while a detectable bioluminescent signal was still observed from mice fed 
with E. mundtii ST4SA (Fig. 3). This indicates that L. plantarum 423 was eliminated from 
the GIT of mice more rapidly than E. mundtii ST4SA, and is associated with a significantly 
higher amount of viable E. mundtii ST4SA in the large intestine compared to L. plantarum 
423 (Fig. 4C). Both strains were excreted in high numbers in the faeces of mice over the 24 h 
period, but it is clear that a small amount of each LAB strain persisted in the GIT after a 
single oral dose as demonstrated with intestinal tissue CFU counts (Figs 4 and 5). Overall, the 
gastrointestinal colonization dynamics of L. plantarum 423 and E. mundtii ST4SA after a 
single dosage are similar to those reported for several LAB strains, including L. reuteri 6475, 
L. casei, L. plantarum SS2, L. plantarum WCFSI, L. plantarum NCIMB8826 and Lc. lactis 
MG1363 (31, 47-49).  
To study more thoroughly the persistence of the bioluminescent strains in the GIT, mice were 
administered orally with either L. plantarum 423 or E. mundtii ST4SA for five consecutive 
days. Results demonstrate that L. plantarum 423 and E. mundtii ST4SA had similar GIT 
transit dynamics during the first 5 days of administration of the respective strains to mice, 
despite the detection of higher bioluminescent signals for E. mundtii ST4SA compared to L. 
plantarum 423 (Fig. 6). At day 6 (one day after last bacterial dosage), the in vivo 
bioluminescent signals of both strains declined to low levels but were maintained at similar 
levels for the next 3 days. This suggests that while most of the administered bacteria transited 
the GIT of mice, small populations of both strains persisted until day 9 (4 days after last 
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bacterial dosage). These observations were confirmed by ex vivo imaging of dissected 
intestines (Fig. 7A and B). At day 9, bioluminescent cells of both strains were predominantly 
localized in the cecum and colon. It has been suggested that the murine cecum may be the site 
where microorganisms adapt to the gastrointestinal environment and where the activation of 
genes required for colonization of the colon occur (27). Interestingly, the cecum and colon 
have also been shown to be the major sites of colonization of several enteric pathogens 
including E. coli O157:H7, Citrobacter rodentium, Yersinia enterocolitica, L. monocytogenes 
and S. typhimurium (40, 50-53). Both L. plantarum 423 and E. mundtii ST4SA have been 
demonstrated to exclude pathogens such as L. monocytogenes, S. typhimurium, C. sporogenes 
and E. faecalis in in vitro or in vivo competitive exclusion experiments (38-40). The presence 
of persistent populations of L. plantarum 423 and E. mundtii ST4SA in the murine 
cecum/colon as demonstrated in this study suggest that their presence may have prevented the 
pathogenic bacteria from becoming established. It is also interesting to note that the 
population of E. mundtii ST4SA in the small intestine increased until day 9 compared to that 
of L. plantarum 423 (Fig. 7C). This could explain why mice pre-colonized with E. mundtii 
ST4SA showed a more rapid decline in L. monocytogenes EGDe cell numbers compared L. 
plantarum 423 in a competitive exclusion experiment (40). Enterococcus mundtii ST4SA 
cells were able to persist in the faeces of mice throughout the trial period (Fig. 8). In contrast, 
L. plantarum 423 could not be detected in faeces after 13 days after the last oral 
administration to mice and in lower numbers compared to E. mundtii ST4SA. Based on 
bioluminescence, the amount of bacteria administered to mice per day (4 x 10
9
 CFU) and the 
amount of E. mundtii ST4SA cells shed in the faeces per day, there is a clear indication that 
E. mundtii ST4SA persists better than L. plantarum 423 in the murine GIT of mice. 
The construction and optimization of LAB reporter strains is an important step towards a 
better understanding of the route and destination of orally administered probiotics in the GIT, 
and the interactions between probiotics and the host. This study demonstrates the application 
of the firefly luciferase system to compare the colonization dynamics of L. plantarum 423 
and E. mundtii ST4SA in mice. The in vivo BLI system revealed the precise location of the 
bacterial strains within the murine GIT after single or multiple doses. Both strains 
prominently colonized the cecum and colon. Enterococcus mundtii ST4SA persisted in the 
GIT and faeces of mice throughout the trial period and also actively colonized the small 
intestine. This is the first report of bioluminescence in vivo imaging of E. mundtii ST4SA in a 
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mouse model. The bioluminescence system developed in this study has the potential to 
elucidate the in vivo colonization dynamics of other important probiotic LAB species. 
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TABLE S1. Primers used in this study 
Target Primer Sequence 5’ to 3’ Restriction 
sites 
Product 
size (bp) 
Pldh Pldh1 GCGCAGATCTAATCTTCTCACCGTCTTG 
 
BglII 520 
 Pldh2 ATATCCATGGTAAGTCATCCTCTCGTAGTG 
 
NcoI  
STldh ldhS1 GCGCAGATCTGAAGAACACAATCCGACT 
 
BglII 166 
 ldhS2 TCCTCCATGGTCTAACACACCTTTCA 
 
NcoI  
ffluc FlucFor ATATCCATGGAGGACGCTAAGAACATCA 
 
NcoI 1669 
 FlucRev GCGCTCTAGACACAATTTCGACTTGCCAC XbaI  
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FIG. S1. Schematic representing the construction of the pNZPldhFfluc and pNZSTldhFfluc luciferase 
expression plasmids. Relevant features are indicated, including restriction sites and PCR primers used for 
Pldh promoter 
Amplicon size: ~ 0.5 kb 
 
STldh promoter 
Amplicon size: ~ 0.2 kb 
 
ffluc gene 
Amplicon size: ~ 1.7 kb 
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cloning; the E. coli/LAB repA and repC replication ori; the chloramphenicol acetyltransferase (cat) gene 
conferring resistance to chloramphenicol; the Pldh promoter from the L. plantarum 423 lactate 
dehydrogenase gene and the STldh promoter from the E. mundtii ST4SA lactate dehydrogenase gene. 
 
                                                     
 
FIG. S2. Different sections of dissected mouse intestinal tract 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG. S3. Experimental design. 
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Development of a Novel Selection/Counter-selection 
System for Efficient Isolation of Double-crossover 
Homologously Recombined Mutants in Lactic Acid 
Bacteria, Enabling Directed Chromosomal Gene Deletions 
and DNA Integrations 
Abstract 
Lactic acid bacteria (LAB) have significant potential as probiotics due to the beneficial 
effects they exert on consumer health. The isolation of stable recombinant DNA integration 
or deletion LAB mutants is desirable when studying probiotic modes of action. The 
functional effects of genes expressed by LAB in vitro or in vivo can only be truly assessed by 
the creation of knockout derivatives of strains expressing these genes, yet this remains a 
major limitation for this important bacterial group. In this report the construction of a novel 
selection/counter-selection system that facilitates the rapid and efficient isolation of stable 
double-crossover integration or deletion mutants is described. The study reports on the 
application of the Lactococcus lactis nisin A inducible promoter in LAB for the expression of 
a toxin gene counter-selection marker to generate stable DNA integrations or deletions at any 
genomic loci. This system is based on the Escherichia coli mazF toxin gene as counter-
selectable marker under control of the inducible nisin promoter and simultaneous expression 
of NisR and NisK signalling proteins. Although this work focuses on two probiotic strains, 
Lactobacillus plantarum 423 and Enterococcus mundtii ST4SA, the system developed here 
could be adapted to most, if not all, LAB species. Large sequences can be inserted or deleted 
in a series of steps, as demonstrated by insertion of the firefly bioluminescence gene (ffluc) 
and erythromycin resistance marker into the bacteriocin operons or adhesion genes of L. 
plantarum 423 and E. mundtii ST4SA. Furthermore, this study reports on the use of the 
FLP/FRT recombination system and an antisense RNA transcript to create markerless 
chromosomal gene integrations/deletions in LAB. This work opens the way to the isolation of 
reliable integration/deletion mutants of LAB and other diverse microorganisms.  
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Introduction 
In recent years a profitable probiotic market has emerged, with an increasing number of 
probiotic-containing supplements conferring specific health benefits to the consumer (1). 
Strains of lactic acid bacteria (LAB) and bifidobacteria are the most frequently used as 
probiotics and form part of many functional foods and dietary supplements (2-4). Probiotic 
LAB have a long history of safe use in food and therapeutic products and an increased 
recognition of their beneficial effects on human health (5). However, the underlying 
mechanisms responsible for these effects on the health of the consumer have yet to be fully 
elucidated and are likely to be multifactorial. If the growing consumer interest in probiotics is 
to continue, it is crucial to identify the precise mechanisms of action by which probiotics 
influence human health. One way to provide verification of probiotic modes of action is the 
use of single or multiple gene knockout analyses of bacterial mutants in in vitro or in vivo 
models (6). 
The functional analysis of proteins expressed by genes that confer specific phenotypical 
properties has underpinned biotechnology for decades. The potential scope of such an 
approach has grown exponentially with the availability of whole-genome sequencing, 
commercial de novo DNA synthesis and synthetic biology (7). While many species of LAB 
are now transformable by electroporation and have thus become amenable to genetic 
manipulation using plasmid vectors, methods for the isolation of stable and irreversible 
genetic mutants are still underdeveloped (8-10). The construction of tailor-made LAB strains 
for functional genetic analyses is dependent on efficient genetic methods and is often reliant 
on chromosomal integrations or deletions of specific target genes (11). This calls for the 
development of techniques that will allow for the easy and efficient selection of 
chromosomally or plasmid located gene excisions/integrations.  
For many years, researchers have used replicative plasmids to express foreign DNA in 
microorganisms, but these are inherently unstable when expressed in vitro or in vivo where 
antibiotic selection is not possible, thus limiting their applied utility (12). To circumvent 
antibiotic selection-related issues, exogenous DNA must be irreversibly incorporated into a 
DNA molecule inside the cell, usually on a chromosome or plasmid of the host 
microorganism. In this way, integration of recombinant DNA is achieved by positioning a 
selectable marker gene alongside a DNA sequence that is homologous to the target gene of 
interest within an allele exchange cassette. This has been achieved successfully in yeast and 
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naturally competent Bacillus subtilis that are easily transformable with linear DNA gene 
exchange cassettes (13). However, most bacteria, including LAB, cannot be transformed with 
linear DNA, thus integration plasmids bearing DNA homologous to the site of chromosomal 
integration are used instead. Desired recombinant cells are specifically selected and isolated 
using the selectable marker, typically an antibiotic resistance gene. Several sequences can be 
inserted at multiple loci by simply alternating between selectable markers, usually antibiotic 
resistance genes as described in the ‘domino’ method of Itaya and co-workers (14). This 
method can be effective, but is not without limitations. A major drawback is the availability 
of suitable antibiotic resistance markers for use as selection/counter-selection markers in the 
strain of interest. According to this strategy, different antibiotic resistance genes have to be 
used to introduce multiple chromosomal modifications. Moreover, multi-antibiotic selection 
pressure could potentially modify the physiology of the recombinant strain.  
One method commonly used for the construction of stable integration mutants in LAB is the 
use of plasmid vectors containing the chromosomally located conjugative transposon Tn919, 
which is utilized as the region of homology required to mediate insertion into the host 
genome (15, 16). While this method has been successfully applied in Enterococcus faecalis 
and Lactococcus lactis, it cannot be used for specific targeted gene deletions. Another 
method often employed for targeted gene inactivation and DNA chromosomal integrations is 
based on the use of suicide vectors. Suicide vectors are plasmids that are unable to replicate 
in a specific host, but which express antibiotic resistance genes and carry sequences 
homologous to a target sequence on the chromosome of the strain to be modified. The site of 
DNA integration then corresponds to the chromosomal locus of the sequence carried by the 
plasmid. This type of insertion has been successfully used in Gram-negative and -positive 
bacteria, including Escherichia coli (17-18), Lc. lactis (16, 19, 20), B. subtilis (21-23), L. 
plantarum (24, 25) and Streptococcus pneumonia (26, 27) to map non-selectable genes. In 
most of these studies, the isolation of successful integrations was straightforward, but strains 
that have lost the plasmid backbone may be difficult to isolate. Moreover, as plasmids are 
circular, single homologous recombination events may be unstable and reversible, resulting 
in single- crossover mutants with the potential to revert back to the wild-type. The isolation 
of stable double-crossover mutants from single-crossover cells is further complicated as both 
contain the selectable marker present in the allele exchange cassette. This can be overcome 
by the use of a counter-selection marker located on the plasmid backbone, but the 
identification of a suitable counter-selection marker under specific conditions to use as a 
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genetic tool can be a challenging task (28, 29). The use of the upp gene, which codes for 
uracil phosphoribosyltransferase has been used as a counter-selectable marker in Lc. lactis 
(30-31). The upp gene is responsible for conferring toxicity to cells in the presence of 5-
fluorouracil, whereas the loss thereof leads to resistance to 5-FU. The main limitation of the 
applied utility of the upp gene as counter-selectable marker is that it is present in the 
nucleotide metabolic pathway of almost every organism (32). Another disadvantage is that 5-
FU may be toxic even in upp mutants, thus further hampering its use as a heterologous 
counter-selectable marker. Nonetheless, counter-selectable markers have been proven 
invaluable in the construction of clean and unmarked gene deletions or insertions in various 
unicellular microorganisms (28, 33-39).  
This study reports on the development of a strategy generally applicable to all LAB species 
for the quick and efficient isolation of double-crossover homologously recombined mutants 
at any genomic loci. The use of a toxin gene as counter-selectable marker placed under the 
control of the Lc. lactis nisin inducible promoter (PnisA) that forms part of the well-
characterized nisin-controlled expression (NICE) system (for a complete review on the NICE 
expression system, see reference 40) is described. The PnisA promoter is auto-inducible by 
nisin in Lc. lactis, but can be induced heterologously in other LAB strains using sub-
inhibitory concentrations of nisin (41). For heterologous exploitation of the NICE system, the 
nisK and nisR nisin regulatory genes required for signal transduction have to be expressed in 
conjunction with the use of the PnisA promoter (42). The NICE system has been successfully 
adapted for gene expression or protein secretion in several LAB species (41, 43). The E. coli 
mazF gene was chosen as a toxin gene for plasmid-borne counter-selection that has been used 
successfully as a counter-selection marker in B. subtilis (38) and Clostridium spp. (39). The 
mazF gene is an mRNA interferase (sequence-specific endoribonuclease) that forms part of 
the MazE-MazF toxin-antitoxin (TA) system of E. coli, encoded by the mazEF operon (44). 
The mazEF TA system comprises a stable MazF toxic peptide that is neutralized by an 
unstable MazE antitoxin under normal conditions. Once the cells are subjected to cellular 
stress, the MazE protein is degraded by proteases, releasing the MazF protein from inhibition 
(45). Ectopic expression of the MazF toxin then promotes cell death by specifically targeting 
mRNAs at ACA sequences (46). In the counter-selection system described here, the 
expression of the MazF toxin under the control of PnisA is directly coupled to the formation 
of desired double-crossover mutants using an associated selectable phenotype. Using this 
method, DNA fragments can be irreversibly inserted or deleted at any genomic locus in L. 
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plantarum 423 and E. mundtii ST4SA in a step-by-step manner. The application of the FLP-
FRT recombination system to generate markerless homologously recombined mutants is also 
demonstrated. This method may be applicable to many, if not all, transformable LAB species. 
Materials and Methods 
Bacterial strains, plasmids and culture media 
Bacterial strains and general cloning plasmids are listed in Table 1. The integration vectors 
and their relevant characteristics are listed in Table 2. All subcloning experiments were done 
in E. coli DH5α (47) and E. coli MC1061 (Mobitech, Goettingen, Germany). Escherichia coli 
strains were grown in Luria-Bertani (LB), brain heart infusion (BHI) broth or solid agar 
(1.5% w/v) (Biolab Diagnostics, Midrand, South Africa) and incubated at 37
o
C with rotary 
shaking at 200 rpm. Forty micrograms per milliliter of X-gal was added to E. coli LB growth 
media when required for blue-white colony screening. The probiotic LAB strains L. 
plantarum 423 and E. mundtii ST4SA were grown as static cultures at 30
o
C in MRS broth 
(Biolab Diagnostics) or on MRS agar plates. Lactococcus lactis pNZ9000 was grown at 30
o
C 
in M17 broth (Biolab Diagnostics) without shaking, or on agar plates supplemented with 
0.5% (w/v) glucose. Escherichia coli strains containing plasmids (Table 1) were cultured in 
LB or BHI medium supplemented with either 200 µg/ml erythromycin (Em), 10 µg/ml 
chloramphenicol (Cm) or 100 µg/ml ampicillin (Amp). Recombinant LAB strains containing 
plasmids, and integrative mutants (Table 2), were cultured in MRS or M17 medium 
supplemented with 10 µg/ml Em or 10 µg/ml Cm for L. plantarum 423, and 5 µg/ml Em or 5 
µg/ml Cm for E. mundtii ST4SA and Lc. lactis pNZ9000. Listeria monocytogenes EGDe was 
grown in BHI media supplemented with 7.5 µg/ml Cm and incubated at 37
o
C on an orbital 
shaker (200 rpm). 
DNA manipulation procedures and transformation 
Nucleic acid manipulations and general cloning procedures were carried out according to 
standard protocols, as described by Sambrook and Russel (48). DNA restriction and 
modification enzymes were purchased from New England Biolabs (NEB, Ipswich, MA, 
USA) and were used as recommended by the manufacturer. Oligonucleotides (Table 3) were 
purchased from Inqaba Biotechnical Industries (Pretoria, South Africa). PCR amplifications 
were performed using Q5 high-fidelity PCR DNA polymerase (NEB) in a SwiftMinipro 
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thermal cycler (Esco Healthcare, Malaysia). DNA fragments were purified from agarose gels 
using the Zymoclean
TM
 gel DNA recovery kit (Zymo Research Corporation, Irvine, CA, 
USA). Escherichia coli plasmid DNA was purified using the PureYield
TM
 plasmid miniprep 
system (Promega, Madison, WI, USA). Genomic DNA (gDNA) of E. coli and LAB strains 
was purified using the ZR Fungal/Bacterial DNA miniprep kit (Zymo Research Corporation) 
following the manufacturer’s instructions. Electrotransformation of E. coli, L. plantarum 423 
and E. mundtii ST4SA was achieved as described previously (25), using the Bio-Rad Gene 
Pulser electroporation system (Bio-Rad Laboratories, Hercules, CA, USA). Lactococcus 
lactis NZ9000 was electroporated as suggested by the supplier, using standard procedures 
(Mobitech). 
TABLE 1. Plasmids and strains 
Strain or plasmid Description Reference or source 
Strains   
E. coli   
    DH5α  
 
    MC1061    
Host strain used for general 
subcloning 
Host strain used for subcloning 
with Lc. lactis derived pNZ8048 
vector; recA positive strain 
(47) 
 
Mobitec, Göttingen, Germany. 
 
Lactobacillus plantarum   
    423    
 
 
 
 
 
    423 pNZmazFnisRK 
 
    423 pNZ8048 
 
    423 pNZCherrynisRK 
 
    423 bac
-
 
Probiotic with multiple adhesion 
genes and a plantaricin 
bacteriocin producer; forms part 
of the entiro
TM
 probiotic; 
originally isolated from sorghum 
beer 
Contains the pNZmazFnisRK 
plasmid; Cm
R
  
Contains the pNZ8048 plasmid; 
Cm
R
   
Contains the pNZCherrynisRK 
plasmid; Cm
R
 
Derivative of L. plantarum 423, 
cured of the plasmid (pPLA4) 
harboring the plaA bacteriocin 
gene  
Cipla Medpro (Pty.) Ltd. 
 
 
 
 
 
This study 
 
This study 
 
This study 
 
(49) 
Enterococcus mundtii   
    ST4SA 
 
 
 
 
    ST4SA pNZmazFnisRK 
 
    ST4SA pNZ8048 
 
    ST4SA pNZCherrynisRK 
Probiotic with multiple adhesion 
genes and a mundticin bacteriocin 
producer; forms part of the 
entiro
TM
 probiotic; originally 
isolated from soybeans 
Contains the pNZmazFnisRK 
plasmid; Cm
R
   
Contains the pNZ8048 plasmid; 
Cm
R
  
Contains the pNZCherrynisRK 
plasmid; Cm
R
  
Cipla Medpro (Pty.) Ltd. 
 
 
 
 
This study 
 
This study 
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Lactococcus lactis 
    pNZ9000 
 
 
 
 
    pNZ9000 pNZmazF 
 
    pNZ9000 pNZCherry 
 
Listeria monocytogenes 
    EGDe 
 
 
Plasmids 
 
Standard host strain for  
nisin regulated gene expression; 
harbors the nisR and nisK nisin 
regulatory genes integrated into 
the pepN gene locus 
Contains the pNZmazF plasmid; 
Cm
R
  
Contains the pNZCherry plasmid; 
Cm
R
  
 
Food-borne clinical pathogen; 
harbors the pPL2 lux plasmid; 
Cm
R
   
 
Mobitec, Göttingen, Germany. 
 
 
 
 
This study 
 
This study 
 
 
Caliper Life Sciences, 
Hopkinton, MA, U.S.A. 
    pNZ8048 
 
 
 
Broad-host range vector; E. coli 
shuttle vector; LAB expression 
vector containing nisin A 
inducible-promoter (PnisA); Cm
R 
Mobitec, Göttingen, Germany; 
(40) 
 
 
    pGKV223D E. coli/LAB shuttle vector; LAB 
expression vector with L23 
promoter; Em
R
 
University of Gröningen, The 
Netherlands 
 
    pNZnisRK pNZ8048 vector carrying the nisR 
and nisK regulatory genes for 
cloning in LAB strains that do not 
have the regulatory genes 
integrated onto the chromosome; 
Cm
R
 
This study 
    pNZmazF pNZ8048 vector carrying the E. 
coli mazF toxin gene under the 
control of the PnisA promoter; 
Cm
R
 
This study 
    pNZmazFnisRK 
 
 
 
    pNZmazFnisRKerm 
pNZnisRK vector carrying the E. 
coli mazF toxin gene under the 
control of the PnisA promoter; 
Cm
R
 
pNZ8048nisRK vector carrying 
the E. coli mazF toxin gene under 
the control of the PnisA promoter 
and the erm gene; Cm
R
, Em
R 
This study 
 
 
 
This study 
    pNZErmFluc423 
 
 
 
 
 
    pGKVCatFflucST4SA 
    
 
 
 
 
    pBluescriptKS 
pNZ8048 vector carrying the erm 
gene fused to the Photinus pyralis 
firefly luciferase gene (ffluc) 
under the control of the 
constitutive L. plantarum 423 
lactate dehydrogenase (ldh) gene 
promoter (Pldh); Em
R
, Cm
R 
pGKV223D vector carrying the 
cat gene fused to the ffluc gene 
under the control of the 
constitutive E. mundtii ST4SA 
lactate dehydrogenase (ldh) gene 
promoter (Pstldh); Em
R
, Cm
R 
PCR cloning vector; Amp
R 
This study 
 
 
 
 
 
 
This study 
 
 
 
 
 
Stratagene, California, USA. 
    pKSplaA::ErmFfluc 
 
 
 
 
pBluescriptKS plasmid carrying 
the erm-ffluc gene cassette 
flanked by L. plantarum 423 plaA 
gene regions of homology ; Em
R
, 
Amp
R
 
This study 
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    pKSmunA::CatFfluc pBluescriptKS plasmid carrying 
the cat-ffluc gene cassette flanked 
by E. mundtii ST4SA munA gene 
regions of homology; Cm
R
, Amp
R
 
This study 
    pKSaap::FRTerm pBluescriptKS plasmid carrying 
the FRT-flanked erm gene 
flanked by L. plantarum 423 aap 
gene regions of homology ; Em
R
, 
Amp
R
 
This study 
    pKSsrtA::FRTerm pBluescriptKS plasmid carrying 
the FRT-flanked erm gene 
flanked by E. mundtii ST4SA 
srtA gene regions of homology ; 
Em
R
, Amp
R
 
This study 
    pKSsrtC::FRTerm pBluescriptKS plasmid carrying 
the FRT-flanked erm gene 
flanked by E. mundtii ST4SA 
srtC gene regions of homology; 
Em
R
, Amp
R 
 
This study 
    pKSFRT 
 
 
 
    pKSFRTErm 
 
 
 
 
    pGKVPldhFLP 
 
 
 
 
    pNZasRNA_repAnisRK 
pBluescriptKS plasmid carrying 
two flippase (FLP) recombination 
target sequences (FRT) in a direct 
repeat orientation; Amp
R
 
pBluesriptKS plasmid carrying 
the erm gene flanked by two FRT 
sequences in a direct repeat 
orientation; Em
R
, Amp
R 
pGKV223D vector carrying the 
flippase (FLP) gene downstream 
of the constitutive L. plantarum 
423 lactate dehydrogenase gene 
Pldh promoter; Em
R 
pNZmazFnisRK vector carrying a 
350 bp asRNA_repA transcript 
downstream of the nisin-inducible 
PnisA promoter; Cm
R
 
This study 
 
 
 
This study 
 
 
 
 
This study 
 
 
 
 
This study 
    pNZasFLPasRNA_repA 
 
 
 
 
 
    pNZCherry 
 
 
 
    pNZCherrynisRK 
pNZasRNA_repAnisRK vector 
carrying the flippase (FLP) gene 
downstream of the constitutive L. 
plantarum 423 lactate 
dehydrogenase gene Pldh 
promoter; Cm
R 
pNZ8048 vector carrying the 
mCherry fluorescence gene under 
the control of the PnisA 
promoter; Cm
R
 
pNZnisRK vector carrying 
mCherry fluorescence gene under 
the control of the PnisA 
promoter; Cm
R
 
This study 
 
 
 
 
 
This study 
 
 
 
This study 
Cm
R
, chloramphenicol resistance; Em
R
, erythromycin resistance; Amp
R
, ampicillin resistance 
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TABLE 2. List of integration vectors and recombinant LAB strains 
Plasmid Modified strain Locus Upstream region of 
homology 
Downstream region of 
homology 
Region deleted on 
chromosome/plasmid 
Element (s) integrated onto 
chromosome/plasmid 
pNZKOplaA::ErmFfluc L. plantarum 423 
plaA::erm-ffluc 
plaA 902 bp upstream of 
plaA 
69 bp internal fragment 
of plaA, 330 bp plaB 
bacteriocin immunity 
gene and 214 bp of plaC 
bacteriocin translocation 
protein 
 
208 bp, including  
102 bp of plaA  
ORF 
3204 bp erm-ffluc gene cassette 
pNZKOmunA::CatFfluc E. mundtii ST4SA 
munA::cat-ffluc 
munA 911 bp upstream of 
munA, including 135 
bp internal fragment 
of munA ORF 
 
633 bp internal fragment 
of munB translocation 
gene 
260 bp, including 18 bp 
of munA ORF 
2471 bp cat-ffluc gene cassette 
pNZKIaap::FRTerm 
 
 
pNZKIaap::FRTerm 
 
L. plantarum 423 
aap::frt-erm 
 
L. plantarum 423 
aap::frt_um 
 
aap 
 
909 bp internal 
fragment of aap ORF  
 
909 bp internal 
fragment of aap ORF  
 
929 bp internal fragment 
of aap ORF 
 
929 bp internal fragment 
of aap ORF 
None 
 
 
1063 bp FRT-flanked 
erm resistance gene 
excised 
1458 bp FRT-flanked erm gene 
 
 
335 bp including a 96 bp FRT-
scar 
pNZKOsrtA::FRTerm 
 
 
 
 
 
 
 
 
 
pNZKOsrtCFRTerm 
 
E. mundtii ST4SA 
srtA::frt-erm 
 
 
 
 
 
 
 
 
E. mundtii ST4SA 
srtC::frt-erm 
srtA 
 
 
 
 
 
 
 
 
 
srtC 
1011 bp upstream of 
srtA, including 57 bp 
internal fragment of 
srtA ORF, 333 bp 
mazG nucleotide 
pyrophosphohydrolase 
gene and 270 bp 
fragment of mfs 
transporter ORF 
 
1011 bp upstream of 
srtC, including 59 bp 
of srtC ORF and 892 
bp of EbpCfm pilus 
subunit protein gene  
1011 bp downstream of 
srtA, including 57 bp 
internal fragment of srtA 
ORF and 576 bp internal 
fragment of bglG 
transcriptional anti-
terminator ORF 
 
 
 
376 bp downstream of 
srtA, including 60 bp of 
srtC ORF and 225 bp 
internal fragment of 
hemolysin III ORF 
580 bp internal 
fragment of the srtA 
ORF 
 
 
 
 
 
 
 
726 bp internal 
fragment of the srtC 
ORF 
1458 bp FRT-flanked erm gene 
 
 
 
 
 
 
 
 
 
1458 bp FRT-flanked erm gene 
 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
106 
 
TABLE 3. Oligonucleotides utilized in this study 
Target Primer Sequence 5’ to 3’ Restrictio
n sites 
Product 
size (bp) 
nisR-nisK nisRK1 GCGCAAGCTTCCCCGGCTTTAGGTATAG 
 
HindIII 2162 
 nisRK2 ATCCCTCGAGTTACTTTTTTATTTTTAGGATA 
 
XhoI  
mazF mazF1 GCTTGGATCCATGGTAAGCCGATACGTACC 
 
NcoI 342 
 mazF2 AGTCAAGCTTCTACCCAATCAGTACGTTAAT
T 
 
HindIII  
erm-ffluc 
gene 
cassette 
erm1 ATACGAATTCCACGACCAAAACTATAAAACC EcoRI 3204 
 fluc2 GCGCAAGCTTCACAATTTCGACTTGCCA 
 
HindIII  
plaA KO 
region 
plaAKO1 GAATTCGTGATATATAATGATGGAATTTATT
C 
 
EcoR1 2012 
 plaAKO2 TCTAGAGCCTTAGCGTACTTATCCCAGGC 
 
XbaI  
munA KO 
region 
munAKO1 GCCGGAATTCGTTTATACGATTAGTGGAATT
A 
EcoR1 1809 
 munAKO2 ATACTCTAGAGACAATATCTCCAGTTTT 
 
XbaI  
cat-ffluc 
gene 
cassette 
cat1 GGAATTCGGATCCATTCTAATGAAG EcoR1 2349 
 fluc2 GCGCAAGCTTCACAATTTCGACTTGCCA 
 
HindIII  
aap KI 
region 
aapKO1 GCCGGAATTCGAGTACTGTGACGACAGCTA EcoR1 1848 
 aapKO2 ATACTCTAGATAATCGTCCGGGTAACCGTT 
 
XbaI  
FRT-erm 
gene 
M13for GTAAAACGACGGCCAG 
 
blunt 1458 
 M13rev CAGGAAACAGCTATGA 
 
blunt  
srtA 
upstream 
region 
srtAKO1for CACCAAGCTTGTAGGTTACTTCATCAACGG HindIII 1011 
 srtAKO1rev GATAGTTAACTAGTAGAAACAATAGGAAAT 
 
HpaI  
srtA down-
stream 
region 
srtAKO2for TATAGTTAACAAAGAAGCCACCCAAGAAAT HpaI 376 
 srtAKO2rev GATATCTAGAGCCGAAAAATTTACTGATGA 
 
XbaI  
srtC 
upstream 
region 
srtCKO1for GAGGAAGCTTATTAGATGGGCAAGACGTAG HindIII 1011 
 
 
srtC down-
stream 
region 
 
strCKO1rev 
 
srtCKO2for 
 
srtCKO2rev 
GATAGTTAACCCGATAAAAAATACCGAGAA 
 
CACCGTTAACTTTTTGTTGCTATTTCTTAT 
 
CACCTCTAGAAGATTATAATTTGAATTTTA 
HpaI 
 
HpaI 
 
XbaI 
 
 
1035 
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FRT target 
1 
 
 
FRT target 
2 
 
 
erm gene 
 
 
 
FLP gene 
 
 
 
asRNA 
repA 
 
 
Pldh-FLP 
amplicon 
 
 
plaA KO 
integration 
region  
 
munA KO 
intergration 
region 
 
aap KI 
integration 
region 
 
aap KI 
unmarked 
integration 
region 
 
srtA KO 
integ ration 
region 
 
srtC KO 
integration 
region 
FRTfor1 
 
FRTrev1 
 
FRTfor2 
 
FRTrev2 
 
erm1 
 
erm 2 
 
FLPfor 
 
FLPrev 
 
asRNAfor 
 
asRNArev 
 
Pldh1 
 
FLPrev 
 
plaAKOc 
 
plaAKO2 
 
munAKOc 
 
munAKO2 
 
aapKOc 
 
aapKOc2 
 
aapKOc 
 
 
aapKOc2 
 
srtAKOc 
 
srtAKO2rev 
 
strCKOc 
 
srtCKOc2 
AGATGGATCCCTCGTTTTCGGAAACGCTTT 
 
GATACTGCAGTTCAGAGCGCTTTTGGTTTT 
 
AGATAAGCTTCTCGTTTTCGGAAACGCTTT 
 
GATAGTCGACTTCAGAGCGCTTTTGGTTTT 
 
ATACGAATTCCACGACCAAAACTATAAAACC 
 
GCTTGAATTCTTACTTATTAAATAATTTATAG 
 
GATACCATGGATGCCACAATTTGGTATATT 
 
AGTAGTCGACTTATATGCGTCTATTTATGT 
 
ATATCCATGGTTCATATGAACCTTTGAT 
 
CACGAAGCTTGATAAGGTAATTATATCAT 
 
GAATTCAATCTTCTCACCGTCT 
 
AGTAGTCGACTTATATGCGTCTATTTATGT 
 
AATATCTTCGTTGCTGTGAT 
 
TCTAGAGCCTTAGCGTACTTATCCCAGGC 
 
ATTCTTGAGAACATTCCACA 
 
ATACTCTAGAGACAATATCTCCAGTTTT 
 
GGCGCCAGCAGCCAACTCAA 
 
CGTAGCCCTCATGGCTCAGA 
 
GGCGCCAGCAGCCAACTCAA 
 
 
CGTAGCCCTCATGGCTCAGA 
 
GATGGTTTTGTTTATTCGAA 
 
GATATCTAGAGCCGAAAAATTTACTGATGA 
 
GAAGGAACGCTGAAGGTCAA 
 
AAACTAGTCCTGTCGTTCCTT 
BamHI 
 
PstI 
 
HindIII 
 
SalI 
 
EcoRI 
 
 
 
NcoI 
 
SalI 
 
NcoI 
 
 
 
EcoRI 
 
SalI 
 
- 
 
XbaI 
 
- 
 
XbaI 
 
- 
 
- 
 
- 
 
 
- 
 
- 
 
- 
 
- 
 
- 
121 
 
 
 
121 
 
 
 
1063 
 
 
 
1293 
 
 
 
350  
 
 
 
1794 
 
 
 
5118 
 
 
 
4190 
 
 
 
3696 
 
 
 
2573 
 
 
 
 
3853 
 
 
 
3183 
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Construction of plasmids 
The integration vectors for use in L. plantarum 423 and E. mundtii ST4SA were based on the 
pNZ8048 Lc. lactis NICE system plasmid (Mobitech), containing the PnisA nisA gene 
promoter region, a multiple cloning site (MCS), E. coli/Lc. lactis repC and repA replication 
genes for replication in LAB and E. coli, the cat gene for Cm resistance and the termination 
(T) sequence of the Lc. lactis pepN gene. DNA primers used are listed in Table 3. The nisin 
nisK and nisR regulatory genes were amplified from Lc. lactis pNZ9000 gDNA, using 
primers nisRK1 and nisRK2. The 2162 bp amplicon was digested with HindIII and XhoI and 
cloned into pNZ8048 after digestion of the vector with the same restriction enzymes, yielding 
plasmid pNZnisRK (Fig. 1). A schematic diagram summarizing the construction of pNZmazF 
and pNZmazFnisRK is shown in Fig. 2. Plasmids pNZmazF and pNZmazFnisRK were 
constructed to test the functionality of the nisin-inducible promoter in Lc. lactis pNZ9000, L. 
plantarum 423 and E. mundtii ST4SA. The mazF toxin gene was amplified from genomic 
DNA isolated from E. coli DH5α, using primers mazF1 and mazF2. The generated 342 bp 
amplicon was cloned into the MCS’s of pNZ8048 and pNZnisRK, using NcoI and HindIII, to 
yield pNZmazF and pNZmazFnisRK, respectively (Fig. 2). All fragments were ligated using 
T4 DNA ligase (NEB) and incubated overnight at 15
o
C, before transformation into 
electrocompetent E. coli MC1061 for plasmid propagation.  
The L. plantarum 423 plaA bacteriocin gene knockout (KO) plasmid was constructed by 
PCR, amplifying the complete 2012 bp region of homology that included the plaA open 
reading frame (ORF), using primers plaAKO1 and plaAKO2 (see Fig. S1 in the supplemental 
material). The generated amplicon was triple digested with EcoRI, HpaI and XbaI, resulting 
in the removal of 108 bp from the plaA ORF, ligated to a blunt-ended erm-ffluc gene cassette 
and pBluescriptKS digested with EcoRI and XbaI, yielding plasmid pKSplaA::ErmFfluc. The 
3204 bp erm-ffluc gene cassette contained the erm gene for erythromycin resistance, the 
firefly luciferase gene (ffluc) from Photinus pyralis fused to the strong constitutive L. 
plantarum ldh gene (Pldh) promoter, generated via PCR using primer pair erm1/fluc2 and 
plasmid pNZErmFfluc423 (Table 1) as source DNA. The pKSplaA::ErmFfluc construct was 
used as template for PCR amplification of a 5013 bp amplicon containing the plaA upstream, 
plaA downstream and erm-ffluc gene cassette using primer pair plaAKO1/plaAKO2. Next, 
the full- length blunt-ended 5013 bp PCR fragment was cloned into the destination plasmid 
pNZmazFnisRK, before digestion of the plasmid with BglII and filling in the 5’ sticky ends, 
yielding plasmid pNZKOplaA::ErmFfluc (Fig. S1). 
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FIG. 1. Schematic representing the construction of pNZnisRK. Relevant features are indicated, 
including restriction sites used for cloning; the E. coli/LAB repA and repC replication ori; the 
chloramphenicol (cat) gene conferring resistance to chloramphenicol; the nisR and nisK nisin 
regulatory genes; and the nisin-inducible PnisA promoter from Lc. lactis pNZ9000. 
 
 
HindIII XhoI 
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FIG. 2. (A) Schematic representing the construction of the MazF toxin expression plasmids 
pNZmazF, pNZmazFnisRK and (B) the arrangement of PnisA promoter placed upstream of the mazF 
gene. Relevant restriction sites are shown. For details refer to “Materials and Methods”. 
HindIII NcoI 
PnisA-mazF 
    545 bp 
 
B. 
A. 
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The E. mundtii ST4SA munA bacteriocin gene KO plasmid was constructed as follows. First, 
a complete 1809 bp region of homology that included the munA ORF was obtained by PCR 
using the primer pair munAKO1/munAKO2, incorporating EcoRI and XbaI digestion sites 
(Fig. S2). The generated amplicon was digested with EcoRI/PvuII and HpaI/XbaI, resulting 
in a munA 911 bp upstream- and a 633 bp downstream-region of homology, respectively, and 
the removal of 18 bp from the munA ORF. Next, the two regions of homology were joined 
together with a blunt-ended 2480 bp cat-ffluc gene cassette generated via PCR amplification 
using primer pair cat1/fluc2 and plasmid pGKVCatFflucST4SA (Table 1) as source DNA. 
This cat-ffluc-interrupted munA region was then cloned into the EcoRI/XbaI double-digested 
pBluescriptKS cloning vector, yielding plasmid pKSmunA::CatFfluc. In this construct, the 
ffluc gene was fused to the strong E. mundtii ldh gene (Pstldh) promoter for constitutive 
expression of the bioluminescence gene. Finally, the cat-ffluc gene cassette flanked by the 
munA upstream/downstream regions of homology (4024 bp) was PCR amplified from 
pKSmunA::CatFfluc and cloned into the StuI-linearized pNZmazFnisRKerm plasmid, 
containing both cat and erm antibiotic resistance genes, yielding plasmid 
pNZKOmunA::CatFfluc (Fig. S2). 
The L. plantarum 423 aap adhesion gene knock-in (KI) plasmid was constructed by PCR, 
amplifying a 1848 bp internal fragment of the aap ORF using primer pair aapKO1/aapKO2 
(Fig. S3). The resulting amplicon was triple-digested with EcoRI/HpaI/XbaI (HpaI has a 
single cut site approximately in the middle of the aap fragment), and ligated to the blunt-
ended flippase (FLP) recombination target (FRT) – flanked erm gene PCR fragment as well 
as the pBluescriptKS plasmid double-digested with EcoRI/XbaI, to yield plasmid 
pKSaap::FRTerm. The 1458 bp FRT-flanked erm gene was generated using primer pair 
M13for/M13rev and plasmid pKSFRTerm as source DNA (Fig. S6). The FRT-erm gene 
flanked by the aap upstream/downstream regions of homology (3305 bp) was PCR amplified 
from pKSaap::FRTerm using primer pair aapKO1/aapKO2 and cloned into the blunt-ended 
(BglII, blunted) destination plasmid pNZmazFnisRK to yield plasmid pNZKIaap::FRTerm. 
(Fig. S3). 
The E. mundtii ST4SA sortase A (srtA) deletion plasmid was constructed by amplifying two 
regions of homology flanking the srtA gene, using primer pairs, srtAKO1for/srtAKO1rev and 
srtAKO2for/srtAKO2rev. The generated amplicons (~1 kb each) were designed to include 
small internal (<60-bp) fragments of the srtA ORF in both the upstream and downstream 
regions of homology (Fig. S4). The upstream and downstream regions were then digested 
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with HindIII/HpaI and HpaI/XbaI, respectively, ligated to the blunt-ended FRT-erm gene 
PCR fragment and pBluescriptKS digested with HindIII and XbaI, yielding plasmid 
pKSsrtA::FRTerm. The complete srtA region of homology including the FRT-erm gene was 
then PCR amplified from pKSsrtA::FRTerm using primer pair srtAKO1for/srtAKO2rev, and 
cloned into the HindIII-linearized and blunt-ended plasmid pNZmazFnisRK, yielding 
plasmid pNZKOsrtA::FRTerm (Fig. S4). 
The pNZKOsrtC::FRTerm plasmid, designed for disruption of the E. mundtii ST4SA sortase 
C (srtC) gene was constructed as follows. Two regions of homology (~1 kb upstream and 
~0.4 kb downstream) flanking the srtC gene were PCR amplified using primer pairs 
srtCKO1for/srtCKO1rev and srtCKO2for/srtCKO2rev, respectively (Fig. S5). The generated 
fragments were digested with HindIII/HpaI and HpaI/XbaI, ligated to the blunt-ended FRT-
erm gene and cloned to the HindIII/XbaI double-digested pBluescriptKS plasmid, yielding 
plasmid pKSsrtC::FRTerm. Finally, the complete FRT-erm –srtC and flanking region was 
amplified from pKSsrtC::FRTerm using primer pair srtCKO1for/srtCKO2rev and cloned into 
the pNZmazFnisRK plasmid as described above, to yield plasmid pNZKOsrtC::FRTerm (Fig. 
S5). 
Plasmids pKSFRTErm and pNZFLPasRNA_repA were constructed for utilization of the 
FLP/FRT recombination system of Saccharomyces cerevisiae for the generation of unmarked 
LAB knockout mutants and antibiotic marker recycling, as follows (see Figs S6 and S7). The 
pKSFRTErm plasmid was constructed by PCR amplification of two 48 bp FRT target 
sequences using primer pairs FRTfor1/FRTrev1, FRTfor2/FRTrev2 and the S. cerevisiae 
2µm (~6.4 kb) plasmid as template DNA. The two generated amplicons containing the FRT 
target sequences were then double-digested with HindIII/SalI and BamHI/PstI, respectively, 
and cloned into the pBluescriptKS plasmid in a direct repeat orientation before digestion with 
the same restriction enzymes. The resulting plasmid (pKSFRT) was then digested with EcoRI 
(located in between the two FRT repeats) and ligated to an erm gene PCR fragment 
(erm1/erm2 primer pair) digested with the same enzyme to yield plasmid pKSFRTErm (Fig. 
S6).   
The pNZFLPasRNA_repA plasmid was constructed as follows. The 1284 bp flippase (FLP) 
gene was amplified from the 2µm plasmid using primer pair FLPfor/FLPrev, incorporating 
the NcoI/SalI digestion sites, and ligated to the EcoRI/NcoI double-digested Pldh promoter 
and double-digested EcoRI/SalI pGKV223D plasmid, yielding plasmid pGKVPldhFLP (see 
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Fig. S7). Next, a 350 bp repA antisense RNA (asRNA) PCR fragment was generated, using 
primers asRNAfor and asRNArev, and was fused upstream of the nisin-inducible promoter 
by digestion of the amplicon with NcoI and HindIII and cloned to the pNZmazFnisRK 
plasmid after digestion with the same restriction enzymes, creating pNZasRNA_repAnisRK. 
The asRNA_repA fragment was designed for inactivation of the repA replication protein by 
binding to the first 350 bp of the repA transcript as a reverse and complement RNA strand 
thus inhibiting its translation. Finally, the 1794 bp Pldh-FLP PCR fragment was amplified 
from plasmid pGKVPldhFLP using primer pair Pldh1/FLPrev and subsequently cloned into 
the BglII blunt-ended pNZasRNA_repAnisRK plasmid, yielding plasmid 
pNZFLPasRNA_repA. The integrity of all plasmids constructed was verified by restriction 
digests and by PCR using appropriate primer combinations (Table 3). 
Optimization of MazF toxin expression using the nisin-inducible promoter in LAB 
Control L. plantarum 423 and E. mundtii ST4SA strains transformed with empty pNZ8048 
plasmid and recombinant L. plantarum 423 and E. mundtii ST4SA transformed with the 
pNZmazFnisRK plasmid were grown in MRS broth for 12 h. One millilitre of the 12-h old 
cultures was used to inoculate 50 ml of pre-warmed MRS broth. The 50 ml cultures were 
supplemented with 0 ng/ml, 100 ng/ml, 200 ng/ml, 300 ng/ml, 400 ng/ml and 600 ng/ml nisin 
(Sigma-Aldrich, St. Louis, MI, USA), respectively, and incubated at 30
o
C for 7 h. Every 30 
min the optical density (OD550nm) reading for each 50 ml culture was measured. All 
experiments were done with three repeats. 
mCherry reporter gene expression in LAB using the nisin-inducible promoter 
To demonstrate the utility of the nisin-induction system using a reporter gene, Lc. lactis 
pNZ9000 transformed with plasmid pNZCherry, L. plantarum 423 and E. mundtii ST4SA 
each transformed with plasmid pNZCherrynisRK were grown in MRS or M17 broth for 12 h 
(Table 1). Each 12-h old culture was then serially diluted and plated onto MRS or M17 agar 
plates supplemented with or without nisin. Expression of the mCherry reporter gene was 
confirmed visually by a colony color change from white to pink or purple. Strains harboring 
the empty pNZ8048 vector were used as controls. 
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Confirmation of bacteriocin gene knockouts 
To confirm bacteriocin gene KO integration mutants of strains L. plantarum 423 and E. 
mundtii ST4SA an overlay lawn assay was performed as described by Van Zyl and co-
workers (25) with the following modifications. The L. monocytogenes EGDe bacteriocin 
sensitive strain was grown for 12 h and 100 µl plated onto a BHI agar plate. The cell-free 
supernatants (adjusted to pH 7.0 with NaOH) of actively growing (12 h) bacteriocin KO 
strains were collected by centrifugation (8000 x g for 5 min). The supernatants were sterilized 
by passage through a 0.22-µm-pore size filter using a 5 ml syringe and 30 µl spotted into 
wells on BHI agar overlaid with L. monocytogenes EGDe. This was followed by incubation 
at 37
o
C for 24 h. As positive controls, supernatant from wild-type strains was used. 
Additionally, bacteriocin KO strains were sonicated for 3 min using an Omni-Ruptor 400 
(Omni International, Kennesaw, GA, USA) for release of intracellular proteins. Briefly, 
bacteriocin KO cultures were grown for 12 h in 100 MRS broth. Cells were harvested at 
13000 x g for 10 min, resuspended in 30 ml 10 mM Tris buffer supplemented with 500 mM 
NaCl and 10 mg/ml lyzozyme, and incubated at 37
o
C for 2 h. After incubation, the cells were 
sonicated for 3 min followed by centrifugation (13000 x g for 5 min) and collection of the 
cell free supernatants. The supernatants containing intracellular proteins were then spotted 
onto BHI agar plates spread with L. monocytogenes EGDe as described before for 
visualization of inhibitions zones. 
Clumping response protocol 
The bacterial clumping protocol for confirmation of the E. mundtii ST4SA srtA gene KO 
strain was adapted from previous studies (51-52) with the following modifications. A 
pheromone-containing supernatant was collected by centrifugation (13000 x g for 5 min) of a 
12-h old wild-type E. mundtii ST4SA strain, followed by filter sterilization through a 0.22-
µm-pore size cellulose nitrate filter using a 5 ml syringe. Wild-type and srtA KO mutant 
strains were grown for 12 h in MRS broth and diluted to an OD600nm of ~0.06 in 5 ml MRS 
broth supplemented with 250 µl sterile supernatant from wild-type E. mundtii ST4SA. The 
cultures were incubated for 12 h at 30
o
C without shaking before visualization of clumping. 
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Detection of in vitro bioluminescence 
Lactobacillus plantarum 423 and E. mundtii ST4SA recombinant strains carrying the ffluc 
bioluminescence gene were analyzed on agar plates for bioluminescence emission using the 
Caliper in vivo imaging system (IVIS; Caliper Life Sciences, Hopkinton, MA, USA). 
Cultures were grown for 12 h in MRS broth, plated onto MRS agar plates using sterile swabs 
and incubated at 30
o
C for 24 h. Prior to imaging, one ml of beetle D-luciferin potassium salt 
substrate (Anatech Instruments, Bellville, South Africa) at 150 µg/ml dissolved in phosphate-
buffered saline (PBS) was added directly to the colonies.
 
Confirmation of successful chromosomal or plasmid integrations 
To confirm successful double-crossover recombination events in LAB gene deletion or 
integration mutants, gDNA was isolated for PCR amplification using the appropriate primer 
combinations listed in Table 3. All LAB KO or KI mutants were confirmed by DNA 
sequencing of PCR products performed by the Central DNA Sequencing Facility of the 
University of Stellenbosch. 
Protocol for isolating double-crossover mutants 
The complete step-by-step design and timeline for this method of quick and easy isolation of 
double-crossover KO or KI mutants is shown in Fig. S8. Upon completion of the construction 
and transformation of an appropriate integration plasmid in LAB strains, transformants were 
enriched for by either direct inoculation into MRS broth or by plating on MRS agar plates 
supplemented with both Cm and Em. After an incubation period of 2 – 3 days at 30oC, cells 
grown in broth or colonies observed on agar plates were streaked on fresh agar plates and re-
incubated for 24 h at 30
o
C until single colonies were observed. Cells carrying the integration 
plasmid were then inoculated into fresh MRS broth supplemented with Cm and Em, followed 
by further incubation at 30
o
C for 12 h. Two-hundred microliters of the cell suspension was 
then inoculated into fresh MRS broth supplemented with the antibiotic present in the 
integrative gene cassette (either Cm or Em) and the appropriate concentration of nisin for 
MazF toxin expression, followed by incubation at 30
o
C for 6 h. After 6 h of incubation and 
growth recorded at OD600 nm, the cell suspensions were serially diluted, and plated onto MRS 
agar plates supplemented with the appropriate antibiotic and nisin as described above. The 
plates were incubated for 24 to 48 h at 30
o
C or until colonies were observed. Double-
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crossover recombined mutants appearing on the antibiotic-nisin plates were isolated and 
screened for the loss of the plasmid-backbone-located antibiotic marker and by PCR for 
confirmation of the desired recombination event. 
Mutant cells carrying a FRT-flanked erm gene were transformed with the 
pNZFLPasRNA_repA plasmid for excision of the erm resistance gene. Upon transforming 
the plasmid in FRT-erm-containing LAB mutants and the appearance of transformants on 
MRS agar plates supplemented with Cm, single colonies were inoculated into MRS broth and 
incubated at 30
o
C for 6 h for constitutive expression of FLP recombinase. Cell suspensions 
were then serially diluted and plated onto MRS agar plates containing Cm for propagation. 
Unmarked mutants that have lost the erm gene via FRT-FLP excision were identified by 
replica plating on MRS agar plates containing Cm or Em. Colonies that did not grow on MRS 
plates supplemented with Em were screened by PCR to confirm erm gene excision.  
To generate unmarked mutants that would allow for further genetic manipulation using the 
nisin-MazF counter-selection marker system, cells carrying the FLP recombinase 
pNZFLPasRNA_repA plasmid were induced with nisin to stimulate plasmid loss. Cells 
carrying the pNZFLPasRNA_repA plasmid were inoculated into MRS broth supplemented 
with nisin, followed by incubation at 30
o
C for 6 h for expression of the asRNA transcript. 
After incubation, the cell suspensions were serially diluted, and plated onto MRS agar plates 
not supplemented with Cm and incubated at 30
o
C for 24 h. Mutant cells that have lost the 
pNZFLPasRNA_repA plasmid were identified by replica plating on MRS agar plates 
supplemented with and without Cm. Colonies that showed no growth on MRS plates 
supplemented with Cm indicated plasmid loss. 
Results 
Construction and optimization of the nisin-inducible counter-selection marker 
The nisin-inducible promoter (PnisA) originating from the Lc. lactis nisin A lantibiotic 
producer strain was developed and optimized for its heterologous use in the probiotics L. 
plantarum 423 and E. mundtii ST4SA. The mazF toxin gene was placed downstream of the 
pNZnisRK plasmid PnisA promoter region that also carries the nisR and nisK nisin signal 
regulatory genes on the plasmid backbone required for heterologous induction of gene 
expression by PnisA (Figs 1 and 2). The resulting plasmid pNZmazFnisRK was introduced 
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into the probiotic LAB strains, giving rise to strains E. mundtii ST4SA pNZmazFnisRK and 
L. plantarum 423 pNZmazFnisRK. Their MazF response to induction with varying 
concentrations of nisin was then evaluated (Figs 3 and 4). Previous studies (40, 41) reported 
that low sub-inhibitory concentrations of nisin, ranging from 0.1 to 5.0 ng/ml, were sufficient 
for Pnis- controlled gene expression in Lc. lactis pNZ9000. Results in this study showed that 
the PnisA promoter responded to much higher sub-inhibitory concentrations of nisin, ranging 
from 300 to 400 ng/ml in E. mundtii ST4SA pNZmazFnisRK (Fig. 3A) and 300 to 600 ng/ml 
nisin in L. plantarum 423 pNZmazFnisRK after 7 h of induction (Fig. 4A). Control strains 
transformed with pNZ8048 and recombinant strains transformed with pNZmazFnisRK 
without nisin induction showed no significant differences in growth after 7 h. These results 
suggested that no significant promoter leakiness was occurring that could potentially result in 
premature cell growth arrest without nisin induction of PnisA. No significant difference in 
growth rate was recorded for control strain E. mundtii ST4SA pNZ8048 with (300 ng/ml) or 
without nisin induction, whereas a significant growth difference was recorded for 
recombinant E. mundtii ST4SA pNZmazFnisRK when induced with nisin at the same 
concentration (Fig. 3A). No significant growth inhibition was observed for control strain L. 
plantarum 423 pNZ8048 when induced with nisin concentrations ranging from 100-600 
ng/ml compared to un-induced. A significant inhibition of growth was recorded when strain 
L. plantarum 423 pNZmazFnisRK was induced with nisin at 600 ng/ml as compared to when 
no nisin was present (Fig. 4A). For all further nisin induction experiments, a nisin induction 
concentration of 300 ng/ml was used for PnisA-carrying E. mundtii ST4SA and 600 ng/ml for 
L. plantarum 423. Taken together, these results confirmed that the MazF protein toxicity 
would enable its application in LAB as an efficient counter-selection marker for the isolation 
of double-crossover mutants. 
Lactococcus lactis pNZ9000 transformed with plasmid pNZmazF, recombinant strains L. 
plantarum 423 pNZmazFnisRK and E. mundtii ST4SA pNZmazFnisRK cultures were plated 
onto M17 or MRS agar plates supplemented with Cm in the absence and presence of nisin. 
After 24 h of incubation at 30
o
C, plates containing nisin showed very little or no growth, 
while those no nisin showed an abundance of growth (Figs 3B, 4B and 5A). To further 
demonstrate the application of the nisin-induction system in LAB, Lc. lactis pNZ9000 was 
transformed with plasmid pNZCherry, while L. plantarum 423 and E. mundtii ST4SA were 
transformed with plasmid pNZCherrynisRK. In both vectors, the mCherry red fluorescence 
gene was placed downstream of the PnisA promoter (Table 1). The PnisA nisin-induced 
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expression of mCherry fluorescence protein was easily detected on agar plates containing 
nisin by the appearance of pink colonies, while those lacking nisin remained white or cream 
(Figs 5B, 5C and 5D). 
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FIG. 3. Optimization of nisin-controlled mazF gene expression in E. mundtii ST4SA. (A) Growth 
comparison of E. mundtii ST4SA transformed with the empty pNZ8048 vector (control) and E. 
mundtii ST4SA transformed with the PnisA-controlled mazF gene pNZmazFnisRK plasmid in sub-
inhibitory concentrations of nisin (0 - 600 ng/ml). Differences were assessed using the Kruskal-Wallis 
nonparametric test,  (P<0.05) for comparison between Control no nisin and Control 400 ng/ml,     
gg((P<0.05) for comparison between mazFRK no nisin and mazFRK 300 ng/ml,   (P<0.05) for 
comparison between mazFRK no nisin and mazFRK 400 ng/ml. (B) MRS agar plates representative 
of the effect of MazF protein expression in E. mundtii ST4SA harboring the pNZmazFnisRK plasmid 
in the absence of nisin (-nisin) and in the presence of nisin (+300 ng/ml nisin). 
Fig. 3B. 
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* 
Fig. 3A. 
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FIG. 4. Optimization of nisin-controlled mazF gene expression in L. plantarum 423. (A) Growth 
comparison of L. plantarum 423 transformed with the empty pNZ8048 vector (control) and L. 
plantarum 423 transformed with the PnisA controlled mazF gene pNZmazFnisRK plasmid in sub-
inhibitory concentrations of nisin (0 - 600 ng/ml). Significant differences (P<0.05; Kruskal-Wallis 
nonparametric test) between mazFRK no nisin and mazFRK 600 ng/ml are indicated with an asterisk. 
(B) MRS agar plates representative of the effect of MazF protein expression in L. plantarum 423 
harboring the pNZmazFnisRK plasmid in the absence of nisin (-nisin) and in the presence of nisin 
(+600 ng/ml nisin). 
 Fig. 4A. 
Fig. 4B. 
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FIG. 5. Plates showing the effect of PnisA promoter-controlled MazF protein expression in Lc. lactis 
pNZ9000 and PnisA promoter-controlled mCherry fluorescence protein expression in Lc. lactis 
pNZ9000, L. plantarum 423 and E. mundtii ST4SA. (A) M17 agar plates representative of the effect 
of MazF protein expression in Lc. lactis pNZ9000 harboring the pNZmazF plasmid in the absence of 
nisin (-nisin) and in the presence of nisin (+5 ng/ml nisin). (B) M17 agar plates showing the 
expression of the mCherry fluorescence gene in Lc. lactis pNZ9000 harboring the pNZCherry plasmid 
in the absence of nisin (-nisin) and in the presence of nisin (+5 ng/ml nisin). (C) MRS agar plates 
showing the expression of the mCherry fluorescence gene in L. plantarum 423 harboring the 
pNZCherrynisRK plasmid in the absence of nisin (-nisin) and in the presence of nisin (+600 ng/ml 
nisin). (D) MRS agar plates showing the expression of the mCherry fluorescence gene in E. mundtii 
ST4SA harboring the pNZCherrynisRK plasmid in the absence of nisin (-nisin) and in the presence of 
nisin (+300 ng/ml nisin). 
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- nisin 
- nisin 
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Integration of large DNA fragments and deletion of the L. plantarum 423 and E. mundtii 
ST4SA bacteriocin genes 
To demonstrate the feasibility and efficiency of the nisin-MazF counter-selection marker 
system in LAB, the plaA plantaricin bacteriocin gene located on the L. plantarum 423 pPLA4 
plasmid (49) and the E. mundtii ST4SA munA mundticin bacteriocin gene located on a 
megaplasmid (52) were targeted for inactivation. The plaA KO plasmid carried a 3204 bp 
erm-ffluc gene cassette (see Fig. S1), while the munA KO plasmid carried a 2471 bp cat-ffluc 
gene cassette (see Fig. S2), flanked by regions of homology required for homologous 
recombination. The pNZKOplaA::ErmFfluc plasmid included a 69 bp internal fragment of 
the plaA ORF in the downstream region of homology, resulting in the deletion of 102 bp of 
the 171 bp plaA gene in all L. plantarum 423 plaA::erm-ffluc mutants (Fig. 6A). Refer to 
Table 2 for a detailed description of the components of all regions of homology for targeted 
gene inactivation. Similarly, plasmid pNZKOmunA::CatFfluc included a 135 bp internal 
fragment of the munA ORF in the upstream region of homology, resulting in the deletion of 
18 bp of the 153 bp munA gene in all E. mundtii ST4SA munA::cat-ffluc mutants (Fig 7A). 
Double crossover mutants were isolated by following the protocol described in ‘Materials and 
Methods’ (Also refer to Fig. S8). Lactobacillus plantarum 423 plaA::erm-ffluc mutants 
retained resistance to Em, but not to Cm, indicating that the erm-fflucc gene cassette was 
successfully integrated onto the pPLA4 plasmid without the plasmid backbone DNA 
encoding the mazF and cat genes. Enterococcus mundtii ST4SA munA::cat-ffluc double- 
crossover mutants retained resistance to Cm, but not Em, in turn indicating the loss of the 
plasmid backbone DNA encoding the mazF and erm genes. Knockout mutants that appeared 
on nisin plates were screened by PCR and DNA sequencing using primer combinations listed 
in Table 3. Lactobacillus plantarum 423 plaA::erm-ffluc mutants contained the 3204 bp erm-
ffluc “cargo” DNA via allelic exchange, with the consequent deletion of a 208 bp DNA 
fragment on the pPLA4 native plasmid as confirmed by PCR as well as sequencing (Fig. 6B). 
Similarly, E. mundtii ST4SA munA::cat-ffluc mutants retained the cat-ffluc cassette via 
allelic exchange and the deletion of a 260 bp fragment from the megaplasmid harboring the 
munA gene as confirmed by PCR and sequencing (Fig. 7B).  
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FIG. 6. Gene deletion and integration via homologous recombination into the genome of L. 
plantarum 423 at the plaA bacteriocin gene locus to create L. plantarum 423 plaA::erm-ffluc. (A) 
Homologous recombination between the WT pPLA4 plasmid and the plaA::ermffluc cassette. Boxed 
regions show the upstream and downstream regions of homology (~ 0.9 kb) on plasmid pPLA4 and 
the pNZKOplaAErmFfluc KO vector. Cells harboring the plaA KO vector were selected on Cm and 
Em, followed by nisin induction for MazF toxin expression to select for mutants that have lost the 
plasmid backbone bearing cat and mazF genes. Double crossover mutants were selected and screened 
by PCR using the primer combinations indicated in purple. (B) PCR amplification of WT and plaA 
deletion and insertion mutants using the primer pair indicated in panel A. (a) Lambda DNA digested 
with PstI (NEB). Amplicons from four plaA mutant and two WT colonies, respectively, are shown. 
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FIG. 7. Gene deletion and integration via homologous recombination into the genome of E. mundtii 
ST4SA at the munA bacteriocin gene locus to create E. mundtii ST4SA munA::cat-ffluc. (A)  
Homologous recombination between the WT E. mundtii ST4SA munA-carrying megaplasmid and the 
munA::catffluc cassette. Boxed regions show the upstream (~ 0.9 kb) and downstream regions (~ 0.6) 
of homology on the megaplasmid and the pNZKOmunACatFfluc KO vector. Cells harboring the 
munA KO vector were selected on Cm and Em, followed by nisin induction for MazF toxin 
expression to select for mutants that have lost the plasmid backbone bearing erm and mazF genes. 
Double crossover mutants were selected and screened by PCR using the indicated primer 
combinations. (B) PCR amplification of WT and munA deletion and insertion mutants using the 
primer pair indicated in panel A. (a) Lambda DNA digested with PstI (NEB). Amplicons from four 
munA mutant and two WT colonies, respectively, are shown. 
Fig. 7A. 
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Supernatants isolated from L. plantarum 423 plaA::erm-ffluc (Fig. 8A) and E. mundtii 
ST4SA munA::cat-ffluc (Fig. 8B) mutants did not result in the formation of clear inhibition 
zones on plates overlaid with the sensitive L. monocytogenes EGDe strain as compared to the 
wild-type derivatives of each strain. Similarly, supernatants isolated from sonicated plaA- and 
munA- mutant cell cultures did not result in the formation of inhibition zones on agar plates 
overlaid with L. monocytogenes EGDe (not shown). These results confirmed that the 
bacteriocin genes of the probiotic strains were successfully inactivated using the nisin-MazF 
counter-selection method. To test the active expression of the integrated ffluc 
bioluminescence gene, L. plantarum 423 plaA::erm-ffluc (Fig. 9A) and E. mundtii ST4SA 
munA::cat-ffluc (Fig. 9B) mutants were imaged using the IVIS. A strong bioluminescent 
signal was detected from colonies formed on agar plates for each of the mutant strains.  
                                                         
                                                       
 
FIG. 8. Zones of inhibition on plates overlaid with L. monocytogenes EGDe. A. (BI) Supernatant 
containing bacteriocin plantaricin 423 isolated from L. plantarum 423 transformed with KO plasmid 
pNZKOplaA::ErmFfluc before induction with nisin, (+) supernatant containing bacteriocin plantaricin 
423 isolated from WT L. plantarum 423 as positive control, (-) supernatant lacking plantaricin 423 
bacteriocin isolated from L. plantarum 423 bac
-
 as negative control and supernatants (1, 2 & 3) 
lacking bacteriocin plantaricin 423 isolated from three L. plantarum 423 plaA::erm-ffluc plaA gene 
deletion mutants. B. (+) Supernatant containing bacteriocin mundticin ST4SA isolated from WT E. 
mundtii ST4SA as positive control and supernatants (1, 2, 3 & 4) lacking bacteriocin mundticin 
ST4SA isolated from four E. mundtii ST4SA munA::cat-ffluc munA gene deletion mutants. 
 
 
A. B. 
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FIG. 9. MRS agar plates showing bioluminescence emission of ffluc luciferase gene integration 
mutants. (A) Bioluminescent L. plantarum 423 plaA::erm-ffluc double-crossover mutant colonies 
harboring the ffluc gene integrated at the plaA locus. (B) Bioluminescent E. mundtii ST4SA 
munA::cat-ffluc double-crossover mutant colonies harboring the ffluc gene integrated at the munA 
locus.  
 
 
 
 
A. 
B. 
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Integration and removal of the FRT-flanked erm gene in L. plantarum 423 for marker 
recycling 
To overcome the limited availability of antibiotic resistance markers that are suitable for use 
in LAB as integrative selective markers, the S. cerevisiae FLP-FRT recombination system 
was adapted for marker recycling. A gene disruption mutant of the L. plantarum 423 aap 
adhesion-associated gene was generated by utilizing the erm gene flanked by two direct 
repeat FRT recombination targets for excision by FLP recombinase. The pNZKIaap::FRTerm 
plasmid carried the FRT-erm gene flanked by two internal regions (~0.9 kb each) of 
homology of the 4035 bp aap ORF that would result in the insertion of the FRT-erm gene 
and simultaneous disruption of the aap gene (see Fig. S3). The generated sizes of the wild-
type L. plantarum 423 and integrant loci are shown in Fig. 10A. Lactobacillus plantarum 423 
aap::frt-erm mutants were successfully isolated via nisin induction of the mazF toxin gene as 
described elsewhere (see Materials and Methods; also refer to Fig. S8). Double-crossover 
mutants selected on nisin-supplemented MRS agar plates retained resistance to Em, but not 
Cm, confirming the loss of the cat and mazF gene encoded plasmid backbone. The 
recombination event, namely, the insertion of the FRT-erm gene onto the aap ORF locus, 
was confirmed by PCR and the resulting amplicon sizes are shown in Fig. 10B. PCR 
amplification of aap mutant gDNA resulted in a 3696 bp fragment compared to the 2238 bp 
fragment in the wild-type derivative.  
Lactobacillus plantarum 423 aap::frt-erm mutants were electro-transformed with the 
pNZFLPasRNA_repA plasmid for FRT-flanked erm antibiotic resistance marker excision. 
Once successful transformants were isolated and confirmed to be resistant to both Em and 
Cm, FLP recombinase activity was induced as described in Materials and Methods. This 
resulted in the isolation of unmarked aap mutant L. plantarum aap::frt_um (um - unmarked) 
colonies that have lost the erm gene via FRT-FLP excision as confirmed by PCR and 
sequencing (Figs 10A and 10B).  
Once excision of the erm antibiotic resistance marker in L. plantarum aap::frt_um colonies 
was confirmed, loss of the FLP recombinase plasmid was stimulated by the expression of a 
350 bp asRNA repA transcript by induction with nisin. Lactobacillus plantarum aap::frt_um 
mutants isolated via replica plating did not show any colony growth on MRS agar plates 
supplemented with nisin, indicating plasmid loss, while colonies that were not induced by 
nisin showed an abundance of growth (indicating the presence of the plasmid) (Fig. 10C).  
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FIG. 10. Gene inactivation and integration via homologous recombination into the genome of L. 
plantarum 423 at the aap adhesion gene locus to create L. plantarum 423 aap::FRTerm and L. 
plantarum 423 aap::frt_um (A) Homologous recombination between the WT L. plantarum 423 
chromosome and the aap::FRTerm cassette and selection of unmarked aap double-crossover mutants. 
Fig. 10A. 
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Boxed regions show the upstream and downstream regions of homology (~ 0.9 kb) on the WT L. 
plantarum 423 chromosome and plasmid pNZKIaap::FRTerm KI vector. Cells harboring the aap KI 
vector were selected on Cm and Em, followed by nisin induction for MazF toxin expression to select 
for mutants that have lost the plasmid backbone bearing cat and mazF genes. Double crossover 
mutants were selected and screened by PCR using the primer combinations indicated in purple. (B) 
PCR amplification of WT L. plantarum 423 and aap insertion mutants using the primer pair indicated 
in panel A. Additionally, the Em resistance marker was recycled via excision by FLP recombinase as 
described in Materials and Methods. (a) Lambda DNA digested with PstI (NEB). Amplicons from 
one WT, two aap::FRTerm insertion mutant and two aap::unmarked colonies are shown. (C). MRS 
agar plates showing the effectiveness of the repA asRNA induction of FLP recombinase-bearing 
plasmid loss in the absence of nisin (no nisin induction) and in the presence of nisin (nisin induction). 
Colonies that have lost the repA-bearing plasmid were isolated via replica plating. 
Isolation of srtA and srtC deletion mutants using regions of homology containing small 
(<60 bp) 5’ and 3’ end sequences 
Although the PnisA-MazF counter-selection system proved to be functional, the E. mundtii 
ST4SA srtA and srtC genes did not contain sufficient restriction enzyme sites to allow 
cloning of integrative gene cassettes flanked by homologous arms. A strategy to introduce 
new restriction sites would facilitate the cloning of integrative genes inbetween homologous 
regions to enable the inactivation of target sequences with insufficient restriction enzyme 
digestion sites. To do this, srtA and srtC KO plasmids carrying upstream and downstream 
regions of homology with new restriction sites for integrative gene cassette insertion were 
constructed (see Figs S4 and S5). Both KO plasmids were designed to facilitate the deletion 
of the majority of the srtA and srtC genes sequences (with <60 bp of the 5’ and 3’ ends 
included in the upstream and downstream regions of homology). The FRT-flanked erm gene 
was utilized as integrative cassette and the anticipated sizes of the wild-type E. mundtii 
ST4SA and integrant loci are shown in Figs 11A and 11B. The deletion mutant isolation 
protocol was followed to enrich for recombinant cells that have undergone the desired 
double-crossover recombination event (refer to ‘Materials and Methods’ and Fig. S8). 
Enterococcus mundtii ST4SA srtA::frt-erm mutants were successfully isolated that resulted 
in the deletion of a 580 bp fragment of the 714 bp srtA ORF as confirmed by PCR and 
sequencing (Fig. 11C). Similarly, the expected band sizes of E. mundtii ST4SA srtC::frt-erm 
mutants were obtained as confirmed by PCR, sequencing and restriction digests, that resulted 
in the deletion of a 726 bp internal fragment of the 826 bp srtC ORF (Fig. 11D). 
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FIG. 11. Gene deletion and integration via homologous recombination into the genome of E. mundtii 
ST4SA at the srtA and srtC loci to create E. mundtii ST4SA srtA::FRTerm and E. mundtii ST4SA 
srtC::FRTerm. (A) Schematic representing the WT E. mundtii ST4SA srtA gene locus and the 
recombinant srtA deletion and FRT-erm integration site.  Boxed regions show the upstream and 
downstream regions of homology (~ 1 kb) on the WT chromosome and the recombinant 
srtA::FRTerm locus. Cells harboring the srtA KO vector were selected on Cm and Em, followed by 
nisin induction for MazF toxin expression to select for mutants that have lost the plasmid backbone 
bearing cat and mazF genes. Double crossover mutants were selected and screened by PCR using the 
indicated primer combinations. (B) Schematic representing the WT E. mundtii ST4SA srtC gene locus 
Fig. 11A. 
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and the recombinant srtC deletion and FRT-erm integration site.  Boxed regions show the upstream (~ 
1 kb) and downstream (~ 0.4 kb) regions of homology on the WT chromosome and the recombinant 
srtC::FRTerm locus. srtC deletion and integration mutants were isolated as described in Fig. 11A. (C) 
PCR amplification of WT and srtA deletion and insertion mutants using the primer pair indicated in 
panel A. (a) Lambda DNA digested with PstI (NEB). Amplicons from one WT and two srtA::FRTerm 
insertion mutant colonies are shown. (D) PCR amplification of WT (3151 bp) and srtC deletion and 
insertion mutants (3183 bp) using the primer pairs indicated in panel B, followed by restriction 
digestion of the amplicons with XbaI. The WT amplicon contained one XbaI restriction site, while the 
srtC mutant amplicons contained three XbaI restriction sites. (a) Lambda DNA digested with PstI 
(NEB). Digested amplicons from one WT and three srtC::FRTerm insertion mutant colonies are 
shown. 
To verify the loss of the E. mundtii ST4SA sortaseA aggregation substances’ (AS) ability in 
srtA knockout mutants to attach secreted adhesion proteins to the bacterial cell surface, a cell 
clumping assay was performed. In wild-type E. mundtii ST4SA cells, AS expression lead to a 
marked clumping of bacterial cells to form large cell aggregates that settled at the bottom of 
the tube (Fig. 12A). In the srtA knockout strain lacking AS, the cell suspension remained 
turbid, thus indicating the loss of the cells’ ability to form aggregates compared to the wild-
type (Fig. 12B). In the tube containing E. mundtii ST4SA sortaseC knockout cells, the 
bacteria maintained the ability to form aggregates that settled at the bottom of the tube (Fig. 
12C). These results confirmed that sorting of AS and subsequent cell clumping is dependent 
on srtA but not srtC. 
                                  
 
FIG. 12. Enteroccoccus mundtii ST4SA sortase A aggregation substance (AS) cell clumping assay. 
(A) MRS broth with the WT strain containing SrtA AS. (B) MRS broth containing the E. mundtii 
ST4SA srtA::FRTerm deletion mutant strain lacking SrtA AS. (C) MRS broth with E. mundtii ST4SA 
srtC::FRTerm deletion mutant strain containing SrtA AS. 
A. B. C. 
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Discussion 
The functional genetic analysis of proteins that confer specific phenotypical properties in 
LAB is highly dependent on the application of an effective counter-selection marker system 
for the easy and efficient isolation of chromosomally- or plasmid-located allelic exchange 
mutants (11, 28-29). While the use of replicative plasmids to study protein functions is easy 
to implement, multi-copy plasmids are not suited for in vitro or in vivo models where 
antibiotic selection for plasmid maintenance is not possible (12). The integration or deletion 
of genes at any specified locus circumvents antibiotic selection related issues. To date, most 
of the techniques used for the isolation of homologous recombination mutants in LAB are 
limited by a lack of broad applicability amongst different LAB species, their inability to 
target specific gene loci, availability of suitable antibiotic resistance markers and the isolation 
of reversible single-crossover mutants (14, 15, 16, 30-32). Counter-selection markers are 
invaluable for the construction of stable double-crossover mutants, especially in probiotic 
LAB, where the mechanisms by which they exert their beneficial effects on the consumer can 
be studied by reverse genetic analysis. Reverse genetics is a powerful tool that can be used to 
study gene function, in which a gene of interest is inactivated to study the resulting effects on 
the microorganism in a particular environment (28, 53). Nevertheless, the identification and 
optimization of suitable counter-selection markers is a challenging and laborious task (28). 
In this study, a method was developed to easily and efficiently isolate stable irreversible 
double-crossover mutants in L. plantarum 423 and E. mundtii ST4SA. This method is based 
on the use of the E. coli mazF toxin gene, an mRNA interferase, as a counter-selection 
marker that has been used successfully in Bacillus subtilis and Clostridium acetobutylicum 
(38-39). The mazF gene was placed under the control of the PnisA nisin-inducible promoter 
that is strictly associated with the nisR and nisK nisin signal regulatory genes to form the 
pNZmazFnisRK destination plasmid (40). A major advantage of the nisin-induction system 
(NICE) over other inducible gene expression systems, is the tightly controlled gene 
expression that has been used to produce large amounts of enzymes for food, medical or 
technical applications (54-55). Compared with the use of the lactose-inducible promoter and 
its divergent regulator as described by Al-Hinai and co-workers (39), results in this study 
have shown that MazF expression is tightly controlled by the nisin-inducible promoter. This 
rules out any potential MazF-induced premature cell growth arrest as a result of promoter 
leakiness. In this study, attempts to use the L. plantarum 423 lactose-inducible promoter and 
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its divergent regulator as an inducible expression system showed it to be poorly regulated 
(unpublished data).  
Growth conditions were successfully optimized for the mazF counter-selection gene to 
promote the death of cells harbouring mazF upon induction of the PnisA promoter with nisin. 
The approach of this method ensures that transformants that have undergone only a single 
event of homologous recombination (thus retaining a copy of the plasmid-located counter-
selection marker in the chromosome), are eliminated in the presence of nisin-induced MazF 
toxin. The method was used to construct deletions within the ORFs of specific genes, to 
introduce a gene of interest, to construct an unmarked mutation and to realize gene deletion 
mutants using small regions of homology. In the first case, bacteriocin gene deletion mutants 
of L. plantarum 423 and E. mundtii ST4SA were constructed, while simultaneously inserting 
the large 1.6 kb ffluc firefly luciferase reporter gene. The L. plantarum 423 plaA bacteriocin 
KO plasmid was designed to delete the majority of the plaA ORF while ensuring that none of 
the adjacent genes would be affected. In a previous study (56), the pPLA4 plaA gene-
encoding plasmid was cured from the L. plantarum 423 wild-type strain to produce 
bacteriocin-deficient mutants. While their approach proved successful, the loss of the whole 
plasmid may be undesirable because of the consequent loss of all bacteriocin-adjacent genes. 
The E. mundtii ST4SA munA bacteriocin KO plasmid was designed to delete 18 bp of the 
munA ORF. The bacteriocin gene deletions of both L. plantarum 423 and E. mundtii ST4SA 
resulted in the loss of bacteriocin production, as was confirmed against L. monocytogenes 
EGDe. Supernatants isolated from the bacteriocin-deficient mutant strains lacked the ability 
to form clear inhibition zones as compared to the wild type derivatives. Bioluminescence 
imaging revealed that the integrated ffluc gene was actively expressed in each of the 
bacteriocin KO mutants. Strong bioluminescence emission was detected from colonies on 
MRS agar plates, indicating the functional expression of the Ffluc protein at the integrated 
loci. These results demonstrate the feasibility and applied utility of the newly developed 
counter-selectable marker system. 
Desired double-crossover mutants are usually isolated using an antibiotic resistance gene as 
integrative selective marker (14). However, repeated manipulations of any bacterial 
chromosome can only be achieved by the generation of markerless integration mutants due to 
a limited availability of suitable antibiotic resistance markers. An easy-to-implement marker 
recycling system for LAB allows microbiologists to genetically engineer LAB strains for 
biotechnological production processes. In this study, the S. cerevisiae FLP-FRT 
Stellenbosch University  https://scholar.sun.ac.za
133 
 
recombination system was modified for application in LAB. The FLP-FRT recombination 
system is present in most yeast strains and is encoded by the 2µm (6.4 kb) plasmid (57-58). 
Two 34 bp FLP recognition targets (FRT) are necessary for successful excision of an 
integrated fragment by FLP recombinase. The yeast FLP-FRT system has been successfully 
applied in several pathogenic and non-pathogenic Gram-negative and Gram-positive bacteria 
(38-39, 59-61). The L. plantarum 423 aap mucus adhesion gene was targeted for inactivation 
with the insertion of an FRT-flanked erm resistance gene (62). Once FRT-erm gene insertion 
was confirmed, a two-step process was followed for marker recycling. In the first step, FLP 
recombinase activity was induced by transformation with plasmid pNZFLPasRNA_repA to 
produce unmarked aap KO mutants. Secondly, once excision of the erm gene was confirmed, 
loss of the pNZFLPasRNA_repA plasmid was stimulated by a 350 bp repA antisense RNA 
(asRNA) transcript placed under the control of the PnisA nisin-inducible promoter. The repA 
asRNA is a single-stranded RNA molecule that is complementary to the repA mRNA 
molecule of pNZ8048 derived vectors. The repA asRNA inhibits translation of the repA 
origin of replication (ori) by binding to the first 350 bp of the complementary repA mRNA 
transcript (63). As a result, the strain was cured of the repA ori-containing plasmid via repA 
ori protein synthesis inhibition. Several studies have used asRNA successfully to modulate 
the expression of specific genes or to prevent the proliferation of bacteriophages in Gram-
positive bacteria, including many LAB sp. (64-70). In a previous study (39), numerous days 
of sub-culturing and replica plating were required to isolate unmarked mutants via FLP-FRT 
excision of an antibiotic resistance gene. The system developed in this study requires less 
effort (days) for the isolation of unmarked mutants based on the strength and specificity of 
the NICE system. The resulting aap KO unmarked strain, free of antibiotic selection markers 
may be used for further genetic manipulations of the L. plantarum 423 chromosome using the 
newly developed method. 
To further demonstrate the strength of the newly developed system, gene deletion mutants of 
the E. mundtii ST4SA srtA and srtC genes were generated using homologous arms containing 
<60 bp regions (5’ and 3’) homologous to the target genes. This approach ensured that none 
of the adjacent genes were affected while deleting the majority of each target. Emphasis is 
placed on the introduction of new restriction sites in homologous arm regions for the 
insertion of integration cassettes to ensure optimal cloning of integrative cassettes. This 
strategy ensures the inactivation of smaller gene targets (<200 bp), that may not contain 
sufficient restriction sites to facilitate the cloning of integrative genes, usually antibiotic 
Stellenbosch University  https://scholar.sun.ac.za
134 
 
resistance genes, flanked by homologous regions. Previous studies reported that the rate of 
recovery of homologous recombinants significantly decreases when the size of homologous 
regions is less than 70 bp in B. subtilis (71), less than 100 bp in Cryptococcus neoformans 
(72) and less than 200 bp in mammalian cells (73). Notwithstanding this, the technique used 
in this study ensures the isolation of recombination mutants by using small regions (<60 bp) 
of homology included in homologous arms also containing sequences adjacent to the target 
genes. 
In conclusion, the method described in this paper is easy to implement, highly efficient and 
can be used to manipulate the chromosomes of Lactobacillus and Enterococcus spp. 
Furthermore, the strategy is well adapted for use in other LAB sp. due to the broad 
applicability of the nisin expression system. This provides a unique opportunity to study the 
role of specific probiotic LAB genes in complex environments using reverse genetics 
analysis. In addition to the efficient deletion or integration of genes at any defined loci, the 
use of FLP/FRT recombination system provides marker recycling for further manipulations 
of LAB strain chromosomes. 
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Amplicon size: ~ 2 kb plaA region of homology on native pPLA4 plasmid 
Amplicon size: ~ 3.2 kb 
EcoRI 
plaA::ErmFfluc amplicon Amplicon size: ~ 5 kb 
BglII blunt 
erm-ffluc blunt PCR 
XbaI 
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FIG. S1. Schematic representing the construction of the pNZKOplaA::ErmFfluc integrative plasmid 
containing the erm gene and two flanking sequences of the plaA bacteriocin gene from L. plantarum 
423. Relevant genes, restriction sites and PCR primers are shown. For details refer to “Materials and 
Methods”. 
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munA region of homology on native megaplasmid Amplicon size: ~ 1.8 kb 
Amplicon size: ~ 2.4 kb cat-ffluc blunt PCR 
EcoRI 
Amplicon size: ~ 4 kb 
munA::catffluc amplicon 
StuI 
XbaI 
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FIG. S2. Schematic representing the construction of the pNZKOmunA::CatFfluc integrative plasmid 
containing the cat gene and two flanking sequences of the munA bacteriocin gene from E. mundtii 
ST4SA. Relevant genes, restriction sites and PCR primers are shown. For details refer to “Materials 
and Methods”. 
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aap gene internal region of homology on WT chromosome 
Amplicon size: ~ 1.8 kb 
Amplicon size: ~ 1.5 kb FRT-flanked erm blunt PCR 
EcoRI 
aap::FRTerm amplicon Amplicon size: ~ 3.3 kb 
BglII, blunt 
XbaI 
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FIG. S3. Schematic representing the construction of the pNZKIaap::FRTerm integrative plasmid 
containing the erm gene and two flanking sequences of the aap mucus adhesion gene from L. 
plantarum 423. Relevant genes, restriction sites and PCR primers are shown. For details refer to 
“Materials and Methods. 
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srtA upstream region of homology on WT chromosome 
srtA downstream region of homology on WT chromosome 
Amplicon size: ~ 1 kb 
Amplicon size: ~ 1 kb 
HindIII 
srtA::FRTerm amplicon 
HindIII, blunt 
Amplicon size: ~ 1.5 kb 
Amplicon size: ~ 3.5 kb 
XbaI 
FRT-flanked erm blunt PCR 
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FIG. S4. Schematic representing the construction of the pNZKOsrtA::FRTerm integrative plasmid 
containing the erm gene and two flanking sequences of the srtA cell wall adhesion associated gene 
from E. mundtii ST4SA. Relevant genes, restriction sites and PCR primers are shown. For details refer 
to “Materials and Methods”. 
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srtC upstream region of homology on WT chromosome 
Amplicon size: ~ 1 kb 
HindIII 
srtC::FRTerm amplicon 
Amplicon size: ~ 1.5 kb 
Amplicon size: ~ 0.4 kb 
Amplicon size: ~ 2.8 kb 
HindIII, blunt 
XbaI 
FRT-flanked erm blunt PCR 
srtC downstream region of homology on WT chromosome 
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FIG. S5. Schematic representing the construction of the pNZKOsrtC::FRTerm integrative plasmid 
containing the erm gene and two flanking sequences of the srtC cell pilus associated gene from E. 
mundtii ST4SA. Relevant genes, restriction sites and PCR primers are shown. For details refer to 
“Materials and Methods”. 
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FRT target 1 
FRT target 2 
Amplicon size: 121 bp 
Amplicon size: 121 bp 
Amplicon size: ~ 1 kb 
erm gene amplicon 
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FIG. S6. Schematic representing the construction of plasmid pKSFRTErm containing the FRT-
flanked erm gene. Relevant genes, restriction sites and PCR primers are shown. For details refer to 
“Materials and Methods”. 
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flippase (FLP) gene amplicon 
Pldh constitutive promoter 
Amplicon size: ~ 1.3 kb 
Amplicon size: ~ 0.5 kb 
Pldhflp amplicon Amplicon size: ~ 1.8 kb 
repA ori antisense RNA amplicon 
Amplicon size: ~ 3.5 kb 
EcoRI 
SalI 
HindIII 
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FIG. S7. Schematic representing the construction of plasmid pNZFLPasRNA_repA containing the flp 
recombinase gene and a repA asRNA fragment. Relevant genes, restriction sites and PCR primers are 
shown. For details refer to “Materials and Methods”. 
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FIG. S8. A workflow diagram showing the step-by-step design and protocol of the newly developed 
counterselection method for the deletion and inactivation of LAB genes or to introduce genes of 
interest followed by resistance marker recycling.   
 
 
1 
• Design and construction of integrative gene cassette 
•PCR amplification of desired target gene regions of homology 
•Insertion of FRT-flanked marker with/without integrative gene of interest between regions of 
homology and cloning into pKSbluescript via restriction digest 
2 
• Construction of integration plasmid 
•PCR amplification of integrative gene cassette and insertion into the pNZmazFnisK destination 
plasmid via blunting 
3 
•Transformation of integration plasmid into LAB via electroporation and selection of transformant on 
liquid or solid media containing appropriate antibiotics 
4 
• MazF toxin nisin induction and isolation of double-crossover mutants 
•Sub-inoculation of integration plasmid bearing colonies in fresh liquid media containing the appropriate 
antibiotic plus nisin for MazF expression 
•Plating of nisin-induced culture on solid media containing appropriate antibiotic plus nisin 
5 
• Confirmation of desired mutants 
•Selection of colonies that have lost plasmid backbone located antibiotic marker and mazF using the 
appropriate antibiotic 
•Screening of mutants via PCR and sequecing  
1 
•Transformation of  flippase containing pNZFLPasRNA_repA into mutant 
LAB for antibiotic resistance gene excision 
•Constitutive FLP induction of transformants followed by replica plating 
•Selection of mutants that have lost FRT-flanked resistance gene and comfirmation by 
PCR and sequencing  
2 
•Curing of FLP plasmid 
•Induction of repA asRNA transcript with nisin 
•Screening for colonies that have lost Cm resistance using replica plating 
1 target gene 
Process complete 
Further modifications required? 
Time required (days) 
2 
2 
3 
2 
2 
4 
2 
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Anti-infective Gastrointestinal Properties of Lactobacillus 
plantarum 423 and Enterococcus mundtii ST4SA, as 
Determined in Mice Infected with Listeria monocytogenes 
EGDe 
Abstract 
Intestinal infectious diseases, and in particular those caused by enteric pathogenic bacteria, 
are a major cause of morbidity and mortality. Probiotics play an important role in maintaining 
a healthy and stable intestinal microbiota, primarily by preventing infection. Probiotic lactic 
acid bacteria (LAB) are known to be inhibitory to many bacterial enteric pathogens, including 
antibiotic-resistant strains. Whilst the positive role that probiotics have on human physiology, 
specifically in the treatment or prevention of specific infectious diseases of the gastro-
intestinal tract (GIT) is known, the precise mechanistic basis of these effects remains a major 
research goal. In this study, molecular evidence to underpin the protective and anti-listerial 
effect of Lactobacillus plantarum 423 and Enterococcus mundtii ST4SA against orally 
administered Listeria monocytogenes EGDe in the GIT of mice is provided. Lactobacillus 
plantarum 423 and E. mundtii ST4SA significantly reduced L. monocytogenes EGDe 
bioluminescence and viable bacterial cell numbers. Bacteriocin-negative mutants of L. 
plantarum 423 and E. mundtii ST4SA failed to exclude L. monocytogenes EGDe from the 
GIT, confirming bacteriocin production as an anti-infective mediator. Lactobacillus 
plantarum 423 and E. mundtii ST4SA failed to reduce Listeria bioluminescence or viable 
bacterial cell numbers in the GIT when mice were administered with L. monocytogenes 
EGDe strains expressing the bacteriocin immunity proteins. Furthermore, the exclusion of L. 
monocytogenes EGDe from the GIT was reduced when mice were administered with L. 
plantarum 423 and E. mundtii ST4SA adhesion gene knockout strains. These results 
substantiate our understanding of the functional attributes of probiotics currently available to 
consumers and the improvement of future probiotic products. 
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Introduction 
The gastrointestinal tract (GIT) is inhabited by the largest microbial community in the human 
body and represents a highly complex ecosystem composed of mainly bacteria (1). The 
intestinal microbiota is essential in the breakdown of food and faecal residue, but also plays a 
major role in the protection of epithelial mucosa, stimulation of the immune system and 
formation of a protective barrier against pathogens (2). The intestinal microbiome is thus a 
‘virtual organ’ that performs a number of significant biochemical and physiological functions 
(3).  
Imbalances of the microbiota (for example following antibiotic treatment) have been 
associated with several disease states, including increased susceptibility to pathogens such as 
Clostridium difficile, irritable bowel syndrome, diabetes, allergies, acute gastro-enteritis and 
obesity (4-6). Significant differences in the microbiota composition of healthy individuals 
compared to patients with various clinical conditions were revealed in a study by Khor and 
co-workers (7). Intervention studies using live probiotic cultures aimed at restoring 
microbiota composition impact health in preventing or ameliorating gastrointestinal 
infections (3, 8, 9).  Most probiotics are composed of lactic acid bacteria (LAB) that prevent 
enteric infections caused by C. difficile, Helicobacter pylori, vancomycin resistant 
enterococci (VRE), Campylobacter, Salmonella enterica serovar Typhimurium and Listeria 
monocytogenes (6, 10-15). Hence, in the last few decades, the use of probiotic LAB for 
health benefits by introducing transiently colonizing probiotic strains has grown significantly 
(3).  
Listeria monocytogenes, the etiological agent of listeriosis, is a ubiquitous Gram-positive 
bacterium that can cause life-threatening systemic disease by mainly affecting 
immunocompromised individuals (16). The cells can grow at low temperatures, presenting a 
high risk for the contamination of refrigerated foods (17). Listeria monocytogenes can also 
proliferate in harsh environments, such as those with low acidity, low water activity and high 
NaCl levels (18). Upon oral infection, L. monocytogenes crosses the intestinal barrier and 
may infect the GIT, liver, gallbladder, brain and spinal cord (2, 19-22). Listeria 
monocytogenes may also affect the central nervous system and cause meningitis, brain 
abscess or bacteraemia (19). Treatment of listeriosis includes the administration of antibiotics 
such as erythromycin, ampicillin, gentamicin and vancomycin (23). Continuous use of these 
antibiotics increases the risk that infectious pathogenic strains may develop resistance. The 
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use of probiotics to treat or prevent gastric infections could potentially decrease the use of 
antibiotics and prevent the emergence of antibiotic-resistant strains. 
Several in vitro and in vivo studies using the murine listeriosis model have shown that LAB 
have antagonistic activities against the growth of L. monocytogenes (2, 24-27). Our own 
studies have shown that the probiotics Lactobacillus plantarum 423 and Enterococcus 
mundtii ST4SA successfully excluded L. monocytogenes in vivo (15). However, the exact 
mode of action remains uncertain (28). Only a few scientific papers provide evidence to 
support the inhibitory activities of probiotic LAB on gastrointestinal pathogens (29). It is 
likely that the probiotic-pathogen inhibitory effects in the GIT are underpinned by diverse, 
poorly understood mechanisms. Probiotics may repress the growth of pathogens by producing 
anti-inflammatory molecules (30) or antimicrobial compounds such as organic acids, 
ammonia, hydrogen peroxide and antimicrobial peptides (bacteriocins) (29, 31-33). Probiotic 
bacteria compete with pathogens for nutrients and receptor sites on intestinal mucus and 
epithelial cells (34). In all of these cases, probiotic bacteria execute their beneficial effects by 
interacting with enteric pathogens to prevent intestinal colonization of the gut and subsequent 
epithelial invasion, infection and the occurrence of disease. 
Bioluminescence imaging (BLI) is used for real-time, non-invasive, monitoring of bacterial 
cells that are genetically tagged with light-producing luciferase enzymes (35). The light 
produced by cells tagged with luciferase is detectable through the tissues of live small 
animals using an in vivo imaging system (IVIS).  Numerous studies have demonstrated the 
use of bioluminescent bacteria genetically tagged with bacterial or eukaryotic luciferase 
genes to monitor real-time progression of infection in vivo (15, 36-39). The BLI technique is 
based on the detection and quantification of visible light produced by luciferases in the 
presence of ATP and oxygen (37). Bioluminescence can thus only be detected if cells are 
metabolically active. The application of the murine listeriosis model using L. monocytogenes 
tagged with the bacterial lux operon, revealed strong bioluminescence signals from within the 
intestinal tract (15). The BLI technique thus provides a way of monitoring the colonization of 
L. monocytogenes in the mouse GIT while at the same time reducing the amount of animals 
required to make significant experimental conclusions. 
In this study, the role of bacteriocins and adhesion proteins in the protective effect of the 
probiotics L. plantarum 423 and E. mundtii ST4SA against mice orally administered with L. 
monocytogenes EGDe are investigated. Both strains constantly produce potent class IIa 
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bacteriocins active against several Gram-positive enteric pathogens, including L. 
monocytogenes (40, 41). Both strains line the gut by using adhesion proteins and displace 
Enterococcus faecalis and Clostridium sporogenes in competitive exclusion experiments 
(42). This study investigated involvement of bacteriocins in the competitive exclusion of L. 
monocytogenes EGDe from the GIT of mice using non-bacteriocin producing mutants of both 
probiotic strains. Plantaricin 423 and mundticin ST bacteriocin immune strains of L. 
monocytogenes EGDe were constructed to confirm the role of the respective bacteriocins in 
the in vivo anti-listerial effect. The involvement of adhesion proteins in the gastrointestinal 
probiotic anti-listerial effect was also investigated. The capacity of a L. plantarum 423 
mutant lacking the aap adhesion associated gene and E. mundtii ST4SA lacking the Sortase 
A and Sortase C genes associated with the anchoring of cell surface proteins to the cell 
surface, to competitively exclude L. monocytogenes EGDe from the GIT was tested. The 
intestinal colonization and exclusion of L. monocytogenes from the GIT were recorded using 
bioluminescence imaging monitored with the IVIS. 
Materials and Methods 
Animals used 
Approval to conduct research on animals was obtained from the ethics committee of 
Stellenbosch University (reference number SU-ACU-2017-0206-454). Eight-week-old non-
specific-pathogen-free (non-SPF) female BALB/c mice were used for challenge studies. 
Animals were fed a standard rodent diet and kept under controlled environmental conditions 
(12 h light/dark cycles, 20-22
o
C). At least nine mice were used per bacterial strain. Animal 
procedures were performed according to the Stellenbosch University ethical guidelines. 
Bacterial strains, media, growth conditions and preparation of dosages 
Lactobacillus plantarum 423 and E. mundtii ST4SA strains were grown in MRS broth 
(Biolab Diagnostics, Midrand, South Africa) without shaking, or on MRS agar, at 30
o
C. 
When necessary, 10 µg/ml chloramphenicol (Cm), or erythromycin (Em) were added to MRS 
medium for recombinant L. plantarum 423 and 5 µg/ml Cm, or Em for recombinant E. 
mundtii ST4SA. Before probiotic dosing of mice, 12-h old cultures were inoculated into 
freshly prepared MRS broth, grown to optical densities (OD550nm) of 2.5 (L. plantarum 423) 
and 2.3 (E. mundtii ST4SA), harvested (8000 x g for 3 min) and washed with sterile 
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phosphate buffered saline (PBS) to remove residual media. Cell numbers were determined by 
plating onto MRS agar, supplemented with the appropriate antibiotic, and diluted with sterile 
PBS to 2 x 10
10
 CFU/ml. 
Listeria monocytogenes EGDe, genetically labelled with an integrated bacterial lux operon of 
Photorhabdus luminescence, was obtained from Bio-ware
TM 
Microorganisms (Caliper Life 
Sciences, Hopkinton, MA, USA). Listeria monocytogenes EGDe is a lineage type II, serotype 
1/2a strain and strains of this serotype are major contributors to the microorganisms-related 
foodborne outbreaks (43, 44). 
Listeria monocytogenes EGDe was grown in Brain Heart Infusion medium (BHI, Biolab 
Diagnostics) at 37
o
C (supplemented with 7.5 µg/ml Cm or 10 µg/ml Em where required) on 
an orbital shaker (200 rpm). Before administration to mice, cell counts were determined by 
plating onto BHI agar supplemented with the appropriate antibiotic, and diluted with sterile 
PBS to 2 x 10
10
 CFU/ml. 
Construction of recombinant L. plantarum 423 and E. mundtii ST4SA mutant strains 
Lactobacillus plantarum 423 and E. mundtii ST4SA bacteriocin- and adhesion-gene 
knockout (KO) mutants were constructed as described previously (chapter 4).  Briefly, an 
erm gene for Em resistance was stably integrated into the plantaricin 423 bacteriocin operon 
(at plaA gene locus) of L. plantarum 423 and a cat gene for Cm resistance into the E. mundtii 
ST4SA mundticin ST bacteriocin operon (at munA gene locus) via homologous 
recombination, yielding L. plantarum 423 plaA::erm and E. mundtii ST4SA munA::cat, 
respectively. Lactobacillus plantarum 423 aap adhesion gene-negative, and srtA and srtC 
adhesion protein related-negative mutants of E. mundtii ST4SA were constructed using the 
same protocol, to yield strains L. plantarum 423 aap::erm, E. mundtii ST4SA srtA::erm and 
E. mundtii ST4SA srtC::erm, respectively.  
Construction of L. monocytogenes EGDe bacteriocin-resistant strains 
The bacteriocin immunity proteins of L. plantarum 423 (plaB) and E. mundtii ST4SA (munC) 
were expressed in L. monocytogenes EGDe using the Lactococcus lactis pNZ8048 plasmid 
vector containing an erm gene for Em resistance. (45). The plaB and munC bacteriocin 
immunity proteins were placed under control of the strong constitutive E. mundtii ST4SA 
lactate dehydrogenase (ldh) gene promoter. Preparation of electro-competent cells, and 
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electroporation of L. monocytogenes EGDe, was carried out using the protocol described by 
Monk and co-workers (46).  Listeria monocytogenes EGDe was transformed with plasmids 
pNZSTldhplaB and pNZSTldhmunC, yielding recombinant strains L. monocytogenes EGDe 
(pNZSTldhplaB) and L. monocytogenes EGDe (pNZSTldhmunC), respectively. 
In vitro assessment of growth of L. monocytogenes EGDe in the presence of plantaricin 
423 and mundticin ST bacteriocins  
Wild-type (WT) L. monocytogenes EGDe, recombinant L. monocytogenes EGDe 
(pNZSTldhplaB) and L. monocytogenes EGDe (pNZSTldhmunC) were grown in BHI broth 
for 12 h. One millilitre of 12-h old cultures was used to inoculate 40 ml BHI broth to a 
starting OD550nm of 0.1. The 40 ml cultures were supplemented with either 10 ml MRS 
(control), sterile supernatant of the bacteriocin producer or bacteriocin-negative strains and 
incubated at 37
o
C for 9 h. Every hour the OD550 reading for each 50 ml culture was 
measured. All experiments were done with three biological replicates. Bacteriocin activity on 
solid media was determined using the overlay lawn assay as described previously (47), but 
with the following modifications. The WT L. monocytogenes EGDe bacteriocin sensitive and 
recombinant bacteriocin-resistant strains were grown for 12 h and 100 µl liquid culture 
spread-plated onto a BHI agar plate. Cell-free supernatants (adjusted to pH 7.0 with NaOH) 
of actively growing (12 h) bacteriocin-producing, or bacteriocin-non-producing, strains were 
collected by centrifugation (8000 x g for 5 min). The supernatants were filter-sterilized by 
passage through a 0.22-µm-pore size cellulose acetate filter using a 5 ml syringe, 30 µl 
spotted into wells on BHI agar spread with WT, or bacteriocin-resistant L. monocytogenes 
EGDe, followed by incubation at 37
o
C for 24 h. 
Dosing of mice 
Ten groups of mice were administered a daily dose of LAB for six consecutive days. At least 
nine mice were used per LAB strain (4 x 10
9
 CFU per mouse). All cell suspensions were 
resuspended in 200 µl gavage buffer (0.2 M NaHCO3 with 1%, w/v, glucose), pH 8.0. Mice 
in groups WT-423 and WT-ST4SA received WT L. plantarum 423 (pGKV) (containing 
pGKV223 empty vector) and E. mundtii ST4SA (pGKV) (containing pGKV223 empty 
vector), respectively. A placebo group (group PBS) of mice were administered 200 µl sterile 
PBS for six days. Mice in groups B-423 and B-ST4SA received bacteriocin-negative L. 
plantarum 423 plaA::erm and E. mundtii ST4SA munA::cat, respectively. Mice in group A-
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423 received L. plantarum 423 aap::erm, mice in group A-ST4SA received E. mundtii 
ST4SA srtA::erm and mice in group C-ST4SA received E. mundtii ST4SA srtC::erm. On day 
6, 4 h after administering LAB, the mice in each group were fed 4 x 10
9
 CFU (per mouse) L. 
monocytogenes EGDe by oral gavage. Mice in groups IL-423 and IL-ST4SA were 
administered WT L. plantarum 423 and E. mundtii ST4SA, respectively, before oral 
administration with L. monocytogenes EGDe bacteriocin-resistant (4 x 10
9
 CFU) variant 
strains on day 6. 
Monitoring of in vivo and ex vivo bioluminescence 
Bioluminescence imaging of L. monocytogenes EGDe in the GIT of infected mice was 
monitored using the Caliper in vivo imaging system (IVIS
®
 100, Caliper Life Sciences, 
Hopkinton, MA, USA), equipped with a cooled charge-coupled-device camera mounted on a 
light-tight specimen chamber. Bioluminescent L. monocytogenes EGDe in the GIT of mice 
was imaged transcutaneously in whole animals at 15 min, 30 min, 1 h, 1.5 h, 2 h, 3 h, 4 h, 5 
h, 6 h and 24 h after oral administration. Before bioluminescence imaging, mice were 
anesthetized with 2% (vol/vol) isoflurane in O2. A constant flow of isoflurane (1.5%, v/v) 
was administered throughout examination through a nose cone. Exposure in the IVIS was 
from 3 to 5 min, depending on the signal strength. Photons emitted from manually selected 
regions of interest (ROIs) were quantified using the Living Image software, version 3.0 
(Caliper Life Sciences). 
Recording of bacteria in faeces 
Faecal samples were collected and weighed (100 mg) over a period of up to 48 h after oral 
adminstration with L. monocytogenes EGDe on day 6. The faecal pellets were homogenised 
after a few minutes in PBS for softening, vortexed for 5 min, serially diluted in the same 
buffer and plated onto MRS agar containing the appropriate antibiotic for enumeration of 
LAB strains. Cells of L. monocytogenes EGDe were selected by plating onto BHI agar 
supplemented with either Em or Cm. After a 24 h incubation period, the number of viable 
LAB and L. monocytogenes EGDe cells present per 100 mg faeces was determined. 
Bioluminescence of L. monocytogenes EGDe cells in faecal samples was recorded by 
transferring 300 µl of homogenised faeces to a 96-well microtiter tray for imaging using the 
IVIS.  
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Recording of bacteria in the GIT 
Two mice from each group were euthanized by cervical dislocation at 4 h, 6 h, 24 h and 48 h 
after oral administration with L. monocytogenes EGDe for ex-vivo bioluminescence imaging 
of their digestive tracts. The digestive tracts were immediately resected, rearranged in a Petri-
dish and examined for the presence of bioluminescent L. monocytogenes EGDe cells using 
the IVIS (refer to Fig. S1 for different sections of mouse GIT). Prior to imaging, each 
resected digestive tract was longitudinally opened with a sterile surgical blade for 
enhancement of the bioluminescent signal. For CFU counts in the digestive tracts, the small 
(duodenum, jejunum and ileum) and large (cecum and colon) intestinal tracts were 
homogenized separately in 3 ml sterile PBS, serially diluted and plated in duplicate onto BHI 
agar (for L. monocytogenes EGDe counts) or MRS agar (for LAB counts) supplemented with 
the appropriate antibiotics. Plates were incubated as described before for 24 h to 48 h and the 
number of viable cells determined in each section of the GIT.  
Statistical Analysis 
All data were analysed using GraphPad Prism (version 6.05) and statistical differences 
between groups were determined using the Kruskal-Wallis nonparametric test and two-way 
analysis of variance (ANOVA). Statistical differences are shown for each data set. Error was 
calculated as standard error of mean (SEM). 
Results 
In vitro effect of plantaricin and mundticin on the growth of L. monocytogenes EGDe 
Listeria monocytogenes EGDe is sensitive to the bacteriocins plantaricin 423 and mundticin 
ST produced by L. plantarum 423 and E. mundtii ST4SA, respectively, as determined by well 
diffusion assay (Fig. 1A). Wild-type L. monocytogenes EGDe was inhibited by twofold 
dilutions of plantaricin 423 up to 1/64 (Fig. 1B), while L. monocytogenes EGDe, transformed 
with pNZSTldhplaB for bacteriocin immunity, showed a complete loss of inhibition at a 
dilution of 1/4 (Fig. 1C). Listeria monocytogenes EGDe transformed with pNZSTldhmunC, 
containing the gene coding for mundticin ST immunity, was resistant to undiluted 
supernatants containing mundticin ST (Fig. 1D). Listeria monocytogenes EGDe 
(pNZSTldhmunC) were inhibited by plantaricin 423, indicating that the immunity protein of 
mundticin ST did not protect the cells against plantaricin 423 (Fig. 1D). Similarly, L. 
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monocytogenes EGDe (pNZSTldhplaB) were inhibited by mundticin ST. Both L. 
monocytogenes EGDe (pNZSTldhplaB) and L. monocytogenes EGDe (pNZSTldhmunC) 
retained resistance to their respective bacteriocins after 7 days of culturing in non-selective 
media, indicating the stability of the autonomous plasmids in the host (not shown). 
                                                    
 
                                                  
 
FIG. 1. Zones of inhibition on plates overlaid with L. monocytogenes EGDe. A. (ST4SA) Supernatant 
containing bacteriocin mundticin ST isolated from WT E. mundtii ST4SA and (423) supernatant 
containing bacteriocin plantaricin 423 isolated from WT L. plantarum 423 spotted into wells on plate 
spread with WT L. monocytogenes EGDe. B, C. (+) Supernatant containing bacteriocin plantaricin 
423 isolated from WT L. plantarum 423, (-) supernatant lacking plantaricin 423 bacteriocin isolated 
from L. plantarum 423 bac
-
 as negative control, and (1/2 to 1/64) supernatants containing bacteriocin 
plantaricin 423 diluted twofold spotted into wells on plates spread with (B) WT L. monocytogenes 
EGDe and (C) L. monocytogenes EGDe (pNZSTldhplaB). D. (ST4SA) Supernatant containing 
bacteriocin mundticin ST isolated from WT E. mundtii ST4SA and (423) supernatant containing 
bacteriocin plantaricin 423 isolated from WT L. plantarum 423 spotted into wells on plate spread with 
L. monocytogenes EGDe (pNZSTldhmunC). 
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Loss of inhibition as determined by a cell growth assay in BHI broth for L. monocytogenes 
EGDe (pNZSTldhplaB) and L. monocytogenes EGDe (pNZSTldhmunC) expressing the 
plantaricin 423 and mundticin ST immunity proteins, respectively, is depicted in Fig. 2. The 
growth of WT L. monocytogenes EGDe was completely inhibited in the presence of two-fold 
dilutions of plantaricin 423 up to 1/64, while the growth rate in non-bacteriocin containing 
MRS remained unaffected (Fig. 2A). A significant increase in growth was recorded for L. 
monocytogenes EGDe (pNZSTldhplaB) in the presence of plantaricin 423 diluted to 1/32 
compared to the WT strain. The growth of L. monocytogenes EGDe (pNZSTldhmunC) was 
not affected in the presence of undiluted mundticin ST compared to a lack of growth for the 
WT strain after the 9 h period (Fig. 2B). The growth of WT, PlaB and MunC immunity 
protein expressing L. monocytogenes EGDe remained unaffected in the presence of non-
bacteriocin containing supernatants isolated from L. plantarum 423 and E. mundtii ST4SA 
bacteriocin-negative strains (Fig. 2A and 2B). 
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FIG. 2. Effect of (A) plantaricin 423 and (B) mundticin ST on growth of WT L. monocytogenes 
EGDe, L. monocytogenes EGDe transformed with pNZSTldhplaB or L. monocytogenes EGDe 
transformed with pNZSTldhmunC, for 9 h, as determined by cell growth in BHI broth. Statistical 
differences were assessed using the Kruskal-Wallis nonparametric test (P<0.05). Identical letters a 
and b denote no significant difference, and different letters indicate which groups have statistically 
significant differences with each other.  
Probiotic administration excludes L. monocytogenes from the GIT 
Luciferase expression by L. monocytogenes EGDe was used to follow the intestinal 
colonization and exclusion of cells from the intestinal tract after probiotic dosing. As early as 
15 min after administering L. monocytogenes EGDe, a strong bioluminescence signal could 
be detected for mice in all groups (Fig. 3). A strong bioluminescence signal was detected 
from mice in the placebo control group (PBS) for 24 h. Mice administered with WT L. 
plantarum 423 or WT E. mundtii ST4SA for six consecutive days before challenge with 
luminescent L. monocytogenes EGDe elicited a significant reduction in the bioluminescent 
signal emitted from the abdominal region of all mice throughout the study period (Fig. 3A 
and 4A). From as early as 2 to 3 h post-infection the bioluminescence signal emitted from 
mice in groups WT-423 and WT-ST4SA was significantly reduced to the background signal 
compared to mice administered with the placebo control (Fig. 3B and 4B). 
a 
b 
Fig. 2B. 
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FIG. 3. (A) Visual images of bioluminescence and (B) the representative signals emitted used to track 
colonization and bacterial load of L. monocytogenes EGDe in the gastrointestinal tract of mice 
administered with PBS (placebo control), WT and recombinant L. plantarum 423 strains for 6 days 
before Listeria challenge. PBS: mice administered with sterile PBS, placebo control; WT-423: wild-
type L. plantarum 423; B-423: plantaricin 423 bacteriocin-negative L. plantarum 423 plaA::erm and 
A-423: Aap-negative L. plantarum 423 aap::erm for 6 days before Listeria challenge. IL-423:  mice 
administered with wild-type L. plantarum 423 for 6 days before challenge with plantaricin 423-
resistant L. monocytogenes EGDe (pNZSTldhplaB). The intensity of the photon emission is 
represented as a pseudo-color image. One representative scale bar is shown (ps
-1
cm
-2
sr
-1
) in A. 
Statistical analysis was determined by two-way ANOVA (P<0.05, P<0.01 or P<0.001). Significant 
differences between groups PBS and WT-423 are indicated with asterisks and with empty circles 
between groups PBS and IL-423. The background level of the bioluminescence signal is represented 
by a dashed line. 
 
 
 
 
 
 
Fig. 3B. 
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FIG. 4. (A) Visual images of bioluminescence and (B) the representative signals emitted used to track 
colonization and bacterial load of L. monocytogenes EGDe in the gastrointestinal tract of mice 
administered with PBS (placebo control), WT and recombinant E. mundtii ST4SA strains for 6 days 
before Listeria challenge. PBS: mice administered with sterile PBS, placebo control; WT-ST4SA: 
wild-type E. mundtii ST4SA; B-ST4SA: mundticin ST bacteriocin-negative E. mundtii 
ST4SA munA::cat; A-ST4SA: SrtA-negative E. mundtii ST4SA srtA::erm and C-ST4SA: 
SrtC-negative E. mundtii ST4SA srtC::erm for 6 days before Listeria challenge. IL-ST4SA:  
mice administered with wild-type E. mundtii ST4SA for 6 days before challenge with 
mundticin ST-resistant L. monocytogenes EGDe (pNZSTldhmunC). The intensity of the photon 
emission is represented as a pseudo-color image. One representative scale bar is shown (ps
-1
cm
-2
sr
-1
) 
in A. Statistical analysis was determined by two-way ANOVA (P<0.05, P<0.01 or P<0.001). 
Significant differences between groups PBS and WT-ST4SA are indicated with asterisks; empty 
circles between groups PBS and A-ST4SA and with filled circles between groups PBS and C-ST4SA.  
Strong bioluminescence emission was detected in dissected intestines of mice in the PBS 
placebo control group (PBS, Fig. 5A). From 4 h post-infection, no bioluminescence was 
observed in the GIT of mice that received L. plantarum 423 and E. mundtii ST4SA for 6 days 
before oral administration with L. monocytogenes EGDe (WT-423 and WT-ST4SA, Fig. 5A). 
The small and large intestinal tracts of mice in all groups were homogenized separately to 
Fig. 4B. 
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enumerate L. monocytogenes EGDe viable cell numbers and these were expressed as the 
percentage reduction of the PBS (PR
P
) placebo control group CFU throughout the trial 
period. Results shown in Figs 5 to 8 represent absolute CFU values, while values in the text 
refer to PR
P
. Enumeration of L. monocytogenes EGDe cells in the small intestinal tracts of 
mice that were pre-treated with WT L. plantarum 423 revealed a highly significant 
percentage reduction of 99.7% after 4 h and stayed consistent until 48 h post-infection 
compared to the PBS placebo control (Fig. 5B). In the same group, cell numbers of L. 
monocytogenes EGDe in the large intestinal tracts were significantly reduced by 89.5% PR
P
 
after 4 h and increased to 99.5% PR
P
 after 48 h (Fig. 5C). The number of L. monocytogenes 
EGDe cells in the small intestinal tracts of mice pre-treated with E. mundtii ST4SA was 
significantly reduced by 41.3% after 4 h but increased further to 98.9% PR
P
 after 48 h (Fig. 
5B). Despite a higher number of L. monocytogenes EGDe cells in the small intestinal tract of 
mice in group WT-ST4SA (41.4% PR
P
) after 4 h compared to mice in group WT-423 (99.5% 
PR
P
), no bioluminescent cells were detected in the small intestines of mice in group WT-
ST4SA (Fig. 5 B). Significant differences in the L. monocytogenes EGDe population between 
mice in group WT-ST4SA and the PBS placebo control group were also confirmed in the 
large intestinal tract by a percentage reduction of 95% to 98.5% during the study period (Fig. 
5C).  
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Fig. 5A. 
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 Fig. 5. A. Visual images to track bioluminescent cells of L. monocytogenes EGDe in the different 
sections of the digestive tract of mice in groups PBS (placebo control), WT-423 and WT-ST4SA (1) 
4 and (2) 6 h after Listeria challenge. PBS: mice administered with sterile PBS, placebo control; WT-
423: wild-type L. plantarum 423 and WT-ST4SA: wild-type E. mundtii ST4SA for 6 days before 
Listeria challenge. Persistence of viable L. monocytogenes EGDe cells in the (B) small and (C) large 
intestinal tracts of mice in groups PBS (placebo control), WT-423 and WT-ST4SA. Results are 
expressed as the percentage reduction of the PBS placebo control group L. monocytogenes EGDe 
CFU. Statistical differences were assessed using two-way ANOVA (P<0.01 and P<0.001). Identical 
letters a and b denote no significant difference, and different letters indicate which groups have 
significant statistical differences with each other.  
Fig. 5B. 
a 
Fig. 5C. 
a a 
a a a 
b 
b 
b b b b b b 
a a 
b 
b 
b 
b b 
b 
b 
b 
Stellenbosch University  https://scholar.sun.ac.za
176 
 
Bacteriocin production as a protective mechanism against L. monocytogenes in the GIT 
Mice administered with bacteriocin-negative L. plantarum 423 plaA::erm and E. mundtii 
ST4SA munA::cat for 6 days emitted a significantly higher bioluminescence signal compared 
to mice administered with WT L. plantarum 423 and WT E. mundtii ST4SA (Fig 3A and 
4A). Throughout the trial period (24 h), mice in groups B-423 and B-ST4SA displayed levels 
of bioluminescence emission similar to mice fed the PBS placebo control compared to a 
significant reduction in bioluminescence in groups WT-423 and WT-ST4SA (Fig. 3B and 
4B). Bioluminescent cells of L. monocytogenes EGDe were detected in the upper section of 
the small intestine in mice that received L. plantarum 423 plaA::erm 4 h post-infection (1, B-
423, Fig. 6A). Two h later, bioluminescent cells of L. monocytogenes EGDe migrated further 
into the large intestinal tract (2, B-423, Fig. 6A). High-intensity bioluminescence was 
observed in the small intestine of mice that were administered E. mundtii ST4SA munA::cat, 
4 and 6 h after challenge with Listeria monocytogenes EGDe (B-ST4SA, Fig. 6A). A 
significantly higher amount of viable L. monocytogenes EGDe cells were observed in the 
small intestinal tract of mice in group B-423 (38.9% PR
P
) compared to mice in group WT-
423 (99.7% PR
P
) 4 h after challenge (Fig. 6B), while there were no significant differences 
between the L. monocytogenes EGDe CFU counts in the large intestinal tracts of mice in 
group B-423 and the PBS placebo control group from 6 to 48 h post-infection (Fig. 6C). 
There was no significant reduction in CFU counts of L. monocytogenes EGDe in the small 
intestinal tract of mice pre-treated with E. mundtii ST4SA munA::cat (33.7% PR
P
) or mice 
treated with the PBS placebo control 4h after they were infected, but there was a significant 
increase to 94.5% PR
P
 44 h later  (Fig. 6B). High cell counts of L. monocytogenes EGDe 
were observed in the large intestinal tract of mice in group B-ST4SA with 61.5% PR
P
 at 6 h 
and 52.3% PR
P
 after 48 h (Fig. 6C).  
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Fig. 6. A. Visual images to track bioluminescent cells of L. monocytogenes EGDe in the different 
sections of the digestive tract of mice in groups WT-423, B-423, WT-ST4SA and B-ST4SA (1) 4 and 
(2) 6 h after Listeria challenge. WT-423: mice administered with wild-type L. plantarum 423; B-423: 
plantaricin 423 bacteriocin-negative L. plantarum 423 plaA::erm; WT-ST4SA: wild-type E. mundtii 
ST4SA and B-ST4SA: mundticin ST bacteriocin-negative E. mundtii ST4SA munA::cat for 6 days 
before Listeria challenge. Persistence of viable L. monocytogenes EGDe cells in the (B) small and (C) 
large intestinal tracts of mice in groups PBS (placebo control), WT-423, B-423, WT-ST4SA and B-
ST4SA. Results are expressed as the percentage reduction of the PBS placebo control group L. 
monocytogenes EGDe CFU. Statistical differences were assessed using two-way ANOVA (P<0.05, 
P<0.01 and P<0.001). Identical letters a and b denote no significant difference, and different letters 
indicate which groups have significant statistical differences with each other.  
To provide additional confirmation of bacteriocin involvement in the anti-infective activity of 
L. plantarum 423 and E. mundtii ST4SA against L. monocytogenes EGDe in the GIT, mice 
administered with the WT probiotic strains for 6 days were challenged with L. 
monocytogenes EGDe (pNZSTldhplaB) and L. monocytogenes EGDe (pNZSTldhmunC 
expressing the plaB plantaricin 423 and munC mundticin ST bacteriocin immunity genes, 
respectively. Mice challenged with L. monocytogenes EGDe (pNZSTldhplaB) and L. 
monocytogenes EGDe (pNZSTldhmunC) in groups IL-423 (Fig. 3A) and IL-ST4SA (Fig. 
4A), respectively, elicited an increase in bioluminescence emission compared to mice 
Fig. 6C. 
a a 
b 
a 
a 
a a 
b b 
b 
b 
b b 
a 
a 
a 
b 
b 
b 
a 
Stellenbosch University  https://scholar.sun.ac.za
179 
 
challenged with the WT L. monocytogenes EGDe strains for 6 h. This result served as an 
early indication of an increase in L. monocytogenes EGDe bacterial load as a direct 
consequence of bacteriocin immunity gene expression. Bioluminescence readings of mice in 
group IL-423 significantly decreased 3 h after they were infected compared to readings 
recorded for mice in the PBS placebo control group (Fig. 3B). However, when examined 1 h 
later, the bioluminescence signal increased and remained at a similar level as observed for 
mice in group PBS for 20 h. There were no significant differences in bioluminescence 
recorded between mice in groups IL-ST4SA and mice in the B-ST4SA or PBS placebo 
control group (Fig. 4B).  
Strong bioluminescence was emitted from L. monocytogenes EGDe (pNZSTldhplaB) in 
dissected intestines of mice in group IL-423 4 h after they were infected, and changed to a 
reduced signal 2 h later (IL-423, Fig. 7A). Similar results were observed for mice in group 
IL-ST4SA, with high bioluminescence emitted from the upper section of the small intestine 
(IL-ST4SA, Fig. 7A). Enumeration of viable cells of L. monocytogenes EGDe 
(pNZSTldhplaB) (IL-423) and L. monocytogenes EGDe (pNZSTldhmunC) (IL-ST4SA) in 
the small intestinal tract revealed levels similar to mice group PBS after 4 h infection, but 
significantly decreased 2 h later (Fig. 7B). The L. monocytogenes EGDe (pNZSTldhplaB) 
and L. monocytogenes EGDe (pNZSTldhmunC) populations in the large intestinal tract 
displayed levels similar to mice that received the placebo control (PBS) throughout the trial 
period (Fig. 7C). 
 
                   
                   
 
1 
2 
B-423 IL-423 B-ST4SA IL-ST4SA 
Fig. 7A. 
Stellenbosch University  https://scholar.sun.ac.za
180 
 
 
4 6 24 48
0
20
40
60
80
100
PBS (placebo)
B-423
IL-423
B-ST4SA
IL-ST4SA
Hours
C
F
U
/S
m
a
ll
 i
n
te
s
ti
n
e
 a
s
 %
 o
f 
p
la
c
e
b
o
 
                            
4 6 24 48
0
20
40
60
80
100
PBS (placebo)
B-423
IL-423
B-ST4SA
IL-ST4SA
Hours
C
F
U
/L
a
rg
e
 i
n
te
s
ti
n
e
 a
s
 %
 o
f 
p
la
c
e
b
o
Fig. 7. A. Visual images to track bioluminescent cells of L. monocytogenes EGDe in the different 
sections of the digestive tract of mice in groups B-423, IL-423, B-ST4SA and IL-ST4SA (1) 4 and 
(2) 6 h after Listeria challenge. B-423: mice administered with plantaricin 423 bacteriocin-negative L. 
plantarum 423 plaA::erm for 6 days before Listeria challenge and IL-423: mice administered with 
wild-type L. plantarum 423 for 6 days before challenge with plantaricin 423-resistant L. 
monocytogenes EGDe (pNZSTldhplaB). B-ST4SA: mice administered with mundticin ST 
bacteriocin-negative E. mundtii ST4SA munA::cat for 6 days before Listeria challenge and IL-
ST4SA:  mice administered with wild-type E. mundtii ST4SA before challenge with mundticin ST-
resistant L. monocytogenes EGDe (pNZSTldhmunC) on day 6. Persistence of viable L. 
monocytogenes EGDe cells in the (B) small and (C) large intestinal tracts of mice in groups PBS 
Fig. 7B. 
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(placebo control), B-423, IL-423, B-ST4SA and IL-ST4SA. Results are expressed as the percentage 
reduction of the PBS placebo control group L. monocytogenes EGDe CFU. Statistical differences 
were assessed using two-way ANOVA (P<0.05, P<0.01 and P<0.001). Identical letters a and b denote 
no significant difference, and different letters indicate which groups have significant statistical 
differences with each other.  
Probiotic adhesion properties as a protective mechanism against L. monocytogenes in 
the GIT 
No significant differences in bioluminescence readings between mice administered with L. 
plantarum 423 aap::erm (lacking the aap adhesion gene) and the PBS placebo control were 
recorded. (Fig. 3A and B). Significantly lower bioluminescence readings, between 2 and 5 h, 
were recorded for mice in groups A-ST4SA and C-ST4SA compared to mice administered 
with the PBS placebo control (Fig. 4A and B). High-intensity bioluminescence was observed 
in the small intestine of dissected mice in group A-423 4 h after they were infected, but 
decreased to a lower intensity 2 h later (A-423, Fig. 8A). Bioluminescent cells of L. 
monocytogenes EGDe were detected in the GIT of mice in group A-ST4SA 4 h after 
infection and were detectable over a larger area of the small and large intestine over the next 
2 h (A-ST4SA, Fig. 8A). No bioluminescence emission was detectable in the small intestine 
of mice administered with E. mundtii ST4SA srtC::erm (C-ST4SA, Fig.8A). In the same 
group, low-intensity bioluminescence was observed in the cecum of the large intestinal tract 6 
h after infection.  
The L. monocytogenes EGDe PR
P
 in the small intestine of mice in group A-423 were 
significantly lower compared to those in the WT-423 group after 4 but decreased to higher 
levels between 6 and 48 h with a percentage reduction of 83.1% to 87%, respectively (A-423, 
Fig. 8B). However, the L. monocytogenes EGDe PR
P
 in the large intestinal tract of mice in 
group A-423 were comparable to those observed in the WT-423 group after 6 h, but 
significantly decreased at 24 h (3.2% PR
P
) and 48 h (39% PR
P
) (A-423, Fig. 8C). At 4 and 6 
h after infection, there was no difference between L. monocytogenes EGDe CFUs in the small 
intestinal tract of mice in group A-ST4SA and the PBS placebo control group (A-ST4SA, 
Fig. 8B), while significant differences in CFUs were observed between group C-ST4SA and 
the PBS placebo control group throughout the study period (C-ST4SA, Fig. 8B).  Highest L. 
monocytogenes EGDe cell numbers in the large intestinal tract of mice in groups A-ST4SA 
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and C-ST4SA were recorded at 6 h (47.7% PR
P
)  and 24 h (45% PR
P
), respectively, followed 
by a decrease to similar levels observed for mice in group WT-ST4SA after 48 h. (Fig. 8C).  
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Fig. 8. A. Visual images to track bioluminescent cells of L. monocytogenes EGDe in the different 
sections of the digestive tract of mice in groups WT-423, A-423, WT-ST4SA, A-ST4SA and C-
ST4SA (1) 4 and (2) 6 h after Listeria challenge. WT-423: mice administered with wild-type L. 
plantarum 423; A-423: Aap-negative L. plantarum 423 aap::erm; WT-ST4SA: wild-type E. mundtii 
ST4SA; A-ST4SA: SrtA-negative E. mundtii ST4SA srtA::erm and C-ST4SA: SrtC-negative E. 
mundtii ST4SA srtC::erm for 6 days before Listeria challenge. Persistence of viable L. 
monocytogenes EGDe cells in the (B) small and (C) large intestinal tracts of mice in groups PBS 
(placebo control), WT-423, A-423, WT-ST4SA, A-ST4SA and C-ST4SA. Results are expressed as 
the percentage reduction of the PBS placebo control group L. monocytogenes EGDe CFU. Statistical 
differences were assessed using two-way ANOVA (P<0.05, P<0.01 and P<0.001). Identical letters a 
and b denote no significant difference, and different letters indicate which groups have significant 
statistical differences with each other. 
Enumeration of viable L. monocytogenes in mouse faeces 
No viable cells of L. monocytogenes EGDe or bioluminescent signals were detected in the 
faeces of mice administered with the PBS placebo control 3 h after infection (Fig. 9). One 
hour later (at 4 h), 9.54 x 10
7
 CFU/100 mg faeces L. monocytogenes EGDe were recorded in 
the faeces of mice in the PBS placebo control group which then increased to 5.73 x 10
8
 
CFU/100 mg faeces after 6 h (Fig. 9A). In group PBS, the maximum bioluminescence signals 
were detected between 5 (1.15 x 10
6
 p/s/100 mg of faeces) and 6 h (2.74 x 10
5
 p/s/100 mg of 
Fig. 8C. 
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faeces) after infection, correlating perfectly with the amount of viable cells recorded during 
the same period (Fig. 9B). The number of viable L. monocytogenes EGDe cells increased 
with time in faeces of mice in groups WT-423, B-423 and IL-423, with the most significant 
differences observed in the first 3 h after infection compared to mice in the PBS placebo 
control group (Fig. 9A). During the same period, there were no significant differences 
between L. monocytogenes EGDe counts or bioluminescence emissions in faeces of mice in 
group A-423 and group PBS (Fig. 9A and B). Highest numbers of L. monocytogenes EGDe 
were excreted in the faeces of mice in groups B-423 and IL-423, reaching maximums of 
approximately 1.8 x 10
6
 CFU/100 mg faeces after 1.5 h and 1.8 x 10
6
 CFU/100 mg faeces 
after 48 h for each group (Fig. 9A) with corresponding bioluminescence signals of 
approximately 1.41 x 10
4
 p/s/100 mg of faeces and 7.19 x 10
4
 p/s/100 mg of faeces, 
respectively (Fig. 9B). Significantly higher cell numbers of L. monocytogenes EGDe were 
excreted in the faeces of mice in group WT-423 compared to group A-423 during the first 4 
h, suggesting that the WT 423 strain more effectively excluded the pathogen from the GIT 
compared to the L. plantarum adhesion gene KO strain. 
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Fig. 9. Persistence of viable L. monocytogenes EGDe in the faeces of mice in groups PBS (placebo 
control), WT-423, B-423, IL-423 and A-423, as recorded with (A) cell counts and (B) 
bioluminescence imaging. PBS: mice administered with sterile PBS, placebo control; WT-423: wild-
type L. plantarum 423; B-423: plantaricin 423 bacteriocin-negative L. plantarum 423 plaA::erm and 
A-423: Aap-negative L. plantarum 423 aap::erm for 6 days before Listeria challenge. IL-423: mice 
administered with wild-type L. plantarum 423 for 6 days before challenge with plantaricin 423-
resistant L. monocytogenes EGDe (pNZSTldhplaB). Statistical analysis was determined by two-way 
ANOVA (P<0.05, P<0.01 or P<0.001). Significant differences between groups PBS and WT-423 are 
indicated with asterisks, empty circles between groups PBS and IL-423, and with filled circles 
between groups PBS and B-423. The background level of the bioluminescence signal is represented 
by a dashed line. 
For mice in group WT-ST4SA, the L. monocytogenes EGDe counts in faeces reached 
approximately 6.23 x 10
7
 CFU/100 mg faeces after 2 h with a bioluminescent signal of 2.58 x 
10
5
 p/s/100 mg of faeces and remained at a plateau for about 4 h (Fig. 10). After 2 h, no L. 
monocytogenes EGDe could be found in the faeces of mice in groups B-ST4SA, IL-ST4SA 
and A-ST4SA, while the number of L. monocytogenes EGDe recorded in the faeces of mice 
in group C-ST4SA reached 7.6 x 10
5
 CFU/100 mg faeces with a bioluminescence signal of 
3.86 x 10
4
 p/s/100 mg of faeces (Fig. 10). After 3 h, the number of L. monocytogenes EGDe 
organisms in the faeces of all probiotic pre-treated mice was significantly higher compared to 
the PBS placebo control group (Fig. 10A). These peaks correlated well with the 
bioluminescent signals recorded at the same time, except for mice in group IL-ST4SA (Fig. 
10B).  
Fig. 9B. 
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Fig. 10. Persistence of viable L. monocytogenes EGDe in the faeces of mice in groups PBS (placebo 
control), WT-ST4SA, B-ST4SA, IL-ST4SA, A-ST4SA and C-ST4SA, as recorded with (A) cell 
counts and (B) bioluminescence imaging. PBS: mice administered with sterile PBS, placebo control; 
WT-ST4SA: wild-type E. mundtii ST4SA; B-ST4SA: mundticin ST bacteriocin-negative E. mundtii 
ST4SA munA::cat; A-ST4SA: SrtA-negative E. mundtii ST4SA srtA::erm and C-ST4SA: SrtC-
negative E. mundtii ST4SA srtC::erm for 6 days before Listeria challenge. IL-ST4SA:  mice 
administered with wild-type E. mundtii ST4SA for 6 days before challenge with mundticin ST-
Fig. 10A. 
Fig. 10B. 
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resistant L. monocytogenes EGDe (pNZSTldhmunC). Statistical analysis was determined by two-way 
ANOVA (P<0.05, P<0.01 or P<0.001). Significant differences between groups PBS and WT-ST4SA 
are indicated with asterisks, empty circles between groups PBS and IL-ST4SA, filled circles between 
groups PBS and B-ST4SA, triangles between groups PBS and A-ST4SA and with diamonds between 
groups PBS and C-ST4SA. The background level of the bioluminescence signal is represented by a 
dashed line. 
Cell numbers of L. monocytogenes EGDe isolated from the faeces of all groups displayed 
similar levels between 4 and 24 h (Fig. 10 A). After 48 h, the number of L. monocytogenes 
EGDe cells recorded in the faeces of mice in group WT-ST4SA declined to approximately 
3.5 x 10
3
 CFU/100 mg faeces compared to 3.5 x 10
6
 CFU/100 mg faeces isolated from mice 
in the PBS placebo control group (Fig. 10A). 
Probiotic CFU counts in the GIT and faeces of mice challenged with L. monocytogenes 
Highest cell numbers of WT L. plantarum 423 and all recombinant L. plantarum 423 strains 
were detected in the large intestine when examined 4, 6, 25 and 48 h after Listeria infection 
compared to the small intestine (Fig. 11A and B). Compared to WT L. plantarum 423 (WT-
423 group), cell numbers of L. plantarum 423 aap::erm (A-423 group) were approximately a 
1000-fold higher in the small intestine 4 h after infection but decreased 2 h later (Fig. 11A). 
Cell counts of WT L. plantarum 423 in both the small and large intestinal tract were 
generally lower compared to that of recombinant L. plantarum 423 strains, with the most 
significant reduction after 24 h in the large intestinal tract (Fig. 11B). There were no 
significant differences between WT L. plantarum 423 and all recombinant strains’ viable 
counts in the large intestinal tract between 4 and 6 h after they were infected. The number of 
viable WT E. mundtii ST4SA and recombinant E. mundtii ST4SA bacteria in the small 
intestinal tract displayed similar levels between 4 and 6 h after infection, ranging from 
approximately 3.44 x 10
5
 CFU/ml to 2.40 x 10
7
 CFU/ml (Fig. 12A). After 24 h, the number 
of viable E. mundtii ST4SA srtA::erm (A-ST4SA group) in the small intestine declined to 
approximately 100 cells per ml. Cell numbers similar to those of WT-ST4SA were recorded 
for all recombinant E. mundtii ST4SA strains in the large intestine between 4 and 6 h, where 
after viable WT E. mundtii ST4SA (WT-ST4SA group) and E. mundtii ST4SA srtA::erm (A-
ST4SA group) cells declined to approximately 2.52 x 10
5
 CFU/ml and 7 x 10
3
 CFU/ml, 
respectively, at 24 h (Fig. 12B). After 48 h, no viable E. mundtii ST4SA srtA::erm cells were 
detected in the intestines of mice (Fig. 12A and B). 
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Fig. 11. Persistence of viable L. plantarum 423 strains in the (A) small and (B) large intestinal tracts 
of mice post Listeria challenge in groups WT-423, B-423, IL-423 and A-423. WT-423: mice 
administered with wild-type L. plantarum 423; B-423: plantaricin 423 bacteriocin-negative L. 
plantarum 423 plaA::erm and A-423: Aap-negative L. plantarum 423 aap::erm for 6 days before 
Listeria challenge. IL-423:  mice administered with wild-type L. plantarum 423 for 6 days before 
challenge with plantaricin 423-resistant L. monocytogenes EGDe (pNZSTldhplaB). Statistical analysis 
was determined by two-way ANOVA (P<0.05, P<0.01 or P<0.001). Underlined letters and lines 
above bars indicate which groups have statistically significant differences. 
b c d  a 
Fig. 11A. 
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Fig. 12. Persistence of viable E. mundtii ST4SA strains in the (A) small and (B) large intestinal tracts 
of mice post Listeria challenge in groups WT-ST4SA, B-ST4SA, IL-ST4SA, A-ST4SA and C-
ST4SA. WT-ST4SA: mice administered with wild-type E. mundtii ST4SA; B-ST4SA: mundticin ST 
bacteriocin-negative E. mundtii ST4SA munA::cat; A-ST4SA: SrtA-negative E. mundtii ST4SA 
srtA::erm and C-ST4SA: SrtC-negative E. mundtii ST4SA srtC::erm for 6 days before Listeria 
challenge. IL-ST4SA:  mice administered with wild-type E. mundtii ST4SA for 6 days before 
challenge with mundticin ST-resistant L. monocytogenes EGDe (pNZSTldhmunC). Statistical analysis 
was determined by two-way ANOVA (P<0.05, P<0.01 or P<0.001). Underlined letters and lines 
above bars indicate which groups have statistically significant differences. 
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On day 6 (last day of probiotic administration to mice), cell number in faeces of WT L. 
plantarum 423 (WT-423 group) increased with time, reaching its maximum level at 2 h after 
oral administration of L. monocytogenes EGDe of approximately 3 x 10
8
 CFU/100 mg faeces, 
but declined to 6.9 x 10
5
 CFU/100 mg faeces (Fig. 13A) at 48 h. Lowest cell numbers were 
recorded in the faeces of mice in groups IL-423 and A-423, declining to 9.1 x 10
4
 CFU/100 
mg faeces WT L. plantarum 423 (IL-423) after 1.5 h and 4.2 x 10
4
 CFU/100 mg faeces L. 
plantarum 423 aap::erm (A-423) after 2 h, respectively (Fig. 13A). The number of WT E. 
mundtii ST4SA reached approximately 3 x 10
8
 CFU/100 mg faeces 1 h after infection with L. 
monocytogenes EGDe, remained at a plateau for about 5 h and then declined (Fig. 13B). 
During the first 6 h after infection, the number WT E. mundtii ST4SA and recombinant E. 
mundtii ST4SA in the faeces of mice in all groups displayed similar levels, except for 
significant reductions in the first 2 h in the faeces of mice in groups B-ST4SA and IL-ST4SA 
compared to WT-ST4SA (Fig.13 B). After 48 h, no significant differences in cell counts were 
observed in the faeces of mice in all groups (Fig. 13A and B). 
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Fig. 13A. 
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Fig. 13. A. Persistence of viable L. plantarum 423 strains in the faeces of mice post Listeria challenge 
in groups WT-423, B-423, IL-423 and A-423. WT-423: mice administered with wild-type L. 
plantarum 423; B-423: plantaricin 423 bacteriocin-negative L. plantarum 423 plaA::erm and A-423: 
Aap-negative L. plantarum 423 aap::erm for 6 days before Listeria challenge.  IL-423:  mice 
administered with wild-type L. plantarum 423 for 6 days before challenge with plantaricin 423-
resistant L. monocytogenes EGDe (pNZSTldhplaB). B. Persistence of viable E. mundtii ST4SA 
strains in the faeces of mice post Listeria challenge at t=0 in groups WT-ST4SA, B-ST4SA, IL-
ST4SA, A-ST4SA and C-ST4SA. WT-ST4SA: mice administered with wild-type E. mundtii ST4SA; 
B-ST4SA: mundticin ST bacteriocin-negative E. mundtii ST4SA munA::cat; A-ST4SA: SrtA-
negative E. mundtii ST4SA srtA::erm and C-ST4SA: SrtC-negative E. mundtii ST4SA srtC::erm for 6 
days before Listeria challenge. IL-ST4SA:  mice administered with wild-type E. mundtii ST4SA for 
6 days before challenge with mundticin ST-resistant L. monocytogenes EGDe (pNZSTldhmunC). 
Statistical analysis was determined by two-way ANOVA (P<0.05, P<0.01 or P<0.001). In A, 
significant differences between groups WT-423 and IL-423 are indicated by an asterisk and with 
filled circles between groups WT-423 and A-423. In B, significant differences between groups WT-
ST4SA and B-ST4SA are indicated with asterisks, empty circles between WT-ST4SA and A-ST4SA 
and with filled circles between groups WT-ST4SA and IL-ST4SA.  
 
 
Fig. 13B. 
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Discussion 
Numerous studies have demonstrated the ability of some LAB strains to control the growth of 
L. monocytogenes both in vitro and in vivo (2, 15, 24-27, 48-51). We have shown previously 
(and reconfirmed in this study), that the probiotics L. plantarum 423 and E. mundtii ST4SA 
successfully excluded L. monocytogenes from the GIT and protected mice from systemic 
infection (15). The functional effects of genes expressed by LAB in vitro or in vivo can only 
be truly assessed by the creation of knockout derivatives of strains expressing these genes. In 
the present study, two potential probiotic mechanisms of action responsible for a defined 
protective and anti-listerial effect in the GIT of mice using reverse genetic analysis are 
investigated.   
First, the in vitro effect of bacteriocins plantaricin 423 and mundticin ST on the growth of 
wild-type (WT) L. monocytogenes EGDe and recombinant L. monocytogenes EGDe variant 
strains expressing the plantaricin 423 plaB and munditicin ST munC bacteriocin immunity 
genes, respectively, were evaluated. The growth of WT L. monocytogenes EGDe was 
completely inhibited in the presence of either plantaricin 423 or mundticin ST (Fig. 1). In 
vitro expression of the mundticin ST munC by L. monocytogenes (pNZSTldhmunC) resulted 
in a complete loss of sensitivity to mundticin ST, while expression of the plantaricin plaB 
immunity gene by L. monocytogenes EGDe (pNZSTldhplaB) resulted only in a partial loss of 
sensitivity to plantaricin 423 (Fig. 2). Usually, the expression of a bacteriocin immunity 
protein provides the bacteriocin-producing cell resistance to its own bacteriocin (52). While 
exact modes of action of immunity proteins remain largely uncharacterized (52-55), several 
studies have indicated that these proteins disrupt bacteriocin aggregation, pore formation or 
they interact with possible bacteriocin membrane-located receptors (47, 52, 54, 55). In this 
study it was observed that a bacteriocin negative L. plantarum 423 strain, cured of the 
bacteriocin and immunity gene containing pPLA4 plasmid (41), remained immune to 
plantaricin 423 (not shown).  Therefore it is possible that the mechanism(s) involved in 
bacteriocin plantaricin 423 resistance in the WT strain include changes in the cell wall 
structure, such as fatty acid and phospholipid composition. These changes could prevent the 
interaction of the bacteriocin and its membrane located receptor, providing the WT L. 
plantarum 423 strain resistance even in the absence of plaB immunity gene expression (54). 
The absence of these changes in the cell membrane of L. monocytogenes EGDe could explain 
why the partial loss of in vitro sensitivity by L. monocytogenes EGDe (pNZSTldhplaB) to 
plantaricin 423.  
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The current study involves the transient colonization of bacterial strains resulting in the direct 
antagonism between an intestinal pathogen and two probiotic strains. Significantly higher 
bioluminescence signals were detected transcutaneously from mice in the PBS placebo 
control group for 24 h, while there was a significant reduction of detectable signals recorded 
from mice that received WT probiotic strains in groups WT-423 and ST4SA from as early as 
2 h after infection with L. monocytogenes EGDe (Figs 3 and 4). This result served as the first 
line of evidence to support the anti-listerial effect of L. plantarum 423 and E. mundtii 
ST4SA. A reduction in bioluminescence correlates with a reduction of bacterial burden, but it 
is important to verify such a reduction in bioluminescence with viable cell counts. Ex vivo 
imaging of dissected intestines revealed strong bioluminescence emission in the small and 
large intestinal tract of mice in the PBS placebo control group, whereas no bioluminescent 
cells were detected in the intestines of mice in groups WT-423 or WT-ST4SA 4 h after they 
were infected (Fig. 5A). Enumeration of viable L. monocytogenes EGDe from homogenized 
intestines of mice in groups WT-423 and WT-ST4SA confirmed significant differences 
between probiotic treated mice and the PBS placebo control group. It is interesting to note 
that significant differences in viable L. monocytogenes EGDe were recorded in the small 
intestines between groups WT-423 and WT-ST4SA 4 h after infection. This result is 
supported by a previous study that suggested that particular probiotic strains differ greatly in 
their in vivo effectiveness (56). Despite a higher number of L. monocytogenes EGDe cells in 
the small intestinal tract of mice in group WT-ST4SA after 4 h compared to mice in group 
WT-423, no bioluminescent cells were detected in the small intestines of mice in group WT-
ST4SA (Fig. 5A and B). This result is probably due to an initial bacteriostatic effect exerted 
by E. mundtii ST4SA on L. monocytogenes EGDe cells in the small intestine that was 
followed by a large reduction in L. monocytogenes EGDe after 6 h, since only metabolizing 
cells can emit bioluminescence. 
The most obvious explanation of the anti-listerial effect of L. plantarum 423 and E. mundtii 
ST4SA suggests direct antagonism in the GIT between each of the probiotics and the 
pathogen as a result of bacteriocin production. Lactobacillus plantarum 423 bacteriocin 
production in an in vitro gastrointestinal model simulating the GIT of a pre-weaned piglet has 
been demonstrated previously (57). To provide in vivo experimental proof of the role of 
bacteriocin production as a mechanism of action against L. monocytogenes EGDe, stable 
mutants of L. plantarum 423 and E. mundtii ST4SA that do not produce the bacteriocins 
plantaricin 423 and mundticin ST, respectively, were constructed. Both bacteriocin-negative 
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probiotic strains failed to exclude L. monocytogenes from the mouse GIT in comparison with 
the WT strains as observed with whole body bioluminescence imaging (Figs 3 and 4) and by 
the presence of bioluminescent Listeria cells in the small and large intestinal tracts (Fig. 6A). 
This was most evident in the large intestinal tract and was confirmed with CFU counts (Fig. 
6B and C). Bernbom and co-workers (27) have demonstrated previously that pediocin AcH-
producing L. plantarum was responsible for the inhibition of L. monocytogenes compared to 
a less successful inhibition from its non-bacteriocin producing variant in an in vitro GIT 
model. Similarly, Corr and co-workers (58) demonstrated that bacteriocin production by L. 
salivarus UCC118 was responsible for the protective effect of the probiotic strain against L. 
monocytogenes in the liver and spleen of mice. 
Viable cell counts also revealed that both bacteriocin-negative strains significantly excluded 
L. monocytogenes EGDe from the small intestinal tract from 6 h after infection (Fig. 6B). 
However, it was clear that the remaining viable L. monocytogenes EGDe cells were still able 
to emit strong bioluminescence, indicating active colonization as a result of a lack of the in 
vivo bacteriocin-related anti-listerial effect. The rapid drop of viable L. monocytogenes EGDe 
cells in the small intestines of mice in groups B-423 and B-ST4SA could also be due to anti-
infective mechanisms other than bacteriocin production. Previous studies have shown that L. 
plantarum 423 and E. mundtii ST4SA adhere to different sections of the GIT and have 
excellent adhesion properties and displace Clostridium sporogenes and E. faecalis in in vitro 
competitive-exclusion experiments (42, 57, 59).  Probiotic or commensal bacteria also 
produce antimicrobial factors (other than bacteriocins) such as organic acids, ammonia and 
hydrogen peroxide that are inhibitory to invading pathogens (29, 31, 32). In another study, L. 
plantarum 423 and E. mundtii ST4SA alleviated symptoms of Salmonella infection, as 
determined in Wistar rats challenged with S. enterica serovar Typhimurium, which is 
insensitive to both plantaricin 423 and mundticin ST bacteriocins (60). This implies that 
protection against S. enterica serovar Typhimurium was not linked to bacteriocin production 
and is likely to be more complex and might be pathogen-specific. 
In addition to direct bactericidal or bacteriostatic effects on pathogenic microorganisms, it is 
important to note that antimicrobial peptides, including bacteriocins, could affect the 
established host microflora and have important roles as host immunomodulators (61). Several 
probiotic LAB are known to produce and excrete extracellular proteins involved in adhesion 
to intestinal surfaces and modulation of the function of epithelial and immune cells, and thus 
to actively participate in cross-talk between themselves and the host (62, 63). If this were the 
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case in the present study, the role of bacteriocins as a mechanism of probiotic action would 
be evident as less significant relative to the sensitivity of L. monocytogenes EGDe to the 
bacteriocins produced by L. plantarum 423 and E. mundtii ST4SA. Therefore, to provide 
additional confirmation of the in situ bacteriocin production in the GIT as a mechanism of 
action against Listeria infection, the bacteriocin immunity genes of plantaricin 423 and 
mundticin ST4SA were expressed in L. monocytogenes EGDe. Results in this study show that 
whole body bioluminescence readings from mice in groups IL-423 (4-24 h, Fig. 3) and IL-
ST4SA (Fig. 4), challenged with L. monocytogenes EGDe strains expressing the respective 
bacteriocin immunity genes, display similar levels compared to that of the PBS placebo 
control group and the respective bacteriocin-negative groups (B-423 and B-ST4SA). The 
high bioluminescence readings were correlated directly with the bacterial load present, due to 
the heterologous expression of the bacteriocin immunity proteins by L. monocytogenes 
EGDe. Bioluminescent signals recorded from mice in group IL-423 were generally less 
intense than those recorded for IL-ST4SA. This was expected, as plantaricin plaB immunity 
gene expression by L. monocytogenes EGDe only provided significant protection from 
plantaricin 423 at a dilution of 1/32 in an in vitro environment. Further confirmation of the 
role of immunity gene expression by L. monocytogenes EGDe in groups IL-423 and IL-
ST4SA is provided by the presence of actively metabolizing bioluminescent cells in dissected 
intestines (Fig. 7A). Viable cell counts of L. monocytogenes EGDe in the intestines of mice in 
groups IL-423 and IL-ST4SA revealed similar results for those obtained from the respective 
bacteriocin-negative groups (Fig. 7B and C).  These results support the proposal that in situ 
bacteriocin production by the probiotic LAB acts as a direct mechanism of action against 
infectious L. monocytogenes EGDe in the GIT.  
One of the major selection criteria of a good probiotic is its ability to adhere to intestinal 
mucus and epithelial cells (64). Probiotic LAB with excellent adhesion properties are able to 
successfully compete with intestinal pathogens for adhesion sites on epithelial cell surfaces 
and thus prevent pathogens from colonizing (42, 65, 66). However, despite extensive genetic 
reports on the adhesion capabilities of probiotic LAB, the mechanisms of attachment are not 
fully understood. The complex and kinetic nature of the human intestinal environment has 
made it difficult to study these processes. Several in vitro intestinal models have been used to 
study the adhesion of LAB to mucosal and epithelial surfaces using human colon 
adenocarcinoma cells such as the Caco-2 and HT-29 cell lines (5, 67, 68). Lactobacillus spp. 
have been the best studied of which a few strains produce specific adhesion proteins. The best 
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researched examples are the mucus adhesion-associated protein (MapA) and the mucus-
binding proteins (mub) produced by L. reuteri (69). Proteins homologous to the MapA and 
Mub proteins of L. reuteri have been described for several other Lactobacillus spp. (69-71).  
Mub and MapA homologs have been reported for L. plantarum 423, of which MapA 
(referred to as Aap in this study) was shown to be extensively up-regulated under normal 
physiological concentrations of bile and pancreatin simulating GIT conditions (72). In this 
study a L. plantarum 423 mutant lacking the aap adhesion gene was constructed to 
investigate its role in the competitive exclusion of L. monocytogenes EGDe in the GIT. Using 
in vivo and ex vivo bioluminescence imaging, results showed that L. plantarum 423 aap::erm 
(lacking the aap adhesion gene) failed to exclude L. monocytogenes EGDe from the GIT of 
mice in group A-423 compared to WT L. plantarum 423 (WT-423 group) (Figs 3 and 8). The 
presence of high numbers of viable L. monocytogenes EGDe cells in the large intestinal tract 
of mice in group A-423 between 24 and 48 h after infection provided further evidence of the 
role of the L. plantarum Aap adhesion protein as a mechanism of action involved in the 
exclusion of the pathogen from the GIT (Fig. 8C). These results are in agreement with studies 
that suggest that probiotic adhesion is a requirement for the realization of specific probiotic 
effects such as immunomodulation and competitive exclusion of pathogens (65-67, 73).  
To investigate the role of cell surface adhesion proteins produced by E. mundtii ST4SA in the 
competitive exclusion of L. monocytogenes EGDe from the GIT, groups of mice were orally 
administered with stable mutants of E. mundtii ST4SA lacking the Sortase A (srtA) and 
Sortase C (srtC) cell wall protein sorting enzymes for 6 days before Listeria infection. In 
Gram-positive bacteria, sortase enzymes decorate the cell surface with a diverse array of 
proteins by covalently joining them to the cell wall (Sortase A) or by polymerizing proteins 
to construct complex multi-subunit pilin structures (Sortase C) on the cell surface (74). 
Although sortase enzymes are not essential to bacterial viability, they play an important role 
by displaying or ‘sorting’ surface proteins on the cell wall that are essential for bacterial 
adhesion to host intestinal mucosal surfaces, colonization and the acquisition of essential 
nutrients (74-76). Furthermore, the surface proteins displayed by probiotic LAB play a key 
role in their interaction with intestinal epithelial cells and mucus by promoting adhesion (64). 
These specific interactions have been associated with the competitive exclusion of pathogens 
from the GIT by probiotic bacteria (64, 71, 77, 78). Using an E. mundtii ST4SA draft genome 
sequence and all available fully annotated reference E. mundtii full genome sequences, 18 
putative Sortase A-dependent cell wall anchored proteins together with a fully dedicated 
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sortaseA gene were identified. In addition, a three-gene locus encoding structural pilus-
subunit proteins consisting of two putative accessory pilus subunits (EbpAfm and EbpCfm) 
and a major pilus subunit protein (EbpCfm) located adjacent to the E. mundtii pilus-dedicated 
sortaseC gene was also identified. 
In vivo whole body bioluminescence signals for mice in groups A-ST4SA and C-ST4SA 
were only slightly higher than those observed for mice in the WT-ST4SA group and 
significantly lower than those recorded for mice in the PBS placebo control group between 2 
and 5 h after infection (Fig. 4). This result indicates that E. mundtii ST4SA mutants lacking 
the srtA or srtC genes are capable of competitively excluding the intestinal pathogen and thus 
lowering the bacterial burden. On the other hand, actively growing bioluminescent cells in 
dissected intestines of mice in groups A-ST4SA and C-ST4SA compared to no 
bioluminescent cells detected in the WT-ST4SA group were detected (Fig. 8A). The L. 
monocytogenes EGDe CFU counts in the intestinal tracts of mice in group A-ST4SA 
confirmed the presence of high numbers in the small intestinal tract between 4 and 6 h (Fig. 
8B). Previous studies have demonstrated that Sortase A play a role in the in vitro adhesion of 
bacterial cells to human cell lines (89, 80), intestinal colonization (75, 81) and virulence (81, 
82). Lalioui and co-workers (75) showed that the capacity of a Streptococcus agalactiae SrtA 
negative strain to colonize the murine intestine was significantly impaired compared to a S. 
agalactiae SrtA positive strain, in a competition assay. However, the current study 
investigates the role of Sortase A and C in the direct antagonism between a probiotic and an 
enteric pathogen, rather than intraspecies competitive exclusion. 
Listeria monocytogenes EGDe cell counts recorded in the intestines of mice in group C-
ST4SA confirmed that the E. mundtii ST4SA srtC mutant efficiently excluded L. 
monocytogenes from the GIT, except for a significant increase in L. monocytogenes EGDe 
cell numbers after 24 h in the large intestinal tract (Fig. 8B). In a recent study by Tytgat and 
co-workers (83), it was demonstrated that L. rhamnosus GG outcompeted vancomycin-
resistant E. faecium via mucus-binding pili in vitro. The role of sortase C and sortase C-
dependent pilus-encoding genes in bacterial adhesion to epithelial cells, host invasion and 
biofilm formation have been studied extensively in virulent E. faecium and E. faecalis strains 
(84, 85). Sillanpää and co-workers (85) identified four pilus-containing gene clusters in the 
genome of E. faecium TX16 each located with an adjacent sortase C gene that is predicted to 
encode four distinct types of pili. However, only one such gene cluster was identified in the 
genome of E. mundtii ST4SA. This could explain the less significant effect that E. mundtii 
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ST4SA Sortase C-negative strain had on the exclusion of L. monocytogenes from the GIT. If 
it were the case that E. mundtii SrtC-dependent pilus proteins played a major role in the 
competitive exclusion of L. monocytogenes EGDe from the GIT, one would expect much 
higher L. monocytogenes EGDe cell numbers in the intestines of mice in group C-ST4SA.  
Listeria monocytogenes EGDe cells excreted in the faeces of mice were then enumerated in 
all groups and the respective bioluminescent signals emitted quantified as a measure of the 
colonization ability of the intestinal pathogen in the presence of the probiotic strains. 
However, it must be noted that enumerations of bacteria in faeces does not truly reflect the 
number of cells that remain colonized in the GIT (86). In general, there was excellent 
correlation between the number of L. monocytogenes EGDe cells excreted in the faeces of 
mice in all groups and the respective bioluminescence signals emitted at each time point (Figs 
9 and 10). This is also an indication that L. monocytogenes EGDe survived conditions in the 
intestinal tract and is in agreement with previous work (15). Listeria monocytogenes EGDe 
was eliminated more rapidly in the faeces of mice in groups WT-423, B-423, IL-423 than in 
the PBS placebo control group and A-423 during the first 3 h of the trial (Fig. 9). This result 
coincided with highest numbers of L. monocytogenes EGDe observed in the intestinal tract of 
mice in groups PBS and A-423 during the same period. At 3 h after infection, high cell 
numbers of L. monocytogenes EGDe were excreted in the faeces of mice treated with either 
WT E. mundtii ST4SA or recombinant E. mundtii ST4SA (Fig. 10). The excretion of high 
cell numbers of L. monocytogenes EGDe in the faeces of mice during the first 2 h after 
infection in groups WT-ST4SA and C-ST4SA suggests that E. mundtii ST4SA and E. 
mundtii ST4SA srtC::erm initially outcompete L. monocytogenes EGDe for intestinal 
adhesion sites more effectively than the recombinant E. mundtii ST4SA strains in the other 
respective groups (Fig. 10). This also correlates with a significant decrease in L. 
monocytogenes EGDe cell numbers in the intestines of mice in groups WT-ST4SA and C-
ST4SA, suggesting that the majority of cells are excreted from the GIT during the first few h 
after infection with L. monocytogenes EGDe.  
Viable cell counts of mice treated with either WT L. plantarum 423 or recombinant L. 
plantarum 423 confirmed the presence of colonizing cells in the intestines of mice in all 
groups for the duration of the study period (Fig. 11). Highest cell numbers of L. plantarum 
423 strains were observed in the large intestinal tract compared to the small intestinal tract. 
Lactobacillus plantarum 423 are reported to colonize the cecum and colon (large intestine) of 
mice more successfully compared to the small intestinal tract (59). The decline in the 
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numbers of WT or recombinant probiotic strains over the 48 h period suggests that it is a 
transient colonization, or at least when in the presence of a competing pathogen. It is 
interesting to note that, in comparison with L. plantarum 423 CFU counts in the intestines of 
mice in groups B-423, IL-423 and A-423, the cell numbers of WT L. plantarum 423 in group 
WT-423 were always lower despite being the most effective in excluding L. monocytogenes 
EGDe from the GIT (Fig. 11). This supports the theory that single gene deletions (or different 
probiotic strains) and the presence of pathogens during competitive exclusion experiments 
may affect probiotic behaviour in vivo (56). Another important observation was the detection 
of high cell numbers of the respective L. plantarum 423 recombinant strains in the small 
intestines of mice in groups B-423, IL-423 and A-423. The fact that L. monocytogenes EGDe 
failed to be excluded from the large intestines of mice in the same groups but was 
significantly excluded from the small intestinal tracts, implies that the ability to produce 
bacteriocins or to adhere to intestinal cells may not be central to all anti-infective mechanisms 
and is likely to be more complex (30, 34). Similar results were obtained for mice treated with 
WT E. mundtii ST4SA and recombinant E. mundtii ST4SA, except for mice in group A-
ST4SA. After 24 h, the number of viable E. mundtii ST4SA srtA::erm in the intestines of 
mice in group A-ST4SA declined to low levels and it was completely excluded from the GIT 
a further 24 h later. This result supports the proposal that sortase A-dependant cell wall 
anchored proteins of E. mundtii ST4SA are directly involved in bacterial adhesion to 
intestinal epithelial cells (76, 82). The colonization abilities of the probiotic strains in mice 
challenged with L. monocytogenes EGDe were also assessed by determining the number of 
cells excreted in the faeces over the 48 h trial period. The probiotic cells in all groups 
survived passage through the intestinal tract, with high viable cell numbers recorded in the 
faeces (Fig. 13). This is in agreement with previous in vitro and in vivo studies that 
demonstrated the survival of L. plantarum 423 and E. mundtii ST4SA in the GIT (15, 59, 87). 
Based on the number of viable cells dosed on a daily basis (4 x 10
9
 CFU), the steady 
excretion of high cell numbers (approximately 10
6
 CFU) of all probiotic LAB strains in the 
faeces and the presence of high cell numbers in the GIT, it is safe to conclude that the 
probiotics colonized the GIT readily.   
In conclusion, the current study performed a comprehensive evaluation on the impact of L. 
plantarum 423 and E. mundtii ST4SA on the exclusion of L. monocytogenes EGDe from the 
GIT of mice. Molecular evidence to underpin the protective and anti-listerial effect of the 
probiotic strains against orally administered L. monocytogenes EGDe, as monitored by 
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bioluminescence imaging is provided. Bacteriocin production by L. plantarum 423 and E. 
mundtii ST4SA represents a direct mechanism of probiotic action in the competitive 
exclusion of L. monocytogenes EGDe from the GIT. A significant increase in viable L. 
monocytogenes EGDe cells in the intestines of mice pre-treated with non-bacteriocin variants 
of L. plantarum 423 and E. mundtii ST4SA confirm this. Additional confirmation of in situ 
bacteriocin production as a mechanism of action was provided by using variant strains of L. 
monocytogenes EGDe expressing the immunity genes of plantaricin 423 and mundticin ST, 
respectively, which provide resistance to the respective bacteriocins. The relevance of 
probiotic adhesion proteins as in vivo probiotic mechanisms of action was demonstrated. 
Wild-type L. plantarum 423 excluded L. monocytogenes EGDe from the GIT more 
effectively than an aap adhesion gene knockout L. plantarum 423 variant strain, clearly 
indicating the direct effect of the adhesion protein. Sortase A- and sortase C-dependent 
adhesion genes of E. mundtii ST4SA had a slightly less effective role in the competitive 
exclusion of L. monocytogenes EGDe from the GIT. This is the first in vivo study using 
targeted gene knockout mutants to investigate the direct roles of bacteriocin and adhesion 
proteins in competitive exclusion experiments in the GIT. Gaining further insights into key 
antimicrobial and protective mechanisms of probiotics in vivo will not only help to improve 
the credibility of the probiotic concept but also contribute to the identification and selection 
of the most suitable ones for prophylactic or therapeutic treatments against specific gastro-
intestinal diseases (64). 
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General Discussion 
Probiotics have an important role in maintaining a healthy and stable intestinal microbiota, 
primarily by preventing infection (1). As a result, there is currently a growing appreciation 
for the beneficial properties of probiotic microorganisms (2, 3). The gastrointestinal tract 
(GIT) is believed to be the major region where orally administered probiotic lactic acid 
bacteria (LAB) exert their health modulating effects against enteric pathogens to prevent the 
occurrence of disease (1). Therefore, understanding the specific activities amongst 
administered probiotic bacteria, the host gastrointestinal system and enteric pathogens is 
crucial. This will permit the selection of the most suitable probiotic strains for the prevention 
and/or treatment of specific enteric diseases. Unfortunately, two aspects still poorly 
understood are the fate of probiotic bacteria in the GIT after oral administration and the 
underlying relationship between their beneficial effects on health and molecular mechanisms 
of action. Gaining insight into these interactions will significantly improve the application of 
probiotics to support and enhance human health. The present study aimed to contribute to this 
area of research and reports on the use of bioluminescence imaging (BLI) and novel 
molecular techniques to provide insight into the gastrointestinal persistence of the probiotic 
strains Lactobacillus plantarum 423 and Enterococcus mundtii ST4SA, and the mechanisms 
of their anti-listerial activity. 
Persistence of Lactobacillus plantarum 423 and Enterococcus mundtii ST4SA in the 
gastrointestinal tract, as reported with bioluminescence imaging in mice 
For probiotics to confer their beneficial effects on the host, they must be able to survive 
through gastrointestinal stresses and persist at high levels in the intestinal tract (3, 4). The 
analysis of faecal samples is often used to study the survival and persistence of orally 
administered probiotic bacteria in the GIT (5). The best probiotic strains generally persist in 
faeces in high numbers and for the longest periods. However, a major limitation of using only 
faecal recuperation to analyse in vivo probiotic persistence is that it does not accurately 
reflect the amount of cells that remain colonized in the GIT nor does it reveal the bacterial 
sites of colonization. This study reports on the application of the firefly luciferase gene (ffluc) 
from Photinus pyralis to monitor the colonization and persistence of L. plantarum 423 and E. 
mundtii ST4SA in the murine GIT. In vivo BLI is a non-invasive imaging technique that 
allows infection rates or colonization dynamics of viable microorganisms to be studied in 
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real-time (6). As opposed to conventional approaches, one of the key advantages of using the 
BLI technique is that it allows for drastic reductions in the number of animals to be sacrificed 
to establish the precise location of bacteria in mouse models (7). 
The stable expression of reporter genes during in vivo imaging is critical for the detection of 
luminescent light through animal tissues (6). The expression of the ffluc luciferase gene in L. 
plantarum 423 and E. mundtii ST4SA was successfully optimized using a high-copy number 
plasmid and strong constitutive promoters. The presence of plasmids carrying reporter genes 
in the recombinant LAB strains should not alter the physiology of the host or its ability to 
survive (6). The ffluc expression plasmids were stable in recombinant L. plantarum 423 Fluc 
and E. mundtii ST4SA Fluc and bioluminescence did not affect the growth of the respective 
host strains compared to the wild-type (WT) derivatives. These results indicate that both 
recombinant LAB strains can produce bioluminescence while stably maintaining the firefly 
luciferase-expressing plasmids. The bioluminescent plasmids constructed may thus be 
functional in other species of LAB. 
Transcutaneous LAB bioluminescence could be detected in live anesthetized mice after a 
single oral administration. In a previous study (8) with strains expressing the mCherry 
fluorescent protein, it was shown that both probiotic strains survived in vivo intestinal transit. 
The current study reconfirmed the survival of the strains using bioluminescence imaging. 
However, with the mCherry construct, no fluorescence was detected when live anesthetized 
mice were scanned. Fluorescence was only recorded when sections of the GIT were scanned 
after animals were sacrificed. Nonetheless, these results clearly demonstrated that both 
probiotic strains survived transit through the stomach, were resistant to high bile 
concentrations in the small intestine and were metabolically active in the large intestinal tract. 
Different transit times were recorded for L. plantarum 423 and E. mundtii ST4SA through the 
GIT of mice after a single oral administration. Lactobacillus plantarum 423 had a slower 
transit time, and was detected in the lower part of the jejunum and in the ileum 45 min post 
gavage, while E. mundtii ST4SA migrated to the ileum, cecum and colon during the same 
period. After 3 h strong bioluminescent signals of both strains were detected in the cecum and 
colon. The rapid transit time through the stomach and small intestine may be indicative of the 
harsh conditions the LAB strains are exposed to in these sections of the GIT and is in 
agreement with previous studies (9, 10). After 24 h, bioluminescent signals could be detected 
from the GIT of mice administered with E. mundtii ST4SA, while no bioluminescent signals 
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could be detected from mice administered with L. plantarum 423. This indicated that L. 
plantarum 423 was eliminated from the GIT of mice more rapidly than E. mundtii ST4SA. It 
also suggests that E. mundtii ST4SA colonizes the GIT of mice at higher numbers compared 
to L. plantarum 423. These findings are in agreement with previous studies (10, 11) reporting 
on the gastrointestinal transit time of Lactobacillus reuteri, L. plantarum and Lactococcus 
lactis. The authors showed that the intestinal transit times differed between two strains of L. 
reuteri, and that a Lc. lactis strain had shorter survival times in the GIT compared to a L. 
plantarum strain. 
In vivo and ex vivo bioluminescence imaging confirmed that both probiotic strains persisted 
in the GIT of mice for several days after five consecutive days of oral administration. The 
persistence of L. plantarum 423 and E. mundtii ST4SA compared well to several other 
commercial probiotic strains, including Lactobacillus rhamnosus GG, Bifidobacterium lactis 
LAFTI B94, L. plantarum 299v and Lactobacillus gasseri SBT2055 (12-15). At day 9 (4 
days after the last bacterial dosage), bioluminescent cells of both strains were predominantly 
localized in the cecum and colon. However, bioluminescent cells of E. mundtii ST4SA were 
also detected in the ileum of mice and persisted in the faeces of mice in higher numbers and 
for a longer period compared to L. plantarum 423, as recorded with bioluminescence imaging 
and CFU counts. This could explain why E. mundtii ST4SA was more effective in reducing 
Listeria monocytogenes EGDe cell numbers compared to L. plantarum 423 in an in vivo 
competitive exclusion experiment (16). These results suggested that the persistence of E. 
mundtii ST4SA in the murine GIT is superior to that of L. plantarum 423. Since the same 
dosage and administration methods were used for both strains, the difference in the intestinal 
persistence between the two probiotic strains might be due to differences in the physiological 
and genotypic properties of the strains. This merits further investigation. The combination of 
bioluminescence and mutant analysis may provide a powerful tool to elucidate the differences 
in intestinal transit and persistence between the two probiotic strains. 
Efficient isolation of double-crossover homologously recombined mutants in lactic acid 
bacteria 
The isolation of stable LAB recombinant DNA integration or deletion mutants is often 
desirable when studying probiotic molecular modes of action (3). The functional effects of 
genes expressed by LAB in vitro or in vivo can only be truly assessed by the creation of 
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knockout (KO) derivatives of strains expressing those genes. However, broadly applicable 
and efficient methods for the isolation of rare and reliable genetic mutants at any genetic 
locus are still underdeveloped. The development of techniques that will allow for the easy 
and efficient selection of chromosomally or plasmid located gene excisions will undoubtedly 
contribute to this area of probiotic research. To date, most of the techniques used for the 
isolation of homologous recombination mutants in LAB are limited by a lack of broad 
applicability amongst species, their inability to target specific gene loci, availability of 
suitable antibiotic resistance markers and the isolation of reversible single-crossover mutants 
(17-20). The aim of this study was to develop a method to easily and efficiently isolate rare 
double-crossover mutants in L. plantarum 423 and E. mundtii ST4SA at any genomic locus. 
The method described here is based on the use of the Lc. lactis nisin A inducible promoter 
(PnisA) and the E. coli mazF toxin gene, an mRNA interferase, as a counter-selection marker 
(21, 22). The PnisA promoter forms part of the well-characterized nisin-controlled expression 
(NICE) system that has been successfully adapted for gene expression or protein secretion in 
several LAB species (21, 23). Tightly controlled gene expression is a major advantage of the 
NICE system over other inducible gene expression systems and it has been used to produce 
large amounts of enzymes for food, medical or technical applications (24, 25). This 
advantage rules out any potential MazF toxin induced premature cell growth arrest as a result 
of promoter leakiness. The appropriate growth conditions required for the mazF counter-
selection gene to promote cell death upon induction of the PnisA promoter with nisin was 
optimized successfully. Crucially, the developed method ensures that transformants are 
eliminated in the presence of nisin-induced MazF toxin when cells have only undergone a 
single event of homologous recombination (or no homologous crossover at all) and retain a 
copy of the plasmid-located counter-selection marker in the chromosome or on the episomal 
plasmid. This ensures the isolation of stable irreversible double-crossover LAB mutants. 
The method was used to construct deletions of specific genes, to introduce a gene of interest, 
to construct an unmarked mutation and to isolate gene deletion mutants using small regions 
of homology. Large sequences can be inserted or deleted in a series of steps, as demonstrated 
by the insertion of the ffluc bioluminescence gene and erythromycin (Em) resistance marker 
into the bacteriocin operons or adhesion genes of L. plantarum 423 and E. mundtii ST4SA. 
All integration plasmids were designed to delete the majority of the targeted ORF, while 
ensuring that none of the adjacent genes would be affected. The successful construction of 
bacteriocin-negative L. plantarum 423 and E. mundtii ST4SA strains were confirmed by 
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overlaying MRS agar plates seeded with L. monocytogenes EGDe and by recording 
bioluminescence. Compared to WT derivatives, supernatants isolated from the bacteriocin-
negative mutant strains lacked the ability to form clear inhibition zones. Bioluminescence 
imaging revealed that the integrated ffluc gene was actively expressed in each of the 
bacteriocin KO mutants.  
Repeated manipulations of any bacterial chromosome can only be achieved by the generation 
of markerless integration mutants due to a limited availability of suitable antibiotic resistance 
markers. Lactic acid bacterial strains can be genetically engineered for biotechnological 
production processes using an easy to implement marker recycling system. The 
Saccharomyces cerevisiae FLP-FRT recombination system was applied successfully to 
recycle the Em antibiotic resistance marker in a L. plantarum 423 aap mucus adhesion gene 
mutant (26, 27). The yeast FLP-FRT system has been successfully applied in several 
pathogenic and non-pathogenic Gram-negative and Gram-positive bacteria (28-30). The 
resulting aap KO unmarked strain, free of antibiotic selection markers may be used for 
further genetic manipulations of the L. plantarum 423 chromosome using the newly 
developed method.  
To further demonstrate the strength of this novel system, gene deletion mutants of the E. 
mundtii ST4SA sortaseA (srtA) and sortaseC (srtC) genes using homologous arms containing 
<60 bp regions (5’ and 3’) homologous to the target genes were generated. Previous studies 
reported that the rate of recovery of homologous recombinants significantly decreases when 
the size of homologous regions is less than 200 bp (31-33). Although the developed strategy 
may be adapted for use in other LAB spp. due to the broad applicability of the nisin 
expression system, further studies are needed to confirm this. Nonetheless, the easy to 
implement and highly efficient gene integration/deletion method described here provides the 
unique opportunity to study the role of specific probiotic LAB genes in complex 
environments using reverse genetics analysis. 
Characterization of the anti-listerial mechanisms of L. plantarum 423 and E. mundtii 
ST4SA in the GIT 
Intestinal infectious diseases, particularly those caused by enteric pathogenic bacteria, are a 
major cause of morbidity and mortality at all ages. Listeriosis has a relatively high mortality 
rate of 20-30% compared to most other food-borne pathogens (34, 35). In the United States, a 
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multistate outbreak of food-borne listeriosis occurred in 2011, with 147 confirmed cases, 
including 33 deaths (36). More recently, the largest ever L. monocytogenes outbreak occurred 
in South Africa. Between January 2017 and April 2018, 1011 laboratory-confirmed listeriosis 
cases were reported, resulting in 193 deaths in just over a year (37).  
In most cases, prevention of infection caused by foodborne enteric pathogens relies heavily 
on good hygiene and sanitation during food preparation (38). Although listeriosis can be 
treated with several antibiotics, this is not without limitations. First, depending on the form or 
location of the disease, the cure rate of debilitated patients infected with L. monocytogenes 
can be low (35). Second, the emergence of antibiotic-resistant bacteria is one of the major 
problems faced by the medical industry today. Bacteria have the ability to acquire resistance 
against antibiotics via random mutation or the dissemination of specific resistance 
mechanisms via the exchange of genetic material (e.g. horizontal gene transfer) (39). 
Therefore, despite having a large arsenal of antibiotics available, it is inevitable that bacteria 
will undergo mutations or adapt. The inappropriate use of antibiotics and over-prescription 
further exacerbate this crisis (40, 41). The search for, and development of, alternative 
prophylactic and therapeutic strategies is therefore of the utmost importance.  
Probiotic LAB have considerable potential as alternatives to antibiotics for prophylactic or 
therapeutic applications in various gastrointestinal disorders (42). Numerous studies have 
demonstrated the ability of some LAB strains to control the growth of L. monocytogenes in 
vitro and in vivo (16, 43-48). However, while many reports on probiotic health claims are 
substantiated by experimental evidence, few address the causal relationship between their 
health benefiting effects and the underlying mechanisms of probiotic action (3). Molecular 
elucidation of the mechanisms of probiotic action in vivo is crucial to identify and select the 
most suitable probiotics for the prevention and/or treatment of particular diseases (49, 50). In 
this study, molecular evidence to underpin the protective and anti-listerial effect of L. 
plantarum 423 and E. mundtii ST4SA against orally administered L. monocytogenes EGDe in 
the GIT is provided. A mouse model was used. The role of bacteriocins and adhesion proteins 
as in vivo probiotic mechanisms of action were investigated. 
Lactobacillus plantarum 423 and E. mundtii ST4SA produce peptide antimicrobial 
bacteriocins known as plantaricin 423 and mundticin ST, respectively, and are active against 
numerous intestinal Gram-positive pathogens, including L. monocytogenes EGDe (51-53). 
Bacteriocins are small, heat stable peptides with potent antimicrobial activity and have 
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received considerable attention as bio-preservatives and as potential alternatives to antibiotics 
(54). Bacteriocin genes may be located on the chromosome or on plasmids and usually occur 
in operons encoding a structural protein, a bacteriocin immunity protein and genes for 
translocation (55). In vitro results in this study demonstrated that the growth of WT L. 
monocytogenes EGDe was completely inhibited in the presence of either plantaricin 423 or 
mundticin ST. These results are consistent with previous studies that have shown that both 
plantaricin 423 and mundticin ST inhibit the growth of Listeria spp. (16, 52, 56). In vitro 
expression of the mundticin ST munC bacteriocin immunity gene in L. monocytogenes EGDe 
resulted in a complete loss of sensitivity to mundticin ST. However, in vitro expression of the 
plantaricin 423 plaB in L. monocytogenes EGDe resulted only in a partial loss of sensitivity 
to plantaricin 423. It is possible that the mechanism(s) involved in bacteriocin plantaricin 423 
resistance in the WT strain include changes in the cell wall structure, such as fatty acid and 
phospholipid composition, which could interfere with bacteriocin binding to membrane-
located receptors. The absence of these changes in the cell membrane of L. monocytogenes 
EGDe could explain the only partial loss of in vitro sensitivity by plaB-expressing L. 
monocytogenes EGDe to plantaricin 423. This merits further investigation. Nonetheless, the 
in vitro activity of plantaricin 423 and mundticin ST against L. monocytogenes EGDe 
suggests a possible mechanism of probiotic action in vivo. 
Significantly reduced transcutaneous bioluminescence signals from L. monocytogenes EGDe 
were detected from mice that were orally administered with either L. plantarum 423 or E. 
mundtii ST4SA for six consecutive days compared to mice that received the PBS placebo 
control prior to infection. This result served as the first line of evidence to support the 
gastrointestinal anti-listerial effect of L. plantarum 423 and E. mundtii ST4SA. Ex vivo 
imaging of dissected intestines and enumeration of viable L. monocytogenes EGDe from 
homogenized intestines confirmed the anti-listerial effect of the probiotics. No 
bioluminescent L. monocytogenes EGDe cells were detected in the intestines of mice 
administered with either L. plantarum 423 or E. mundtii ST4SA as early as 4 h after infection 
compared to the PBS placebo control group. These results correlated with a previous study 
that demonstrated the ability of L. plantarum 423 and E. mundtii ST4SA to successfully 
exclude L. monocytogenes from the GIT when administered to mice either individually or in 
combination (16).  
Cell-free bacteriocin-containing culture supernatants of L. plantarum 423 and E. mundtii 
ST4SA have been shown to inhibit the invasion of Caco-2 cells by L. monocytogenes Scott A 
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(57). To provide experimental proof of the role of bacteriocin production as an in vivo 
mechanism of action against L. monocytogenes EGDe, stable mutants of L. plantarum 423 
and E. mundtii ST4SA that do not produce the bacteriocins plantaricin 423 and mundticin ST, 
respectively, were constructed. Lactobacillus plantarum 423 and E. mundtii ST4SA 
bacteriocin production in in vitro GIT models simulating human gastrointestinal conditions 
have been demonstrated previously (57, 58). Both bacteriocin-negative mutants of L. 
plantarum 423 and E. mundtii ST4SA failed to exclude L. monocytogenes EGDe from the 
GIT, in comparison with the WT strains as observed with whole body bioluminescence 
imaging and by the presence of bioluminescent Listeria cells in the small and large intestinal 
tracts. These results support the proposal that bacteriocin production is an anti-infective 
mediator against L. monocytogenes in the GIT. Previous studies (45, 46) have shown that 
other bacteriocin-producing LAB strains inhibit L. monocytogenes in vitro and in vivo 
compared to non-bacteriocin producing strains.  
To provide additional confirmation of the in situ bacteriocin production in the GIT as a 
mechanism of action against L. monocytogenes, the bacteriocin immunity genes of plantaricin 
423 and mundticin ST4SA were expressed in L. monocytogenes EGDe. Lactobacillus 
plantarum 423 and E. mundtii ST4SA failed to reduce L. monocytogenes EGDe 
bioluminescence or viable bacterial cell numbers in the GIT when mice were administered 
with L. monocytogenes EGDe strains expressing the bacteriocin immunity proteins. Mice 
challenged with bacteriocin-immune L. monocytogenes EGDe strains, displayed similar 
bioluminescence levels compared to that of the PBS placebo control group and the respective 
bacteriocin-negative groups. These results confirm the proposal that in situ bacteriocin 
production by the probiotic LAB acts as a direct mechanism of action against infectious L. 
monocytogenes EGDe in the GIT. Results in this study indicates that in vivo bacteriocin 
production as a probiotic mechanism of action is specific for L. monocytogenes or other 
bacteriocin-sensitive pathogens since the alleviation of infection by L. plantarum 423 and E. 
mundtii ST4SA in rats challenged with the naturally bacteriocin-resistant Salmonella enterica 
serovar Typhimurium foodborne pathogen is clearly not linked to bacteriocin production 
(59).  
Probiotic LAB expressing adhesion genes are able to successfully compete with intestinal 
pathogens for adhesion sites on epithelial cell surfaces, which help to prevent pathogens from 
colonizing (53, 60, 61). The surface proteins displayed by probiotic LAB play a key role in 
their interaction with intestinal epithelial cells and mucus by promoting adhesion, 
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colonization and the acquisition of essential nutrients (50, 62). These specific interactions 
have also been associated with probiotic competitive exclusion of pathogens (50, 64-66). The 
role of several surface bound proteins of L. plantarum 423 in the adhesion of the strain to 
Caco-2 cells and in the competitive exclusion of pathogens in vitro was demonstrated 
previously (53). Chemical removal of selected surface-bound proteins of L. plantarum 423 
reduced the adhesion of the strain to Caco-2 cells and altered the strain’s competitive ability 
in vitro (53). To assess the involvement of adhesion proteins in the probiotics’ 
gastrointestinal anti-listerial effect, groups of mice were administered (for 6 consecutive 
days) with either a L. plantarum 423 mutant lacking the aap adhesion associated gene, or E. 
mundtii ST4SA lacking the srtA or srtC genes associated with the anchoring of cell surface 
proteins to the cell surface, before challenge with L. monocytogenes EGDe. 
Using in vivo and ex vivo bioluminescence imaging, it was demonstrated that L. plantarum 
423 aap::erm (lacking the aap adhesion gene) failed to exclude L. monocytogenes EGDe 
from the GIT of mice compared to WT L. plantarum 423. These results were confirmed by 
the presence of high numbers of viable L. monocytogenes EGDe cells in the large intestinal 
tract of mice administered with L. plantarum 423 aap::erm between 24 and 48 h after 
infection. In a previous study, expression of the L. plantarum 423 Aap protein was shown to 
be extensively up-regulated under normal physiological concentrations of bile and pancreatin, 
simulating GIT conditions (67). Furthermore, the role of several Lactobacillus spp. cell wall 
proteins in adhesion to enterocytes in vitro and in in vivo intestinal persistence is well 
documented (68-71). The results presented here indicate that the L. plantarum Aap adhesion 
protein is actively involved in the exclusion of the L. monocytogenes EGDe from the GIT. 
In Gram-positive bacteria, sortase enzymes covalently join cell surface proteins to the cell 
wall (Sortase A) or polymerize proteins to construct complex multi-subunit pilin structures 
(Sortase C) on the cell surface (72). In silico analysis of an E. mundtii ST4SA draft genome 
sequence and all available fully annotated reference E. mundtii full genome sequences, 
revealed 18 putative Sortase A-dependent cell wall anchored proteins, two putative accessory 
pilus subunits (EbpAfm and EbpCfm) and a major pilus subunit protein (EbpCfm). In vivo 
whole body bioluminescence signals for mice administered with stable mutants of E. mundtii 
ST4SA lacking the srtA (group A-ST4SA) and srtC (C-ST4SA) cell wall protein sorting 
enzymes were only slightly higher than those observed for mice administered with WT E. 
mundtii ST4SA and significantly lower than those recorded for mice in the PBS placebo 
control group between 2 and 5 h after infection. However, actively growing bioluminescent 
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cells in dissected intestines of mice in groups A-ST4SA and C-ST4SA were detected 
compared to no bioluminescent cells detected in the WT-ST4SA group. Taken together, these 
results indicate that the Sortase A- and Sortase C-dependent adhesion genes of E. mundtii 
ST4SA have a slightly less effective role in the competitive exclusion of L. monocytogenes 
EGDe from the GIT compared to the WT strain. It has been reported previously, that Sortase 
A plays a role in the in vitro adhesion of bacterial cells to human cell lines, intestinal 
colonization and virulence (73-75). Recently, it was demonstrated that L. rhamnosus GG 
outcompeted vancomycin-resistant E. faecium via mucus-binding pili in vitro (76). The role 
of sortase C and sortase C-dependent pilus-encoding genes in bacterial adhesion to epithelial 
cells, host invasion and biofilm formation have been studied extensively in virulent E. 
faecium and E. faecalis strains (77, 78). 
Concluding remarks and future perspectives 
Understanding the full potential of probiotics for therapeutic or prophylactic applications 
against gastrointestinal diseases requires thorough investigations of probiotic-host and 
probiotic-pathogen interactions. Enhanced understanding of these interactions will enable the 
identification of true probiotics to target specific enteric diseases. The BLI imaging technique 
and a novel molecular recombination system were successfully applied to gain crucial 
insights into the persistence of L. plantarum 423 and E. mundtii ST4SA in the GIT and the 
molecular mechanisms of action against L. monocytogenes EGDe. 
The application of the BLI technique allowed demonstration of the precise location of the 
bacterial strains and their persistence within the murine GIT after single or multiple doses. To 
exploit all the beneficial effects of these two organisms to improve human health, 
understanding the fate of the individual strains in the GIT is an important step. Future 
recommendations will encompass the expression of different reporter genes in each probiotic 
strain to assess possible in vivo interactions between the two strains that may potentially 
affect their individual colonization dynamics in the GIT. 
A novel selection/counter-selection system that facilitates the rapid and efficient isolation of 
double-crossover integration/deletion mutants of L. plantarum 423 and E. mundtii ST4SA 
was developed. The system was useful in the construction of L. plantarum 423 and E. mundtii 
ST4SA bacteriocin and adhesion gene mutants. The newly described method expands the 
LAB molecular research genetic toolkit and has significant potential to allow genetic 
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modification of most, if not all LAB species. Besides mutant analysis, the method may be 
used to expand the repertoire of beneficial probiotic strains by genetically engineering 
designer probiotics for the treatment or prevention of particular gastrointestinal diseases. The 
genetic modification of not only other LAB species but also other Gram-positive bacteria 
using the described method is underway. The system also has significant potential for 
application in Gram-negative bacteria in future research. 
Finally, this study showed that the probiotics strains L. plantarum 423 and E. mundtii ST4SA 
can competitively exclude L. monocytogenes EGDe from the GIT. Additionally, valuable 
information is gained on the in vivo molecular mechanisms of the probiotic strains 
responsible for the protective and antimicrobial effect against L. monocytogenes EGDe. The 
characterization of other potential mechanisms of probiotic action against gastrointestinal 
pathogens such as the inactivation of novel adhesion genes should be considered for future 
research. Although the objectives of this study have been achieved, greater emphasis is 
required in this area of probiotic research. Unravelling the intricacies of probiotic-host and 
probiotic-pathogen interactions will not only improve the in vitro selection of the best 
probiotics based on key properties such as bacteriocin production and adhesion genes but will 
also increase the likelihood of in vivo probiotic efficacy. Demonstrating key antimicrobial 
and protective probiotic mechanisms in vivo will allow for industry and consumers to choose 
scientifically validated probiotics for the prevention or treatment of various health problems.  
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